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Eric Greve, B.Sc. 
 




1. Dual amine/pi Lewis acid catalyst systems have been reported for intramolecular 
direct additions of aldehydes/ketones to unactivated alkynes and occasionally alkenes, 
but related intermolecular reactions are rare. We reasoned that bulky metal ligands and 
bulky amine catalysts could minimize catalyst poisoning and could facilitate certain 
examples of direct intermolecular additions of unactivated aldehydes/ketones to 
alkenes/alkynes. Density Functional Theory (DFT) ground state calculations on putative 
catalytic intermediates for alkyne versus organocatalyst complexation to the p-acid, and 
also the key carbon-carbon bond formation were used to prioritize ligand/organocatalyst 
combinations. Our calculations suggested that PyBOX-Pt(II) catalysts for alkene/alkyne 
activation could be combined with certain organocatalysts for aldehyde activation. With 
such combinations, alkene/alkyne coordination to the p-acid were calculated to be more 
exergonic than catalyst poisoning pathways. Consistent with the calculations, preformed 
enamines generated from the MacMillan imidazolidinone did not displace ethylene from a 
biscationic (t-Bu)PyBOX-Pt2+ complex. This novel catalytic system facilitated an 
intramolecular C-C bond formation with a formyl alkyne substrate, and modified conditions 
have recently extended this to an analogous intermolecular reaction. Investigations into 
alternative metal, ligand, organocatalyst, and substrate combinations are ongoing. 
 
2. The enzyme protein disulfide isomerase (PDI) is essential for the correct folding 
of proteins and the activation of certain cell surface receptors, and is a promising target 
for the treatment of cancer and thrombotic conditions. A previous high-throughput screen 
identified the commercial compound STK076545 as a promising PDI inhibitor. To confirm 
its activity and support further biological studies, a resynthesis was pursued of the reported 
b-keto-amide with an N-alkylated pyridone at the a-position. Numerous conventional 
approaches were complicated by undesired fragmentations or rearrangements. However, 
a successful 5-step synthetic route was achieved using an aldol reaction with an a-
pyridone allyl ester as a key step. An X-ray crystal structure of the final compound 
confirmed that the reported structure of STK076545 was achieved, however its lack of PDI 
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1.1 Introduction to Alpha Alkylations and Alkenylations of Carbonyl Compounds 
 
 
The alpha functionalization of carbonyl compounds, a fundamental organic 
transformation, is important for the synthesis complex molecule synthesis in 
pharmaceuticals and natural products.1-2 The resulting products of these reactions are 
saturated alkylated carbonyl compounds or either a,b or b,g unsaturated carbonyl 
compounds (Figure 1.1.1). 
 
 





The a-alkylated moieties discussed above are found in many natural products. 
One example of an a-alkylated product is (S,S,S)-serricornin, a female-produced sex 
pheromone generated by the cigarette beetle Lasioderma serricorne (Figure 1.1.2A).3 
This beetle is a serious pest of cured tobacco leaves. Another example is Nicolaou et al. 













































M = Li, Na





of natural products inhibits squalene synthase, the enzyme responsible for the 
biosynthesis of cholesterol. Inhibition of this enzyme has implications in the treatment of 
coronary heart disease. Both syntheses formed hydrazone intermediates from an ketone 
or aldehyde and performed a-alkylation by treatment of hydrazone intermediates with LDA 
and alkyl iodide reactants. In the synthesis of the side chain of zaragonic acid, removal of 
the hydrazine auxiliary and subsequent Wittig olefination on the resulting aldehyde yielded 
the a,b-unsaturated ester. 
 
 




Natural products and biologically active compounds containing b,g unsaturated 
moieties have also been reported (Figure 1.1.3). One example is euphosalicin, which has 
been shown to be an inhibitor of P-glycoprotein, a transporter responsible for the efflux of 
drug-like molecules from cells. Multiple types of cancer lines overexpress this transporter, 
leading to multidrug resistance and subsequent failure of chemotherapy.5 Another 
example is Trictostatin A, which is a known inhibitor of histone deacetylase and found to 
be active in studies of cancer, lupus, malaria, and several other disease.6-7 Macquarimicin 
A was isolated from Micromonospora chalcea by researchers at Abbott in 1995.8 Later, it 
was found to be a selective inhibitor of membrane-bound neutral phingomyelinase that 
































































 Conventionally in industry, carbonyl alkylation or alkenylation involves generation 
of metal enolates followed by the addition of an alkyl halide (Figure 1.1.4A). In these 
cases, both the carbonyl nucleophile and alkylating agent electrophile are preactivated. 
While this method can be effective and is frequently utilized, this approach bears several 
drawbacks. First, stoichiometric strong metal bases, such as lithium diisopropylamine, are 
required to preform the metal enolate. In order to avoid self-condensation, the enolate 
formation may also need to take place under cryogenic conditions. Secondly, 
unsymmetrical ketones pose challenges in controlling regioselectivity and restraining 
overalkylation to di- or trisubstituted products. The alkyl halides reagents are significantly 
more expensive than their corresponding olefins, which are frequently used in the 
preparation of terminal alkyl halides.10-11 Finally, activated enolate nucleophiles and alkyl 
halide electrophiles form stoichiometric metal halides and conjugate acids of the bases as 
byproducts. 
Complementary strategies to the alkylation via an enolate are instead to either use 
an aza-enolate or silyl enol ether. An aza-enolate is formed when an imine is treated with 
LDA, or another strong base equivalent, to generate a nitrogen equivalent of an enolate 
(Figure 1.1.4B).12 Silyl enol ethers can be prepared from carbonyl compounds by silylation 
of the corresponding enolate anions (Figure 1.1.4C).13 These can be particularly useful 



























substituted silyl enol ether under conditions of kinetic control (i.e. LDA, low temperature), 
and the more-substituted silyl enol ether by equilibration using a weaker base such as 
triethylamine at elevated temperature. Alkylation with an electrophile, such as an alkyl 
halide, affords the corresponding alkylated carbonyl. One advantage with silyl enol ethers 
is that they can can alkylated with tertiary alkyl halides, using a strong Lewis acid to 
generate a tertiary carbocation electrophile. 
 
 




An alternative a-alkylation strategy is the Stork enamine alkylation (Figure 
1.1.5).14-15 An aldehyde or ketone is condensed with a secondary amine to generate a 
nucleophilic enamine intermediate, which is alkylated upon treatment with an alkyl halide 
or Michael acceptor. The Stork enamine reaction affords monoalkylation with high 
regioselectivity at the less hindered a carbon under less basic conditions. After hydrolysis 
with acid, the desired alkylated aldehyde or ketone is generated; however, a stoichiometric 
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 A variety of methods exist for a-alkenylation alpha of carbonyl compounds; 
however, many of these methods also require pre-activation of one or more coupling 
partners (Figure 1.1.1). Methods (A) also uses a stoichiometric amount of base to 
generate a metal enolate, followed by reaction with a pre-activated alkene using a 
transition metal catalyst (i.e. Pd or Ni). Method (B), as with method (A), requires pre-
activation of both reactants and utilizes a metal catalyst. Finally, method (C) only requires 
pre-activation of the alkene coupling partner as the carbonyl is activated catalytically with 
an organocatalyst to generate the enamine nucleophile. All of these outlined methods 
have the common disadvantage that one or both reaction partners must be pre-activated. 
Accessing these activated substrates can be both inefficient and uneconomical. In the 
synthesis of a complex intermediate or natural product, activation of one or both substrates 
would also add an additional unnecessary complication to the synthesis. 
Given the inherent value of compounds containing an alkylated or unsaturated 
carbonyl moiety, there have been great efforts in the development of efficient a-
alkylation/alkenylation reactions to access these structures. Currently, there are few/no 
examples of intermolecular reactions direct addition reactions that don’t use pre-activated 
coupling partners or sensitive catalysts. The development of catalytic methods for the 
direct additions of unactivated carbonyl-based nucleophiles to unactivated alkenes and 
alkynes would permit efficient and economical access to valuable intermediates and final 

























1.2 Metal Catalyzed Cross Coupling Reactions 
 
 
 Transition metal catalysts (Pd and Ni) are commonly used to generate a,b or b,g-
unsaturated compounds via cross coupling reactions between enolates or enolate 
derivatives and activated alkenes (e.g. alkenylhalides, boronic esters, triflates, etc.). The 
reaction starts with oxidative addition of an activated alkene to the metal (Figure 1.2.1).  
Transmetalation occurs with intermediate I and the enolate or enolate derivative, with loss 
of the leaving group (X) to generate intermediate II. Finally, reductive elimination affords 
the unsaturated compound and regenerates the metal catalyst. In a few cases, a 
catalytically generated enamine can be used instead of an enolate. Despite the need for 
using a pre-activated electrophile, cross coupling reactions remain a powerful tool to form 
these carbon-carbon bonds. 
 
 






























The first a-alkenylation of an enolate was reported by Rathke and Millard in 1977 
using NiBr2 to couple lithium ester enolates and vinyl bromides; however, a stoichiometric 
amount of NiBr2 was required to achieve optimum yields (Figure 1.2.2A).16 There were no 
examples of nickel catalyzed a-alkenylations under mild reaction conditions, until 2015, 
when Helquist and co-workers reported a Ni-catalyzed alkenylation of ketone enolates 
(Figure 1.2.2B).17  
 
 




Ligand screening led to the investigation of N-heterocyclic carbenes (NHCs), which 
demonstrated the ability to retain the Ni in solution throughout the course of the reaction. 
Under the optimized reaction conditions, alkenylation without migration or cis/trans 
isomerization was achieved on aryl, cyclic, and aliphatic ketones coupled with alkyl or aryl 
vinyl bromides.17 
 Besides nickel, palladium has been more commonly used to facilitate the alpha 
vinylation of amide, ester, and ketone enolates. For example, in 2007, Huang and co-
workers first reported the coupling of vinyl bromides, vinyl triflates, and vinyl tosylates to 
3-methoxyindole using [Pd(PtBu3)Br]2 as a catalyst (Figure 1.2.3).18 The vinyl tosylates, 
prepared from ketones, proved to be effective coupling partners with a vinyl halide 




































biological compounds,19-21 cyclic and acyclic aryl ketone and piperidine ester enolates 
were also shown to react with vinyl bromides and triflates in 48-95% yield.18 
 
 




Despite various attempts by Barriault to use the sodium enolate of 2,2,-
dimethylcyclohexanone and perform a palladium catalyzed alkenylation under milder 
reaction conditions, the reaction afforded only 28% yield,22 which suggested the need for 
improved conditions.23 Since zinc enolates had been shown to be effective in related a-
arylation reactions,24 Helquist and Cosner reported in 2011 the use of a zinc enolate in a 
series of palladium catalyzed alkenylations and dienylations in the synthesis of 
Trichostatin A (Figure 1.2.4).25 The coupling was found to be very ligand dependent, with 
Pd(dba)2 and the electron-rich, sterically demanding alkyl phosphine 1,1’-bis(di-tert-
butylphosphino)ferrocene (dtbpf) ligand giving the best results. Additionally, no 
isomerization in the cross-coupled product was observed under the mild reaction 
conditions.25 Overall, nickel has been shown to be a low cost alternative to palladium in 
these cross-coupling reactions; yet, nickel and palladium catalyzed a-alkenylation 
reactions still suffer from the need to preform enolates using strong bases. 
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1.3 Aminocatalysis for a-Functionalization of Aldehydes/Ketones 
 
 
 An important intermediate for these a-alkylation reactions is a carbanion 
equivalent (i.e. enolate, azaenolate, metal enamide, etc) that is typically generated prior 
to the C-C bond forming step and requires a stoichiometric reagent. Processes where a 
nucleophile is generated in situ and catalytically have the inherent advantage of being 
more atom economical. A particularly useful strategy for catalytic in situ generation of 
nucleophiles involves the transformation of carbonyl containing substrates into enamine 
intermediates via a Lewis basic primary or secondary amine catalyst. In contrast to the 
Stork enamine reaction,14-15 the basis of enamine catalysis is a reversible and catalytic 
generation of enamines which undergo addition reactions with various electrophiles (X = 
Y) (Figure 1.3.1A). After hydrolysis of the resulting iminium ion (iv), the a-substituted 
carbonyl product is generated.26-28 
 
 
Figure 1.3.1 (A) General catalytic cycle for alpha functionalization reactions via enamine 
catalysis. (i-ii) Condensation between an amine and carbonyl compound to form an 
enamine via an iminium ion intermediate; (iii) Nucleophilic addition of the enamine to an 
electrophile; (iv) Hydrolysis of the iminium ion. (B)  Features of primary amine catalysis 




This enamine mechanism is analogous to type I aldolases seen in Nature to 
accomplish aldol reactions.29 Nature’s aldolases have provided inspiration for chemists in 






















































catalyzed by proline was the Hajos-Parrish-Eder-Sauer-Wiechert cyclization reported in 
1971.30-33 This enamine-catalyzed asymmetric aldol reaction method has since been 
extensively studied to extend the substrate scope, optimize the selectivity, and improve 
the utility of these aminocatalysts.34 Besides the addition to aldehyde electrophiles in aldol 
reactions, amine-catalyzed ketone activation has been reported for asymmetric Michael 
additions, Mannich-type reactions, and Diels-Alder reactions.26-28, 35 Secondary amines, 
such as chiral pyrrolidines or imidazolines, are highly utilized structural motifs for 
aminocatalysts over primary amines.26, 28 Due to the inherent structural constraints, 
secondary amine catalysts tend to be ineffective when bulkier intermediates (e.g., a-
branched aldehyde/ketone substrates or Z-enamines) are involved (Figure 1.3.1B). The 
development of chiral primary amines, particularly vicinal diamine scaffolds, has proven 




1.4 Diastereoselective Intermolecular Alpha Alkylations 
 
 
Although a-alkylation via derived enolates has been shown to be a viable method 
with ketones, it is not particularly useful with aldehydes, and enantioselective versions of 
these reactions would be desirable. For both aldehydes and ketones, the use of 
azaenolates has been generally more effective in terms of reactivity, product yield, and 
regioselectivity. Furthermore, azaenolates also provide a means for incorporation of a 
nitrogen-based chiral auxiliary to achieve asymmetric reactions. In 1976, Enders 
developed (S)- and (R)-1-amino-2-methoxypyrrolidine hydrazine (SAMP/RAMP) 
auxiliaries that have been widely used for asymmetric a-alkylation of ketones and 










Although the asymmetric alkylation of SAMP/RAMP hydrazones has been 
employed in many natural product syntheses,35 the removal of the auxiliary is most often 
achieved using one of two harsh approaches: ozonolysis or quarternization with methyl 
iodide followed by hydrolysis with 3-4 M HCl.38-40 These methods limit substrate scopes 








Not until 2008, when Coltart and Lim reported the use of chiral N-amino cyclic 
carbamate (ACC) auxiliaries, did broadly useful alternatives to the SAMP/RAMP-based 
auxiliaries appear.41 In contrast to the SAMP/RAMP auxiliaries, ACC auxiliaries have 
these notable advantages: easier introduction into and removal from ketones, rapid 
deprotonation of the hydrazones, and alkylation does not require extreme cryogenic 
conditions (Figure 1.4.2). While ACC hydrazone formation can typically occur by 
condensation of the ACC auxiliary and the ketone under mild refluxing conditions in the 
presence of 10 mol% p-TsOH x H2O by refluxing in dichloromethane, chiral nonracemic 
a-hydroxy ketone derivatives require a combination of pyridinium p-toluenesulfonate 






1. LDA, 0 ºC
2) R3X, -110 ºC































1) LDA, THF, -40 ºC
    30 min
2) R3X to RT 2 h
    81-99% yield






















readily undergo hydrazone exchange in the presence of p-TsOH x H2O in a 4:1 mixture of 
acetone and water without any detectable epimerization.42 A significant benefit of the ACC 
auxiliaries over the SAMP/RAMP auxiliaries is recovery of the unmodified auxiliary by 
liberating the hydrazone with NH2OH x HCl in the presence of 20 mol% p-TsOH x H2O.41 
However, for applications using asymmetric ketones, mixtures of the E- and Z-hydrazones 








MacMillan and co-workers reported several methods that utilize an amine co-
catalyst to activate an aldehyde, rather than pre-forming an enolate using a strong base.43-
44 In addition to being used for a cross aldol reaction, the chiral amine co-catalysts were 
found to facilitate enantioselective couplings of the intermediate enamine and pre-
functionalized alkenes. In 2012, MacMillan reported the first a-alkenylation of aldehydes 
with vinyl iodonium triflate salts (Figure 1.4.3).45 In this synergistic catalysis approach, the 
aldehyde becomes activated using a chiral imidizolidinone organocatalyst to form a chiral 
enamine, which reacts with a highly electrophilic alkenylcopper(III) intermediate. After 
reductive elimination to furnish an a-alkenyl iminium and a copper(I) salt, regeneration of 
the organocatalyst is accomplished through hydrolysis of the a-alkenyl iminium. The 
substrate scope included both alkyl- and aryliodonium electrophiles with yields ranging 
























loadings of 20–30% CuBr when using an internal or branched linear vinyl iodonium triflate 
salt. 
MacMillan reported a similar a-alkenylation of aldehydes in 2013 using boronic 
acids and a similar bulky imidazolidinone organocatalyst catalyst (Figure 1.4.4).46 One 
significant difference is that the iodonium salts used Cu(I) as a co-catalyst, while the 
boronic acids used the less sensitive Cu(II) co-catalyst. The substrate scope was similar 
for both systems and the boronic acid coupling method had slightly poor yields and 
enantioselectivity. Additionally, 30 mol% Cu(OAc)2 and 20 mol% organocatalyst were 
reported for all substrates. In contrast to the RAMP/SAMP or ACC approaches, these 
enantioselective a-alkenylations occur under catalytic and mild, room temperature 
conditions facilitated by dramatically lowering the HOMO-LUMO gap. However, these 
coupling routes require the use of expensive alkenylboronic acids and modest quantities 
of a co-catalyst copper salt. 
 
 




1.5 Alkene Functionalization via Nucleometalation 
 
 
There would be substantial advantages in the use of simple unactivated olefins as 
alkylating agents. A general activation mode for the coupling of simple ketones and olefins 
still remains in development, yet catalytic alkene functionalizations have been present in 
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Pd-catalyzed process for the oxidation of ethylene to acetaldehyde.47 While the 
stoichiometric oxidation of ethylene by Pd(II) salts was known since the 19th century,48 the 
Wacker oxidation owes its success to the ability to regenerate the Pd catalyst using 
cocatalytic CuCl2 and molecular oxygen (Figure 1.5.1).47 The reaction proceeds through 
the p-Lewis acidic palladium coordinating to ethylene, which activates ethylene for the net 








This hydroxypalladation step has been the subject of extensive mechanistic 
research and controversy over whether the reaction proceeds by a cis- or trans-
hydroxypalladation pathway.49 After the discovery of the Wacker oxidation, numerous 
research groups have demonstrated that Pd(II) can facilitate the addition of several 
nucleophiles to alkenes (i.e. oxypalladation, aminopalladation, and carbopalladation) 




Figure 1.5.2: Nucleopalladation examples: A) alcohol cyclization, B) carboxylic acid 
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Vitagliano and co-workers reported the first class of dicationic Pd(II) and Pt(II) PNP 
complexes of simple alkenes, which undergo stoichiometric reactions with oxygen or 
nitrogen nucleophiles.57-59  After nucleophilic attack by water or anilines, the s–alkyl 
intermediates are notably stable towards b–H elimination, a result of the lack of an 
available adjacent coordination site in these tridentate systems. These dicationic olefin 
complexes were found to be much more activated towards nucleophilic addition than the 
neutral species,60 and no nucleophilic attack on the coordinated olefin was observed in 
monocationic complexes containing the isoelectronic and isostructural complexes with 
pyridine replaced with arene (i.e. PCP) (Figure 1.5.3).61 
 
 





Vitagliano and co-workers also reported a catalytic hydrovinylation reaction, where 
electron-rich alkenes can attack Pt-coordinated ethylene to generate stabilized 
carbocation intermediates, which undergoes a series of 1,2-hydride shifts to generate the 
olefinic product (Figure 1.5.4).62  Unfortunately, other Pt-coordinated ethylene complexes, 
i.e. propene and 1-butene, were not reactive. This substrate scope limitation allowed a 

































Inspired by Vitagliano’s reports, Gagné and co-workers investigated PNP-Pd(II) 
complexes capable of performing stoichiometric polyolefin cascade reactions to form a 
variety of polycycles.63 These reactions were proposed to proceed through a carbocation 
intermediate with b-H elimination inhibited due to the lack of an open cis coordination site. 
Pt(triphos)2+ was also found to be an effective cyclization initiator.64 However, the 
development of a catalytic cyclization was not achievable via the resulting bulky 
(triphos)Pt-alkyl+ complexes because protonolysis (protodemetalation) required strong 
acids not compatible with polyene substrates. Gagné and co-workers found that 
platinum(II)-PyBOX (pyridine-2,6-bisoxazoline) complexes were capable of promoting 
catalytic cyclization/protonation reactions of a variety of polyenes, generating polycyclic 
products with good yields (49-93%) and diastereoselectivities (Figure 1.5.5).65 
 
 




1.6 Pi Acid Catalyzed Intramolecular Additions to Alkenes/Alkynes 
 
 
Activation of alkenes or alkynes with the use of p-Lewis acid metal catalysts has 







































of pre-activated coupling partners. There are numerous examples of intramolecular 
reactions using p-acids to facilitate the addition of enol/enolate nucleophiles to unactivated 
C-C bonds, but very few intermolecular reactions. A review by Enders and coworkers 
specifically discusses these Conia-ene type intramolecular addition reactions.66 In a 
Conia-ene reaction, the alkene/alkyne is activated by coordination to the p-acid. Enol or 
enolate formation followed by attack on the activated unsaturated C-C metal complex 
gives a metal-alkyl intermediate. Protodemetalation or b-hydride elimination then affords 
the cyclized product (Figure 1.6.1). 
 
 




Palladium(II) has been shown to be an effective p-acid to catalyze oxidative 
alkylation of unactivated olefins with highly reactive carbon nucleophiles, such as 
malonate anions or silyl enol ethers.67-68 Hydroalkylation of less reactive alkenyl alkyl 
ketones can occur thermally via the Conia-ene reaction without a metal catalyst, but may 
require temperatures in excess of 350 ºC.69 Widenhoefer and co-workers first reported 
Pd-catalyzed intramolecular hydroalkylation reactions of 3-butenyl- b-diketones and b-
keto esters (Figure 1.6.2).54-55 The hydroalkylation tolerated substitution at the terminal 
acyl carbon atom, enolic carbon atom, and the terminal olefinic carbon (38-89%), but not 
at the allylic and homoallylic positions. 
 
 







































The mechanism of the hydroalkylation was studied through a series of deuterium-
labeling experiment, which were in agreement with a mechanism involving an outer-
sphere attack on the pendant enol on the palladium-complexed olefin I to form a palladium 
cyclohexyl intermediate II (Figure 1.6.3).55  Migration of the palladium via a series of b-
hydride elimination/addition steps (III to V) followed by protonolysis of a palladium enolate 
VI regenerates the palladium catalyst and yields 2-acylcyclohexanones. 
 
 





While 3-butenyl b-diketones and 3-butenyl b-keto esters undergo selective 
hydroalkylation in the presence of palladium(II), Widenhoefer and co-workers found that 
4-pentenyl b-diketones and some 4-pentenyl b-keto esters underwent selective oxidative 
alkylation in the presence of PdCl2(CH3CN)2 to form cyclohexanone derivatives (Figure 
1.6.4).70 The catalytic oxidative alkylation was achieved via a CuCl2 co-catalyst under an 
oxygen atmosphere. In contrast to the hydroalkylation of 3-butenyl b-dicarbonyls, 
palladium-catalyzed oxidative alkylation of 4-pentenyl b-diketones tolerated substitution 
along the 4-pentenyl chain. Palladium-catalyzed hydroalkylation could not be extended to 


































to form a palladium enolate complex that undergoes protonolysis. Thus, the palladium 








Widenhoefer sought to circumvent this issue with palladium by finding a suitable 
transition metal complex that would catalyze hydroalkylation through a pathway involving 
nucleophilic attack on a metal-olefin complex followed directly by protonolysis of the 
resulting metal-alkyl intermediate. Pt(II) complexes were found to be a suitable choice, 
since Pt(II)-alkyl complexes are more stable with respect to b-hydride elimination but can 
undergo protonolysis more easily.71 Since lanthanide Lewis acids are known to catalyze 
the addition of b-dicarbonyl compounds to Michael acceptors,72 EuCl3 was employed as a 
Lewis acid co-catalyst and was found to improve yields for the hydroalkylation of 4-
pentenyl b-dicarbonyl compounds from 45 to 64% (Figure 1.6.5).73 While these 
intermolecular hydroalkylation reactions catalyzed by Pd(II) and Pt(II) complexes are not 
generalizable beyond yielding 2-acylcyclohexanone compounds, they do demonstrate the 




























EuCl3 (2 mol%), HCl (1 eq)





 In Widenhoefer’s reported hydroalkylation reactions, the substrates were limited to 
those containing activated methylene units, such as b-diketones and b-keto esters. 
However, simple ketones remain challenging substrates for performing hydroalkylation of 
unactivated alkenes, because they possess a less acidic C-H bond and a significantly 
lower enol/ketone equilibrium constant than b-diketones and b-keto esters. While 
Widenhoefer and co-workers did report a few examples of palladium-catalyzed 
intramolecular hydroalkylation of alkenes with a-alkyl or aryl ketones, these reactions 
require stoichiometric or substoichiometric CuCl2 as an oxidant and either 
trimethylsilylchloride or HCl to facilitate ketone enolization.74-75 More recently, gold 
complexes were demonstrated to be efficient catalysts for the addition of enol equivalents 
to unactivated alkynes,76-77 and can promote the enolization of ketones.78 In 2011, Che 
and co-workers found that Au(I) complexes efficiently catalyze the direct intramolecular 
hydroalkylation of unactivated alkenes with simple ketones (Figure 1.6.6).79 
 
 




This Au(I) catalyzed hydroalkylation also goes through an exo-trig cyclization 
pathway, similar to Widenhoefer’s hydroalkylation reactions on 4-pentenyl b-diketones.74-
75 Using their optimal reaction conditions with the absence of additives, alkenyl alkyl and 
aryl ketones provided new five- and six-membered rings in excellent yields (71-99%) and 
good diastereoselectivity.79 This process was also applied to the synthesis of bicyclic 
ketones. When an alkyl ketone was treated with a catalytic amount of [IPrAuCl]/AgClO4 










R1 X = C(CO2Me)2
      C(CH2OBn)2









the ketone was observed. Yet, no deuterium exchange occurred in the absence of the 
gold catalyst, which supported their hypothesis that the gold complex facilitates enolization 
of these a-ketones. However, no examples of substrates without geminal diesters, 
geminal diethers, or an N-tosyl moiety were reported. 
 
 




 Toste and coworkers went on to develop an asymmetric version of their gold 
catalyzed intramolecular reaction with alkynes, but enantioselectivity was not achieved. 
This was presumably due to linear nature of Au(I)-alkyne complexes. However, a Pd(II) 
catalyst with a chiral SEGPHOS ligand with substituents projected towards the b-ketoester 
yielded ~90% ee for most substrates (Figure 1.6.7).80 
 After these initial reports for p-acid catalyzed Conia-ene reactions, the next major 
advancement involved utilization of two catalysts, with each catalyst activating a different 
coupling partner. In these systems, the p-acid activates the unsaturated C-C bond and an 
organocatalyst activates the carbonyl compound via an enamine intermediate. This dual 
activation by two independent catalysts makes this a dual catalytic system, which allowed 
for the substrate scope to be include alkynyl aldehydes and ketones as opposed to limited 
to only 1,3-dicarbonyl compounds. 
 Dixon and Kirsch reported in 2008 that either a copper81 or gold82 catalyst 
respectively with an amine organocatalyst could cyclize formyl alkynes in a non-
asymmetric fashion. Shortly after, Michelet reported a similar reaction using InCl3 as the 
O
O
O (DTBM-SEGPHOS)Pd(OTf)2 10 mol%
AcOH 10 eq
Yb(OTf)3 10 mol%
















p-acid (Figure 1.6.8).83 Michelet’s cyclization used an alpha-branched aldehyde, versus 
Dixon’s and Kirsch’s non-alpha branched substrates, thus resulting in the generation of 








Attempts to develop an enantioselective version of this reaction with InCl3 was not 
very successful, as reactions gave both poor yields and enantioselectivities.84 Cu(I) 
instead proved to be an effective catalyst with high yields and enantioselectivities possible 
(Figure 1.6.9). The chiral phosphine ligand served two purposes: 1) in situ reduction of 
Cu(II) to Cu(I) instead of using air sensitive Cu(I) complexes, 2) the bulky tert-butyl 
substituents gave better enantioselectivity. Cyclohexylamine was found to be the optimal 
organocatalyst for its ability to form an enamine with alpha branched aldehydes compared 
to bulkier, secondary amines or linear primary amine organocatalysts.  
 
 




Unfortunately, the formyl alkyne substrate scope is apparently limited to the bulkier 






























intramolecular a-alkenylation reactions with dual catalysts demonstrated that p-acid 
catalysts were compatible in a reaction mixture with Lewis basic amine co-catalysts. 
 
 
1.7 Methodology for Intermolecular Additions to Alkenes/Alkynes 
 
 
In both the formation of metal enolates and the Stork enamine reaction, there is 
the requirement of using activated alkyl halide electrophiles. Additionally, only primary 
alkyl halides react effectively in most alkylation reactions. There is a substantial economic 
advantage in the use of simple unactivated olefins as alkylating agents. However, due to 
the unfavorable thermodynamics and kinetics,67, 85 the addition of a metal enolate to a 
simple olefin requires complexation with a metal salt.86 For example, Nakamura and co-
workers in 2004 were able to overcome this challenge by generating a zinc enamide 
intermediate from the corresponding N-aryl imine (Figure 1.7.1).87 The zinc enamide 
reacts smoothly with terminal alkenes in carbometalation reactions to generate g-zincated 
imine intermediates. The organozinc intermediates can be quenched to yield a ketone or 
can react further with electrophiles in subsequent C-C bond formation reactions. While the 
use of these highly reactive zinc enamides demonstrates a possibility for the utilization of 
unactivated terminal olefins, the zinc enamide formation still requires the use of lithium 
diisopropylamine and n-butyl lithium. 
 
 




Alternatively, free radical reactions in organic synthesis are a useful approach for 























metal ions, such as Mn(III), Ce(IV), Ag(II), and Pb(IV), have been found to be effective for 
the generation of a-keto radicals and subsequent addition to alkenes.88-89 While most 
reports require stoichiometric quantities of metal reagent, two methods using catalytic 
AgNO3 or Mn(OAc)3 and respective reoxidants Na2S2O3 or KMnO4 were found to be 
effective for the addition of a-keto radicals to alkenes.90-91 Molecular oxygen would be the 
most desirable candidate for catalyst regeneration. In 2000, Ishii and co-workers found 
Mn(II)/Co(II) to be a novel catalyst system for the radical addition of ketones to alkenes 
using molecular oxygen as a reoxidant.92 Under the optimal reaction conditions, cyclic and 
aliphatic ketones were added to oct-1-ene or isopropenyl acetate in decent yields (61-
85%) (Figure 1.7.2). An interesting observation was noted for the addition of 
cyclohexanone to styrene, which did not yield the expected product, but rather a six-
membered cyclic peroxide. It was hypothesized that the stability of the intermediate benzyl 
radical preferentially reacted with O2 rather than undergoing a radical terminiation step. 
While this novel catalytic method provides an alternative route for a-alkylation of cyclic 
ketones, there are several drawbacks, i.e. limited regioselectivity for unsymmetrical linear 
ketones and limited functional group tolerance. 
 
 
Figure 1.7.2 Mn(II)/Co(II) catalyzed radical addition of ketones to oct-1-ene (A), 





Due to success for the intramolecular hydroalkylation and oxidative alkylation of 
alkenyl b-diketones catalyzed by PdCl2(CH3CN)2, Widenhoefer and Wang looked to 
extend similar reaction conditions for the addition of stabilized b-diketone nucleophiles to 
O Mn(OAc)2 (0.5 mol%)
Co(OAc)2 (0.1 mol%)
AcOH, N2:O2 (1:1)





















ethylene and propylene.93 Initially, the reaction of 2,4-nonanedione with ethylene (15 psi) 
in the presence of catalytic Pd(II) and stoichiometric CuCl2 yielded a 36:64 mixture of 
alkene:alkane (Figure 1.7.3A). By increasing the ethylene pressure to 200 psi, both the 
efficiency and selectivity increased leading to exclusive formation of the alkenylation 
product as a separable mixture of E and Z isomers. 
 
 




This improved selectivity is likely due to the increased rate of olefin displacement 
relative to protonolysis. The optimized reaction conditions were utilized on other 
unsymmetrical and symmetrical b-dicarbonyls (59-86% yields). Similar to the above 
mentioned intramolecular hydroalkylations of 4-pentenyl b-diketones, ethylene 
hydroalkylation catalyzed with a Pt(II) complex yielded only the a-alkylation product and 
no detectable amount of the alkene (Figure 1.7.3B). However, extending the palladium-
catalyzed alkylation to propylene required additional activation of the b-diketones with 
stoichiometric EuCl3 and led to the formation of furan byproducts,93 formed via palladium-










A) H2C=CH2 (200 psi)
    PdCl2(CH3CN)2 (10 mol%)
    CuCl2 (3 eq)
    dioxane, 90 ºC
B) H2C=CH2 (50 psi)
    [PtCl2(H2C=CH2)]2 (2.5 mol%)
    HCl (0.2 eq)
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 Similar to intermolecular additions to alkenes, the analogous intermolecular 
additions to alkynes are also rare and typically limited to the more reactive 1,3-dicarbonyl 
substrates. In 2007, Nakamura and coworkers reported a In(OTf)3 catalyzed addition of 
alkynes to a b-ketoester.95 The In(OTf)3 is proposed to activate both the b-ketoester and 
the alkyne. The Nakamura lab later developed a diastereoselective version of this 
intermolecular reaction (Figure 1.7.5).96-97 Although, this example required pre-forming an 
enamine with a chiral amine and an extra hydrolysis step at the completion of the reaction. 
 
 





The structure of the chiral auxiliary was crucial for obtaining higher enantioselectivity. 
Auxiliaries containing more sterically demanding groups (t-Bu, s-Bu, or i-Pr) afforded 
similar ee values of 91, 94, and 89% respectively, while smaller substituents were less 
selective and afforded ee’s of ~70%. The methoxy group on the chiral auxiliary was found 
to be more crucial as removal of this group resulted in a similar overall yield, but the ee 
dropped to 12%. This was hypothesized to be due to a 5-membered ring structure that 
forms between the methoxy group, nitrogen, and the metal center. Although this sequence 
was high yielding and highly enantioselective, this method suffers from being limited to 
1,3-dicarbonyl compounds and is not catalytic with respect to the amine. Similarly to the 
Enders SAMP/RAMP hydrazone alkylation reaction, the chiral auxiliary needs to be 
hydrolyzed in a separate step. 
An alternative non-asymmetric Nakamura reaction was reported by Xi and 








1) In(OTf)3 10 mol%
    BuLi 10 mol%











reaction was achieved where gold activates the alkyne and undergoes nucleophilic attack 
by a gallium generated enolate. This synergistic catalyst system was required as control 
experiments with only gold or gallium individually gave <5% yields. 
 
 




The main drawback for many of these intermolecular reactions is the requirement 
of readily enolized b-dicarbonyl substrates. A rare example of the direct addition of 
unactivated ketones to unactivated alkenes or alkynes was reported by Dong and 
coworkers.99-100 This method utilizes a bifunctional ligand that acts as both an 
organocatalyst and a directing group. This ligand in combination with the bulky electron 
rich N-heterocyclic carbene (NHC) ligand IMes for Rh facilitated a highly atom economical 
reaction capable of coupling inexpensive coupling partners such as simple olefins and 
alkynes. It was also discovered that 10 mol % TsOH.H2O promoted enamine formation. 
Using their optimized conditions, alkylation with ethylene or other terminal olefines on 
cyclopentanones, substituted in the 3 position, tolerated a range of functional groups, 
including secondary amides, malonates, and aliphatic esters with competitive alkylation 
sites (Figure 1.7.7). The reaction was regioselective for the less-hindered 5 position of 
cyclohexanone and selective for mono alkylated products.  
Using a similar catalytic system, the Dong lab has also reported a method for a-
alkenylation of ketones.100 While Dong’s reports demonstrate that a bifunctional 
precatalyst strategy may be promising, significant disadvantages include the required 

















amine catalyst for the addition to alkynes. Additionally, only terminal olefins were effective 
and provided the linear products. 
 
 




Another synergistic catalyst system for a-alkylation of aldehydes using alkenes 
was reported by MacMillan and coworkers in 2017 (Figure 1.7.8).101 This method 
employed the use of three synergistic catalytic processes: photoredox, enamine, and 
hydrogen-atom transfer (HAT). A bulky organocatalyst activates the aldehyde via an 
enamine and concurrent irradiation of the iridium photocatalyst with visible light produces 
an excited-state Ir(III) complex.  
 
 
Figure 1.7.8 Intermolecular a-alkylation of aldehydes using synergistic photoredox, 




A variety of substituted aldehydes and a variety of electron-rich and electron-
deficient vinyl arenes were tolerated and gave 50–94% yields and typically 90% ee. 





























































reactive, while p-nucleophilic 1,1-disubstituted olefins (i.e. methylenecyclopentane) gave 
a moderate yield of 47% and 88% ee. Overall, this multicatalytic process facilitated both 
intra- and intermolecular aldehyde coupling with simple olefins for the construction of 
cyclic and acyclic products. 
Although there are numerous methods available for the addition of 
aldehydes/ketones to alkenes/alkynes, they have significant limitations, particularly with 
regard to substrate scope. An ideal reaction would proceed through a catalytically 
generated nucleophile capable of adding to a p-acid activated unsaturated C-C bond in 
an intermolecular fashion using an air stable and functional group tolerant catalyst system. 
To overcome these challenges in the previously described methods, a Lewis acid/Lewis 
base catalyst system has been proposed via the following two approaches: (1) bifunctional 
catalyst systems, where the two discrete catalytic sites are tethered together in a single 
molecule, and (2) bulky dual catalysts with binding pockets selective for smaller 
alkynes/alkenes over bulkier amines/enamines. The design, synthesis, and study of both 









Bifunctional Group 10 Metals and Cu(I) Catalysts for Additions of Aldehydes and 
Ketones to Alkenes/Alkynes 
 
 
2.1 Introduction to Bifunctional Catalysis 
 
 
 Though there are a substantial number of reports using dual catalysts for 
intramolecular additions of unactivated carbonyl compounds to alkynes and several for 
the additions to alkenes, intermolecular variants of these addition reactions are rather 
scarce. It is first important to define what is intended when referring to “dual” versus 
“bifunctional” catalysts. A dual catalytic system is one with two distinct catalysts that are 
separate molecules, and each catalyst activates a different substrate (Figure 2.1.1). After 
both substrates are activated by separate catalysts, the reaction proceeds. One challenge 
in a dual catalytic system is ensuring that the two catalysts are compatible. Instead of the 
catalysts activating each substrate, they could interact with each other during the course 
of the reaction. This possible unproductive catalyst poisoning interaction, which we will 
refer to as self-quenching or poisoning, is one limitation of using a dual catalytst strategy. 
In contrast, a bifunctional catalyst possesses two more-or-less independent 
catalytic sites on a single molecule. The activation of the substrates proceeds in the same 
manner as with dual catalysts. However, since the two catalytic components are tethered 
together, it allows for the possibility of using two catalysts which may not be compatible in 
a dual catalyst system due to self-quenching. One disadvantage of intermolecular 
reactions with dual catalysts is that they may be entropically unfavorable. A bifunctional 
catalyst has the potential to overcome this challenge by allowing the substrates to react 
via an “pseudo-intramolecular” transition state. This is because each catalytic component 
is tethered together within a single molecule, causing the intermediate after the key bond 





the catalyst scaffold positioning each activated substrate in a geometrical orientation that 
is at an optimal orientation and distance for the desired reaction to occur. However, 
bifunctional catalysts are less flexible than a dual catalyst and the tether could be a 
hindrance for reactivity if the activated substrates are in the wrong orientation. 
 
 




Bifunctional catalysis is a rare strategy in organic chemistry,102-103 but presented 
here are several representative examples. In Nature, type II aldolases catalyze 
asymmetric aldol reactions; a Zn2+ cofactor coordinated to three histidine residues 
polarizes the carbonyl donor through coordination, and a tyrosine residue (Tyr-113) 
activates the aldehyde acceptor by donating a proton to stabilize the developing charge.29 
(Figure 2.1.2A) Other synthetically useful examples include Shibasaki’s report of a 
phosphine oxide/aluminum Lewis acid catalyst for asymmetric cyanosilylations (Figure 
2.1.2B),104 and Wang’s amino acid-derived catalyst for asymmetric Michael105 (Figure 





acidic metal to activate an electrophile tethered to a Brønsted or Lewis base that is capable 
of activating a nucleophile. This general bifunctional catalyst approach has been extended 
in the design of bifunctional catalysts described below. 
 
 
Figure 2.1.2 Select Examples of Bifunctional Lewis Acid/Organo Catalysts: A) Type II 




 In 2020, Luo and coworkers reported an arene-containing chiral primary 
amine/palladium synergistic catalyst for an asymmetric allylic alkylation of b-keto esters or 
1,3-diketones.108 The primary amine served as the organocatalyst to activate the carbonyl 
via enamine formation, while the arene acted as a p-ligand for Pd, essentially forming in 
situ a bifunctional catalyst. This enhanced the reaction rate and reversed the chiral 
induction when compared to nonarene aliphatic derivatives (Figure 2.1.3). Vinylethylene 
carbonates or vinylepoxides were used to access the alcohol derivatives via a zwitterionic 
Pd-allyl intermediate. Their catalytic system was also capable of coupling with N-aryl 
carbamates to afford N-allylic aniline adducts with good yield and high enantioselectivity. 
 
 















































































A final example of a bifunctional catalyst system was reported by Dong and 
coworkers (previously discussed in Chapter 1).99 The bifunctional ligand, 7-azaindoline, 
was found to activate the ketone a-C-H bonds via enamine formation, while the linked 
pyridyl directing group facilitated oxidative addition of a low-valent Rh(I) metal into the 
resulting enamine C-H bond, giving a metal hydride species (Figure 2.1.4 a-b). A model 
complex using 2-indanone, [Rh(ethylene)2Cl]2, 7-azaindoline, and PMe3 were used to 
obtain a crystal structure of an intermediate after enamine C-H bond insertion. The 
rhodium catalyst also serves to activate the olefin via coordination to the metal. 
Subsequent Ru-H migratory insertion (c) and reductive elimination (d) yields the alkylated 
enamine, which undergoes hydrolysis to regenerate the catalyst (e). 
 
 
Figure 2.1.4 Proposed catalytic cycle of Dong’s bifunctional catalyst. (a) Enamine 
formation; (b) Oxidative addition of enamine C-H bond; (c) Migratory insertion into olefin; 






















































 These examples demonstrate how a bifunctional catalyst approach can be utilized 
to facilitate several important transformations. Further examples of bifunctional catalysts 
can be seen in reviews by Trost,109 Feng,110 Shibasaki,111 and Xiao.112 Designing a 
bifunctional catalyst requires careful consideration of each component (Lewis acid, Lewis 
base, ligand, additives, etc) during the development of an active catalyst. In the sections 
to follow we describe our approach in the design and synthesis of bifunctional catalysts. 
 
 
2.2 Design and Prioritization of Bifunctional Lewis Acid/Lewis Base Catalysts for 
Additions of Aldehydes/Ketones to Alkenes or Alkynes using DFT 
 
 
When designing these bifunctional catalysts, there are three critical components: 
amine organocatalyst, p-Lewis acid metal, and the “tether” (scaffold) between catalyst 
sites. Each need to be finely tuned to fulfill their individual task, while still cooperatively 
functioning with the other two components. Our proposed catalytic cycle starts with a late 
electrophilic, pi acidic transition metal (i.e. Cu(I), Ni(II), Pd(II), Pt(II)) complexed to a 
bidentate or tridentate ligand with a pendant amine organocatalyst A (Figure 2.2.1). The 
pendant amine of A undergoes condensation with a ketone/aldehyde to form an enamine, 
and the olefin is activated via coordination to the metal (intermediate I). Nucleophilic attack 
of the enamine on the activated coordinated olefin would forms metal-alkyl intermediate 
II. Hydrolysis of the imine/iminium intermediate and protodemetalation or b-hydride 
elimination of the metal-alkyl intermediate yields the respective a-alkylated or a-
alkenylated product and regenerates the active catalyst A. The b-hydride elimination 
option would require a co-oxidant to regenerate the active M(II) catalyst. 
The pendant amine organocatalyst that activates the ketone or aldehyde via the 
formation of an enamine could be either a primary or secondary amine, which would alter 





secondary amines may be utilized. Cyclic amines contain a more rigid structure, which 
could be advantageous in maintaining a strict geometry around the enamine. Acyclic 
amines provide more flexibility during macrocyclization and can be synthetically easier to 
diversify via substitution reactions; however, the additional flexibility may decrease the 
macrocyclization C-C bond reaction rate. Any intermolecular catalyst-catalyst interaction 
between an amine on one catalyst and a Lewis acidic site on another must be either 
geometrically impossible, rapidly reversible, and/or sterically disfavored. 
 
 




The p-Lewis acid metal is required to activate the alkene for an outer sphere attack 
by the enamine nucleophile. After nucleophilic attack, the subsequent metal-alkyl 
intermediate II requires the metal to be capable of undergoing protodemetalation or b-
hydride elimination (with a co-oxidant) to regenerate the active catalyst and achieve 
catalytic turnover (Figure 2.2.1). Furthermore, the catalyst needs to be moisture tolerant, 
since the catalytic cycle mentioned above also includes the generation of 
























































the use of late transition metals such as Ni, Pd, Pt, Cu, Ag, Au, that also have 
demonstrated the ability to coordinate and activate alkenes and alkynes. 
While the amine organocatalyst and p-Lewis acid metal are critical to activate the 
respective aldehyde/ketone and alkene/alkyne starting materials, the structure of the 
scaffold itself is also critical, which includes the “spacer” between the catalytic sites. The 
Lewis acid and Lewis base sites need to be close enough to enable carbon-carbon bond 
formation, but far enough away to prevent self-quenching. A suitable chelating section of 
the precatalyst scaffold needs to act as a ligand for the p-acidic metal capable of activating 
an alkene (or alkyne). When the alkene/alkyne coordinates to the metal, its reactive p*-
orbitals are on the opposite face of the alkene from the metal. Thus, the precatalyst 
scaffold requires the alkene or alkyne to be sandwiched between the metal and the 
pendant enamine to facilitate an anti-addition. The spacer between the chelating section 
and the amine organocatalyst needs to position the amine far enough away from the 
metal, while minimizing steric interactions with the coordinated alkene or alkyne. 
Since the synthesis of these complex precatalysts has been the rate-limiting step 
in our research endeavors, we have turned towards a computational approach to help 
prioritize our precatalyst designs. The presumed structures before and after C-C bond 
formation are optimized using density functional theory (DFT), and the free energy change 
between the ground state optimized structures is calculated (Figure 2.2.1). We assume 
that the C-C bond formation step needs to be exergonic for catalysis to be achieved, and 
this step may also be the rate-determining step. Such computational rational design 
approaches are currently rare, but are becoming increasingly promising tools for catalyst 
discovery.113  
We believe our proposed precatalysts are ideal for this computational approach 





well understood and can be effectively modeled using current DFT functionals and basis 
sets. Additionally, in our bifunctional catalyst systems the C-C bond formation step is an 
intramolecular macrocyclization, and macrocycle ring strain can be effectively estimated 
via DFT calculations114 to prioritize our precatalyst scaffolds. 
 
 
2.3 Design of Bifunctional Cu(I) Catalysts for Direct Additions of Carbonyl 
Compounds to Alkynes  
 
 
Our general strategy to approach developing bifunctional catalysts for the direct 
addition to alkenes and alkynes was conducted in a similar fashion: i) design bifunctional 
catalysts guided by DFT calculations, ii) synthesize the most promising precatalysts, iii) 
screen the precatalysts using a variety of alknes/alkynes and ketones/aldehydes. This 
bifunctional Cu(I) catalyst project was spearheaded by Jacob Porter and our novel catalyst 
design strategy and initial efforts at the identification of an active catalyst led to the 
publication of a report titled “DFT-assisted design and evaluation of bifunctional copper(I) 
catalysts for the direct intermolecular addition of aldehydes and ketones to alkynes.”115 A 
brief summary of these studies with emphasis on aspects I contributed towards are 
described here. 
In designing our catalyst system, we first sought to explore Lewis acid and ligand 
combinations that would be suitable for alkyne activation. Based on the literature 
precedent for intramolecular reactions with formyl alkyne substrates, alkyne 2.1 and 
intramolecular reaction conditions reported by Michelet84, 116 were selected as a model 
reaction system (Figure 2.3.1). Lewis acids previously reported for additions of carbonyl 
compounds to alkynes80-83, 95-97, 116-118 or alkenes93, 119 were screened. The Group 11 salts 
Cu(I), Au(I), and Ag(I) resulted in the highest yields. Due to previous reports of Cu(I) 
catalysts in Conia-ene type reactions, we decided to proceed with a Cu(I) system to 





Ph-BOX, and 1,10 phenanthroline) were screened with the Cu(I) salt (CH3CN)4CuBF4 and 
resulted in a decrease in reactivity. We hypothesize this may be due to 2:1 ligand:metal 
binding or other complex binding modes that do not leave a vacant coordination site on 
Cu for alkyne activation.115 
 
 




Prior to proceeding with our strategy to build novel bifunctional catalysts, we 
wanted to rule out the possibility of using dual catalyst conditions for intermolecular 
reactions that were productive for intramolecular reactions. An NMR study was performed 
using a (2,2’-dipyridylamine)CuOTf complex to determine whether an electron-rich 
enamine intermediate could displace a coordinated alkyne and simply act as a competing 
ligand for the p-acid (Figure 2.3.2).115 After addition of phenylacetylene to the Cu(I) 
complex, a downfield shift from 3.07 ppm to 4.01 ppm was observed in the 1H NMR signal 
for the alkyne proton of phenylacetylene. This is consistent with the formation of Cu-alkyne 
complex 2.3. Upon addition of the enamine derived from cyclohexanone and pyrrolidine, 
the signal for the uncoordinated alkyne reappeared at 3.07 ppm. Additionally, evidence 
for enamine coordination to the metal was observed as the vinyl enamine proton shifts 
upfield from 4.29 ppm to 3.99 ppm, suggesting that coordination of the enamine to the 
metal is highly favored over alkyne coordination. Subsequent formation of 1,2-addition 
product 2.4 was observed, which presumably forms via addition of a Cu-acetylide to a 
transient iminium ion. Variations of this transformation were recently reported by Larsen120 
and Ma.121 With our hypothesis of a dual catalyst strategy being problematic with thus 
















sought after the design of a Cu(I) bifunctional catalyst that would not suffer from 
competitive displacement of coordinated alkynes by an enamine. 
 
 
Figure 2.3.2: Enamine displacement of alkyne from (2,2’-dipyridylamine)Cu(I) complex 




In 2016, Dockendorff and coworkers reported heterocycle based bifunctional 
catalysts for cross aldol reactions.122-123 We chose those bifunctional catalyst scaffold 
templates to be repurposed for additions of carbonyl compounds to alkynes. Based on the 
results of our Lewis acid study that found Group 11 Cu(I), Ag(I), and Au(I) salts to give the 
best yields in an intramolecular Conia-ene reaction,115 and reports of Cu(I) catalyzed 
intramolecular additions of aldehydes to alkynes by Michelet,116, 124 we hypothesized that 
a bifunctional Cu(I) catalyst could promote an intermolecular reaction if the alkyne could 
be coordination at a suitable orientation and distance from the enamine moiety (Figure 
2.3.3). Additionally, we hypothesized that a tridentate ligand moiety would be necessary 
to promote 1:1 ligand:metal binding as opposed to more complex binding modes (2:1 or 
2:2; ligand:metal binding) that could be catalytically inactive. A tridentate ligand could 
adopt a favorable distorted tetrahedral Cu(I) geometry when coordinated to the alkyne. 
Inclusion of a central heterocycle closest to the organocatalyst portion of the bifunctional 
catalyst we hypothesized could also act as a hemilabile ligand and relieve ring strain of 








































DFT calculations were implemented to help us prioritize our precatalyst scaffolds 
and limit the number of precatalysts synthesized. Geometry optimizations and ground 
state energies were computed for complexes before (2.5) and after (2.6 or 2.7) C-C bond 
formation (Figure 2.3.3). We hypothesized that an energetically unfavorable C-C bond 
formation step would preclude catalysis, thus more exergonic catalyst systems for this 
step were prioritized. A series of calculations were performed to evaluate different 
organocatalyst moieties (pyrrolidine, N-methyl, and N-benzyl), heterocyclic portions 
(imidazole, oxazole, and thiazole), and the eastern ligation portion of the catalyst 
(phenolate, quinoline, and phosphine based ligands). The addition of the enamine to the 
alkyne could proceed in a syn or anti fashion to generate cis or trans adduct intermediates 
and for almost all cases the trans isomer was found to be energetically unfavorable. 
The thaizole-based catalyst was identified as the most exergonic for C-C bond 
formation. We hypothesized that sterically hindered amines may avoid intermolecular 
poisoning of a metal center on a second catalyst molecule; however, a bulkier amine would 
also slow the rate of enamine formation. Catalysts with the N-benzyl amine (–3.8 kcal/mol) 
was prioritized as it was found to be more energetically favorable than the N-methyl (–2.9 
kcal/mol) or pyrrolidine (–2.1 kcal/mol), with the lower favorability of the pyrrolidine 
presumed to be due to the increase in strain on the macrocycle intermediate. Although the 
pyrrolidine varieties were computed to not be as energetically favorable as the N-benzyl 





























∆G (kcal/mol) reported for R3 = A
R1,R2 = Me, H (–2.9)
              Bn, H (–3.8)







pyrrolidine as a Lewis base was still of interest to us due to its established effectiveness 
as an organocatalyst, particularly with other bifunctional systems. DFT calculations on 
variations of the eastern ligating portion of the N-benzyl catalyst (R3) showed a significant 
improvement in ∆G with the quinoline (–10.2 kcal/mol) over the phenolate ligand (–3.4 
kcal/mol). This increase in exergonicity for the C-C bond formation step is believed to be 
attributed to the Cu(I) species with the quinoline being cationic versus the neutral Cu(I) 
with the phenolate. The reduction in electron density around Cu(I) allows for more sigma 
donation from the coordinated alkyne, resulting in it being more electrophilic and C-C bond 
formation predicted to be more favorable. The phosphine-based ligand (–10.3 kcal/mol, 
R1 = Me, R3 = C) was comparable the quinoline (R3 = B), but attempts to synthesize this 
ligand failed due to decomposition of the phosphine via oxidation during purification. 
 
 
2.4 Synthesis of Pyrrolidine Based Precatalysts for Cu(I) 
 
 
 After using DFT calculations to prioritize the tridentate thiazole bifunctional 
catalysts, our next objective was to develop modular syntheses to access the desired 
heterocyclic precatalysts with either the pyrrolidine (Scheme 2.4.1) or N-benzyl amine 
(Scheme 2.4.2) as the Lewis base moiety. Starting with Boc-L-proline (2.8), EDC coupling 
with threonine methyl ester 2.9, followed by DMP oxidation, yielded known dipeptidyl 
ketone 2.11 in good yield. Heating with Lawesson’s reagent provided the thiazole 2.12,125 
followed by reduction of the ester with sodium borohydride and catalytic sodium 
triacetoxyborohydride. Mesylation of primary alcohol 2.13 followed by addition of sodium 
azide generated azide 2.14, which was reduced with hydrogen and catalytic palladium on 
carbon. The resulting primary amine 2.15 could be combined in a modular fashion with a 
variety of aldehydes using reductive amination conditions to generate final precatalysts 









Reductive amination of the quinoline-based precatalysts in THF was complicated 
by the prominent formation of the bis-alkylated products which were not easily separable 
by column chromatography. Stepwise attempts to reduce the pre-formed imine with 
sodium borohydride yielded identical results. The use of acetic acid as a solvent was 
discovered to suppress the formation of the overalkylated byproduct, though reactions 
with these substrates were difficult to push to completion. A sulfonic acid resin (Amberlyst 
15®) was effective for both Boc removal and trapping the final diamine products, which 
allowed impurities to be washed away and the desired products released in high purity 
after basification with ammonia in methanol. The analogous N-benzyl-based precatalysts 
(2.17a-d) were synthesized by Jacob Porter using a similar synthetic route starting from 
N-Boc glycine (Figure 2.4.1).115 
 
 













































    TEA
    DCM, 24 h
2) NaN3
    DMF, 19 h















    DCM, 16 h
3) 3.5 N NH3 in MeOH















2.16b: R2,R3 = H (60%)
2.16c: R2 = Cl, R3 = H (43%)


























2.17b: R2,R3 = H (46%)
2.17c: R2 = Cl, R3 = H (33%)







2.5 Reaction Screening with Cu(I) and Thiazole-based Precatalysts 
 
 
With a focused library of precatalysts in hand, we proceeded to test them in a 
variety of reaction screens with Cu(I) salts ((CH3CN)4CuBF4), utilizing GC-MS to analyze 
each reaction. For an initial solvent screen, cyclopentanone was selected due to its well-
established reactivity for enamine formation.125-126 Internal alkynes (1-phenyl-1-propyne or 
2-hexyne) were chosen as initial substrates due to the possibility that terminal alkynes 
may form undesired copper-acetylide species (Figure 2.5.1). Reactions with polar 
solvents (DMSO, DMF, and MeCN) gave no reaction at 50 °C. It is plausible that the 
coordinating nature of these solvents prevented interaction of the metal salt with the 
substrates. Chloroform and toluene also showed only starting material after 24 h at 50 °C. 
Nitromethane and THF produced an unknown, undesired byproduct that was also present 
in a control reaction run in THF where the 2-hexyne had been omitted. DCE and dioxane 
led to consumption of cyclopentanone, but gave complex, intractable mixtures of products. 
 
 




Given the use of DCE in the known analogous intramolecular carbocyclization 
reactions, we explored additional substrates in this solvent with our library of precatalysts 
(Figure 2.5.2). This screening showed that phenol-based precatalysts (2.16b–d and 
2.17b–d) were inactive under the reaction conditions. Quinoline-based precatalysts (such 
as 2.16a and 2.17a) showed complex mixtures of products. Analysis of these mixtures 

























example, reactions 2-hexyne and all of the carbonyl substrates yielded a set of common 
byproducts that did not correspond to any desired products nor their derivatives, such as 
multiple alkenylation products, as determined by GC-MS and 1H NMR of scaled up 
reactions. No GC-MS peaks were identified that were unique to a specific set of 
substrates, which would have suggested a unique and potentially desirable reaction. 
 
 




Based on the GC-MS data, we believe that the products formed under these 
conditions are primarily due to carbonyl-carbonyl or alkyne-alkyne coupling reactions. GC-
MS evidence for aldol self-condensation products was obtained in some cases, most 
notably when phenylacetaldehyde was used as the carbonyl compound. A second 
prominent byproduct seen via GC-MS for reactions that contained phenylacetylene was 
1,4-diphenylbutadiyne, presumably via a Glaser coupling.127 The presence of this 
byproduct in these samples was confirmed by comparison of the GC-MS traces to that of 
a commercial sample of 1,4-diphenylbutadiyne. Additionally, select reactions were run 
with AgBF4 as the metal salt instead of (CH3CN)4CuBF4, and no reactions were observed 
in any of these cases. A range of acidic additives (4-nitrophenol, benzoic acid, pTsOH, 
acetic acid, and TFA) or a non-coordinating base (2,6-di-tert-butylpyridine) were 
additionally tested for the addition of cyclopentanone to 2-hexyne and found to result in 

































DCE, 50 °C 16 h
2.17a
(20 mol%)
R1 = H, Me





 To ensure that we could detect desired product formation, a control reaction was 
run to confirm that trace amounts of desired product could be detected in our crude 
reaction mixtures via GC-MS. An authentic sample of product from the addition of acetone 
to phenylacetylene (2.18) was synthesized according to a protocol reported by 
Trofimov.128 Two parallel reactions were set up containing acetone and phenylacetylene 
substrates, and one reaction was doped with the positive control (2.17) at 5 mol% (Figure 
2.5.2). After stirring at 50 ºC for 24 h, both reactions were analyzed via GC-MS. The 








 Although the DFT calculations were promising for the tridentate thiazole 
precatalysts with Cu(I), no desired product was afforded for the addition of an aldehyde or 
ketone to an alkyne. X-ray and NMR studies were carried out to investigate the lack of 
reactivity of this catalyst system. While we were unable to obtain single crystals of any 
Cu(I) complex with our precatalysts, Jacob Porter obtained a Ag(I) crystal with a 2:2 ligand 
to metal stoichiometry (Figure 2.5.3).115 One key observation was that neither Ag(I) atom 





quinoline, thiazole, and the secondary amine proximal to the quinoline. Additionally, 
coordination of the N-benzylamine, instead of the quinoline, to Ag(I) was observed and 
could provide an explanation for the lack of reactivity of this catalyst class as the N-
benzylamine is required to serve as the organocatalyst. 
 
 
2.6 Design and DFT Prioritization of Bifunctional Catalysts for Additions of 
Ketones/Aldehydes to Alkenes  
 
 
In tandem with our studies on Cu(I) bifunctional catalyst aimed to promote a-
alkenylation using alkynes, we also sought after a complementary strategy focused on a-
alkylations of carbonyl compounds with alkenes. The general strategy was consistent in 
that we first utilized DFT calculations to guide our bifunctional catalyst design prior to 
precatalyst synthesis and reaction screening. Our novel bifunctional design with a meta-
substituted benzene spacer and initial efforts at identification of an active catalyst led to 
the publication of a report titled “DFT-assisted design and evaluation of bifunctional 
amine/pyridine-oxazline metal catalysts for additions of ketones to unactivated alkenes 
and alkynes.”129 A summary of these studies and additional complementary DFT 
calculations are described here.  
 
 
Figure 2.6.1 General bifunctional catalyst design for intermolecular addition of 



















M = Ni, Pd, or Pt


























spacer needs to position
enamine close to the
olefin's π * orbitals, but





Prior to the selection of potential catalysts for more detailed DFT calculations, 
bifunctional catalyst scaffolds were initially visualized using physical, hand-held models 
and on the computer using software such as Avogadro, which was also used for simple 
molecular mechanics minimization of the structures. This prescreening was used to 
observe whether the organocatalyst tether could position the activated aldehyde/ketone 
(via enamine formation) anti to a complexed olefin, to permit its nucleophilic addition 
(Figure 2.6.1). We reasoned that the square planar coordination geometry of Group 10 
transition metals could be ideal for providing access to coordinated olefin’s p*-orbitals, 
while at the same time minimizing accessible geometries for poisoning by other functional 
groups. Precatalysts featuring oxazoline ligands were initially chosen due to the excellent 
precedent for oxazolines in Pd(II) catalysts promoting asymmetric Wacker-type 
oxidations.130 Our initial goal was to determine a suitable oxazoline-based bidentate ligand 
and organocatalyst tether combination predicted to promote nucleophilic addition to the 
olefin. The organocatalyst tether variables we considered included: attached position to p-
acid moiety; tether length; and 1º and 2º amines. 
Logical initial tether placements were either at the 3-position on the pyridine or the 
4-position on the oxazoline (Figure 2.6.1). In our first scaffold design, a 3-substituted 
pyridine would space the tether further away from the metal than being at the 2-position. 
To minimize steric interactions between the coordinated olefin and an atom at the 2-
position, a 3-substituted pyridazine was utilized rather than a pyridine. In the design for a 
tether on the oxazoline, an aryl substituent was utilized to again minimize any steric 
interactions with a coordinated olefin and position the organocatalyst an appropriate 
distance from the metal center. Using physical models to examine hypothetical transition 





with respect to p*-orbitals of the coordinated olefins, the most promising two scaffolds 2.19 
and 2.26 were optimized using DFT (Figure 2.6.2). 
 
 
Figure 2.6.2 Example of key olefin complex and iminium adduct intermediates before 




The presumed intermediate structures before and after C-C bond formation were 
optimized using DFT, and the free energy changes between the ground state optimized 
structures were calculated (Figure 2.6.4). When performing the DFT calculations, 
conformational sampling was used to increase the probability of obtaining the ground state 
energy of a global minimum instead of a local minimum. This approach was used for each 
alkene complex, but not on the adduct intermediates due to their conformational 
constraint. A total of 9 different conformations were sampled for each enamine complex 
we report. These 9 conformations arise from all permutations resulting from 120º rotation 
of the C1C2C3C4 and C2C3C4N5 dihedral angles (Figure 2.6.3). Representative examples 
of their relative G298 (kcal/mol) are provided below for conformers of 2.20-complex. In 
parentheses are the Gibbs free energies relative to the lowest energy conformer 2.20i.  
Assuming that the C-C bond formation step needs to be exergonic for catalysis to 
be achieved, catalyst systems with more exergonic C-C bond formation were considered 





addition to the olefin, the iminium adduct intermediate could be an E- or Z-iminium 




Figure 2.6.3 Conformational sampling of DFT optimized 2.20-complex. Computed 





DFT calculations of the Pd(II)-ethylene complex and iminium adduct after C-C 
bond formation indicated that the free energy change was favorable for both the pyridyl- 
and pyridazine-oxazoline bifunctional precatalysts. Variations of both precatalysts were 
also calculated (Figure 2.6.4). Oxazoline 2.21 and nonplanar ligands 2.22 and 2.23 were 
all found to be less exergonic than 2.19. There was only a marginal energy difference 















added benefit of ethylene coordination to palladium cis to the oxazoline being 2.9 kcal/mol 
favored over the trans position, while cis coordination in 2.22 was found to only be 1.2 
kcal/mol lower in energy than trans coordination (Figure 2.6.4). 
 
 





Decreasing the steric interactions by using pyridazine 2.26 rather than pyridine 
2.28 was seen to be beneficial. Shortening the amine tether by one methylene unit in 2.29 
had the dramatic effect of making the C-C bond formation very endergonic due to a high 
enthalpic penalty (+17.5 kcal/mol) due to ring strain. This confirmed our hypothesis that 
the amine tether length was crucial when designing these bifunctional precatalysts. 


























2.19: -17.2 (R = H)
















2.26: -9.1 (R = H)



























calculation of a more exergonic reaction. This was surprising, as the Thorpe-Ingold effect 
is a kinetic, not a thermodynamic, effect. The adduct formation for secondary acyclic 
precatalysts 2.20 and 2.27 and cyclic amine precatalysts 2.24(R) and 2.30 were more 
exergonic than their respective primary amines. 
With the strong dependence on the tether length observed in the pyridazine 
system, we sought to test the effect of the tether length and position of substitution on the 
aryl ring in precatalyst 2.20 (Table 2.6.1). Having the tether in the meta position was the 
most favored, confirming our hypothesis using 3D models. Positioning the tether in the 
ortho position (entry 1, ΔG2 = –16.8 kcal/mol) seems reasonable given its comparable 
thermodynamics to the meta position (entry 2, ΔG2 = –18.8 kcal/mol), however this would 
place the amine or enamine in close enough proximity to poison the metal. This 
phenomenon was observed when performing DFT optimization on the enamine adding to 
the Pd(II) center and displacing ethylene to give the "quenched" structures (Table 2.6.1).  
 
 
Table 2.6.1 DFT calculations on bifunctional PyOX precatalysts with varying tether 
length and position on the aryl ring 
 




1 ortho 1 –19.9 –16.9 
2 meta 1 –8.3 –18.8 
3 para 1 –1.6 –12.6 
4 meta 0  –11.8 
5 meta 2  –19.9 
 
 
When the tether is in the ortho position, the addition of the enamine to the metal is 


























19.9 kcal/mol vs ΔG2 = –16.9 kcal/mol). Moving the tether to the meta or para position 
(entries 2, 3) results in the desired adduct formation to be at least 10 kcal/mol more 
favorable than intramolecular quenching. As the length of the alkyl chain increases, the 
C–C bond formation is calculated to become more exergonic. A tethered ethylamine (entry 
2) was found to be ideal. A shorter chain length (entry 4, ΔG2 = –11.8 kcal/mol) is less 
exergonic, and a catalyst with a longer chain length (entry 5, ΔG2 = –19.9 kcal/mol) is 
calculated to be most favorable for this transformation, but will likely lead to self-quenching 
via amine–metal coordination. Overall, these preliminary DFT calculations led us to 
prioritize the catalyst of entry 2 (Table 2.6.1) as our lead scaffold to study in further detail. 
 
 
Table 2.6.2 DFT calculations of bifunctional PyOX precatalysts with varying counter ion 
and pyridyl substituents 
 
Entry Counter Ion (X) Substituent (Y) R DG298 (kcal/mol) 
1 Cl H Me -18.8 
2 Br H Me -19.9 
3 I H Me -20.5 
4 PF6 H Me -30.8 
5 Cl H H -17.2 
6 Cl F H -17.2 
7 Cl Cl H -18.5 
8 Cl Br H -19.0 
9 Cl OMe H -15.0 
 
 
We sought to study the effect of the metal counter ion X and the electronics of the 
pyridyl ring (substituent Y) on the C–C bond forming step (Table 2.6.2). More weakly 
coordinating counterions result in more exergonic calculated reactions (entries 1–4), 



















under study here, may be difficult to quantify using these calculations. The weaker sigma 
donors yield more electrophilic metal centers, which in turn are expected to generate a 
more electrophilic ethylene complex that should provide more exergonic reactions. 
Although not as prominent, this trend was also observed for 4-substituted pyridyl 
precatalysts. Electron-withdrawing substituents (entries 7–8) yielded a more exergonic 
calculated C–C bond formation, and the electron-donating methoxy group (entry 9) 
resulted in a less exergonic reaction, though fluoride (entry 6, ΔG = –17.2 kcal/mol) was 




Figure 2.6.5 A) DFT calculations of metal-ethylene complexes and adducts after C-C 




These ligands were designed to provide square planar coordination geometries 
with group 10 transition metals. This geometry allows the coordinated alkene to be 
“sandwiched” between the metal and the appended enamine intermediate, providing 
access to the p*-orbitals on the alkene. Coordination of an alkene in this fashion, cis to the 
oxazoline and proximal to the organocatalyst tether, was found to be 3.0 kcal/mol more 





2.6.5A), the ethylene complex takes on a distorted tetrahedral coordination geometry, thus 
positioning the alkene p*-orbitals much further away from the enamine (Figure 2.6.5B). 
The macrocyclization for Cu(I) with precatalyst 2.28 was calculated to be very endergonic, 




Figure 2.2.6 Estimation of transition state energy for C–C bond formation by DFT 
calculations of structures with fixed distances between enamine and ethylene. Values 
are normalized to the complex in its most stable conformation prior to C–C bond 





 While these ground state DFT calculations are used to screen our precatalysts for 
exergonicity of the C–C bond forming step, the activation energy for this step also 
determines the catalyst viability. Given the computationally intensive nature of calculating 
these transition states, we sought to estimate the activation energy by fixing the distance 
between the new C–C bond formed between the ethylene carbon (C1) and enamine (C2), 




















2.6.6). The free energies reported are with respect to the lowest energy conformation of 
the ethylene complex (Figure 2.6.3). The free energy barrier for C–C bond formation was 
estimated to be 7.4 kcal/mol, with 4.1 kcal/mol of that energy arising from the 
organocatalyst tether changing from an extended conformation (C1–C2 = 9.035 Å) to a 
more closed conformation (C1–C2 = 5.065 Å). This energy barrier should be low enough 
to overcome at elevated temperatures. 
 
 
2.7 Synthesis of Bifunctional PyOx Precatalyst 
 
 
After our initial DFT prioritization, we pursued the synthesis of the bifunctional 
precatalyst 2.20. Retrosynthetically, we surmised the oxazoline ring formation of 2.32 
would be a natural disconnect for the synthesis of precatalyst 2.20 (Scheme 2.7.1). 
Alcohol 2.33 could be generated by an amide coupling of carboxylic acid 2.34 and amino 
alcohol 2.35. The amino alcohol was envisioned to arise via a Sharpless 
aminohydroxylation of the respective substituted styrene 2.36.131 With this retrosynthetic 
analysis, we recognized that the late stage peptide coupling would potentially enable more 
efficient access to precatalyst modifications on the eastern end. 
 
 




In the forward direction (Scheme 2.7.2), the Boc protection of the primary amine 
2.37 using Boc anhydride and triethylamine gave the desired carbamate 2.38 in good 
yield. While earlier stage reactions used commercially available 2-(3-





































of nitrile 2.44 using LiAlH4 (Scheme 2.7.3).132 A Suzuki cross-coupling of aryl bromide 2.38 
with 2,4,6-trivinylcyclotriboroxane-pyridine, prepared according to the literature,133 
generated the substituted styrene 2.36.134 Sharpless asymmetric aminohydroxylation of 
on styrene 2.36 using (DHQD)2PHAL, K2OsO2(OH)4 and in situ generated benzyl N-
chloro-N-sodiocarbamate afforded the carbobenzyloxy-protected amino alcohol 2.40 in 
40% yield, with a predicted absolute stereochemistry of (R) when using the (DHQD)2PHAL 
ligand.131 This enantioselectivity arises via an asymmetric induction. The main 
disadvantage to this route was the low yield in the aminohydroxylation step from the lack 
of regioselectivity, though regioisomer 2.39 was separable via flash chromatography. The 
hydrogenolysis of 2.40 was carried out using Pd/C and H2 (3.5 bar) in MeOH to yield amino 
alcohol 2.35 in excellent yield. HATU amide coupling of various picolinic acids with amino 
alcohol 2.35 provided amides 2.41a-c in reasonable yields. 
 
 




Oxazoline formation proceeded smoothly using DeoxoFluor® to afford compounds 
























  aq. NaOH
  t-butylhypochlorite
  nPrOH, 0 ˚C
ii) (DHQD)2PHAL (6 mol%)
    K2OsO2(OH)4 (4 mol%)
    3 (1 eq)






































2.41a (R = H, 54 %)
2.41b (R = Cl, 85 %)
2.41c (R = Br, 65 %)
R Deoxo-Fluor



















2.42a (R = H, 50%)
2.42b (R = Cl, 65%)





mixture of mono- and bis-alkylated products, which were not separable via flash 
chromatography. Subjection of the mono- and bis-alkylated crude material to Boc 
deprotection using Amberlyst® 15 still yielded a mixture. To avoid these issues, we chose 
to test alternative N-methylation reaction conditions.135 The use of the weaker base 
potassium hydroxide in dimethyl sulfoxide demonstrated spot-to-spot conversion to the 
desired monoalkylated product with no bisalkylated byproduct evident via LC-MS (not 
shown). 
 While this first-generation synthesis of these PyOx bifunctional catalyst scaffolds 
provided a proof of concept, there were several drawbacks. First, the key Sharpless 
asymmetric aminohydroxylation was low yielding. Second, the late stage N-methylation 
using sodium hydride yielded inseparable overalkyalted byproduct. Although this over 
alkylation problem was solved using potassium hydroxide, there was still concern over 
epimerization of the chiral oxazoline. Finally, the Suzuki cross coupling with 2,4,6-
trivinylcyclotriboroxane-pyridine was not reliable, producing a wide range of conversions 
(25-90%). 
To address the drawbacks from the first generation PyOx synthesis, several 
modifications were made. Rather than using a Sharpless asymmetric aminohydroxylation 
to access the key amino alcohol, we opted to utilize a styrene epoxidation/azide ring-
opening sequence. Additionally, the N-methylation was implemented earlier in the 
synthesis. While this avoids the possibility of overalkylation, it does preclude any late stage 
modifications to the organocatalyst amine tether. Finally, potassium vinyltrifluoroborate, 
rather than the 2,4,6-trivinylcyclotriboroxane-pyridine complex, was used in the Suzuki 
cross coupling. 
Utilizing the same first two synthetic steps in (Scheme 2.7.2), the BOC protected 
amine 2.38 can be made on a 10 g scale. At this stage, we decided to N-methylate 2.38 





yield. Suzuki coupling of aryl bromide 2.45 with potassium vinyltrifluoroborate136 generated 
the substituted styrene 2.46, with more consistent results compared to vinyl triboroxine–
pyridine complex. Subsequent epoxidation of styrene 2.46 with mCPBA followed by 
regioselective ring-opening with sodium azide in hot water gave azido alcohol 2.48 in 66% 
over two steps. While this synthetic route yields racemic material, optically active catalysts 
could optionally be generated from via asymmetric epoxidation methods. The current 
styrene epoxide opening method using sodium azide and hot water has been shown to 
give clean inversion of stereochemistry.137 Reduction of 2.48 using Pd/C under H2 afforded 
amino alcohol 2.49 in excellent yield. EDC amide coupling with picolinic acid followed by 
oxazoline formation using DeoxoFluor®138-139 proceeded smoothly to afford 2.51. Finally, 
Boc removal using excess trifluoroacetic acid (TFA) yielded the final precatalyst 2.20. 
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2.8 Intermolecular Reaction Screening using Bifunctional PyOx Catalyst 
 
 
With the synthesized precatalyst 2.20 in hand, we proceeded to test it in a variety 
of reaction screens for the direct additions of ketones to alkenes and alkynes, using GC-
MS to analyze each reaction. Cyclopentanone was selected due to its well-established 
reactivity for enamine formation.140 Additionally, methyl acetoacetate was chosen for its 
frequent use in alkene hydroalkylation reactions. Ethylene, 4-(4-fluorophenyl)-1-butene, 
and 6-phenyl-2-hexyne were chosen as representative electrophiles in the reactions 
(Tables 2.8.1 and 2.8.2); the aromatic handles were included with several substrates to 
facilitate product identification. Due to its polar, non-coordinating nature, nitromethane was 
used for all reactions; less polar solvents are often unable to dissolve the cationic metal 
salts of interest. For metal salts with halide counterions, the metal/precatalyst solution was 
reacted with 1 or 2 equivalents of AgBF4, and the resulting silver halide salts were filtered 
off prior to the addition of substrates. 
 Results from a representative metal salt screen with precatalyst 2.20, 
cyclopentanone, and either 4-(4-fluorophenyl)-1-butene (2.52) or ethylene (2.53) are given 
in Table 2.8.1. All reactions with ethylene (entries 1–16) produced no detectable desired 
products such as 2.54 or 2.55 via GC-MS, as confirmed by analysis of low concentrations 
of the positive control 2-ethyl-cyclopentanone (2.55, R1, R2 = H) added to a sample 
reaction mixture. Similarly, when we used 4-(4-fluorophenyl)-1-butene 2.52 (entries 1–
16,), no desired adducts were detected and only starting material peaks were prominent 









Table 2.8.1 Screening of group 10 metal salts in reactions with cyclopentanone 
 




.6H2O/ AgBF4 A A 
2 NiI2/AgBF4 A A 
3 Ni(OAc)2
.4H2O A A 
4 NiCl2(DME)/AgBF4 A A 
5 Ni(OTf)2 A A 
6 Pd(OAc)2 A A 
7 Pd(CH3CN)4(BF4)2 B A 
8 Pd(CH3CN)2Cl2/AgBF4 B A 
9 Pt(DMSO)2Cl2/AgBF4 A A 
10 Pt(DMSO)2l2/AgBF4 A A 
11 Pt(DMSO)2Cl2/2AgBF4 A A 
12 Pt(DMSO)2l2/2AgBF4 A A 
13 AgBF4 A A 
14 none A A 
15 Pd(CH3CN)4(BF4)2
d C C 
16 Pd(CH3CN)2Cl2/AgBF4
d C C 
a Precatalyst 2.20 (2 mg, 0.007 mmol) was dissolved in NO2Me (0.3 mL) and 
added to the respective metal salt (0.007 mmol) in a 1.5 mL HPLC vial. The 
alkene (0.070 mmol) and cyclopentanone (0.070 mmol) were added as solutions 
in NO2Me (0.100 mL). The vials were heated at 50 ºC for 24 h, and analyzed 
directly via GC-MS. b Reactions were flushed with ethylene and stirred at 50 ºC 
for 24 h at 50 psi in a pressure flask. c Results: A: No reaction; B: trace amount 




Olefin isomerization products and trace amounts of dimerization products were 
found in samples with 2.52 and palladium metals (entries 7–8). Precatalyst 2.20 appears 
to suppress olefin oligomerization, as control reactions without 2.20 (entries 15–16) had 
nearly complete consumption 2.52 and conversion to alkene dimer and trimers, as 
detected by GC-MS. In the case of ethylene, a peak with a mass corresponding to octene 
was detected in the GC-MS. Pt(II) and Pd(II) salts are known to promote the 
polymerization of alkenes.141-143 A reaction screen for the addition of cyclopentanone to 6-
phenyl-2-hexyne was also performed, but also yielded only peaks for the starting materials 


















R1 = H 







Table 2.8.2 Screening of group 10 metal salts in reactions with methyl acetoacetate 
 
Entrya Metal Temperature (ºC) Result with:
c 
2.52 2.53b 2.56 
1 NiCl2(DME)/AgBF4 50 A A A 
2 Ni(OTf)2 50 A A A 
3 Pd(CH3CN)4(BF4)2 50 B A A 
4 Pd(CH3CN)2Cl2/AgBF4 50 B A A 
5 Pt(DMSO)2Cl2/AgBF4 50 A A A 
6 Pt(DMSO)2l2/AgBF4 50 A A A 
7 Pt(DMSO)2Cl2/2AgBF4 50 A A A 
8 Pt(DMSO)2l2/2AgBF4 50 A A A 
9 AgBF4 50 A A A 
10 – 50 A A A 
11 Pt(DMSO)2Cl2/AgBF4 90 - C A 
12 Pt(DMSO)2l2/AgBF4 90 - C A 
13 Pt(DMSO)2Cl2/2AgBF4 90 - C A 
14 Pt(DMSO)2l2/2AgBF4 90 - C A 
15d Pt(DMSO)2Cl2/AgBF4 90 - C D 
16d Pt(DMSO)2l2/AgBF4 90 - C D 
17d Pt(DMSO)2Cl2/2AgBF4 90 - C D 
18d Pt(DMSO)2l2/2AgBF4 90 - C D 
aPrecatalyst 2.20 (2 mg, 0.007 mmol) was dissolved in NO2Me (0.3 mL) and added to the respective metal 
salt (0.007 mmol) in a 1.5 mL HPLC vial. The alkene or alkyne (0.070 mmol) and methyl acetoacetate (0.070 
mmol) were added as solutions in NO2Me (0.100 mL). The vials were heated at 50 ºC for 24 h, and analyzed 
directly via GC-MS. bReactions were flushed with ethylene and stirred at 50 ºC for 24 h at 50 psi in a pressure 
flask. cResults: A: No reaction; B: trace amount of olefin dimerization; C: a peak with a mass corresponding 
to octene was present in the GC-MS; D: alkyne dimerization and trimerization observed. dPrecatalyst 2.20 
was not added to these reaction vials. 
 
 
Due to the limited solubility of some of the nickel metal salts and Pd(OAc)2 with our 
precatalyst in NO2Me, we chose to exclude these metal salts in our additional screens. 
Mixtures of methyl acetoacetate with ethylene (2.53), 4-(4-fluorophenyl)-1-butene (2.52), 
or 6-phenyl-2-hexyne (2.56) were screened with precatalyst 2.20 and either palladium or 
platinum metal salts (Table 2.8.2). Similar results were obtained as in the screens using 
cyclopentanone. Only starting material peaks were present in the GC-MS, except when 
using palladium with 4-(4-fluorophenyl)-1-butene (column 4), where trace amounts of 
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reactivity, platinum monocationic and biscationic metal salt systems were tested at 90 ºC 
for the addition of methyl acetoacetate to either ethylene or 6-phenyl-2-hexyne (2.56). In 
the absence of precatalyst 2.20, ethylene presumably underwent oligomerization, as a 
peak with a mass corresponding to octene was detected by GC-MS (entries 15–18). 
Additionally, 6-phenyl-2-hexyne in the absence of 2.20 underwent dimerization and 
trimerization. With the incorporation of precatalyst 2.20, the alkyne dimers and trimers 
were completely suppressed when using 6-phenyl-2-hexyne, but a detectable amount of 
octene was present when using ethylene. 
 
 
Table 2.8.3 Additive screen with methyl acetoacetate 
 
Entrya Additive Resultb 
1 4-nitrophenol NR 
2 benzoic acid NR 
3 p-TsOH NR 
4 acetic acid NR 
5 TFA NR 
6 2,6-di-tert-butylpyridine NR 
7 – NR 
aPrecatalyst 2.20 (1 mg, 0.0035 mmol) and Pd(CH3CN)4(BF4)2 (0.0035 mmol) were dissolved in 
NO2Me (0.05 mL) in a 1.0 mL test tube. Methyl acetoacetate (0.035 mmol) and the additive (0.0035 
mmol) were added as solutions in NO2Me (0.100 mL). The samples were heated at 50 ºC for 24 
h, aliquots were taken for analysis directly via GC-MS, and the samples were heated at 90 ºC for 
an additional 24 h and analyzed directly via GC-MS. bReactions were flushed with ethylene and 
stirred under 50 psi in a pressure flask. NR = no reaction. 
 
 
A range of additives was additionally tested for the addition of methyl acetoacetate 
to ethylene, along with the non-coordinating base 2,6-di-tert-butylpyridine (Table 2.8.3). 
These reactions were initially run at 50 ºC for 24 h, and allowed to cool to room 
temperature before ~50 µL aliquots were taken for GC-MS analysis, then the temperature 
was increased to 90 ºC for an additional 24 h. No reactions were observed with any of the 
additives after heating at 50 or 90 ºC. Despite promising DFT calculations, we were unable 
















via our PyOX bifunctional catalyst. Without this promising hit, we aimed to rationalize this 
lack of reactivity through NMR experiments and X-ray crystallography. 
 
 
2.9 NMR Experiments with Pd(II)-PyOX Complexes and Attempted Crystallizations 
 
 
In parallel with our efforts to screen our bifunctional PyOX precatalyst 2.20 under 
different reaction conditions, we attempted to obtain single crystals of various Pd(II) and 
Pt(II) complexes. Crystallization trials were run via slow diffusion using nitromethane, 1:1 
nitromethane: benzene, or acetonitrile as the strong solvent and diethyl ether or pentane 
as the weak solvent. Unfortunately, our attempts were unsuccessful. To further probe the 
dynamics of the PyOX precatalyst with the metal salt, 1H NMR spectra were obtained in 
CD3NO2 before and after the addition of 1 equivalent of Pd(CH3CN)2Cl2 to bifunctional 
precatalyst 2.20 (Figure 2.9.1).  
 
 
Figure 2.9.1 1H NMR (CD3NO2, 300 MHz) spectra of PyOX precatalyst 2.20 (B) and its 




In the presence of Pd(II), all of the ligand peaks broaden significantly. Furthermore, 
















of the precatalyst peaks upon addition of Pd(CH3CN)2Cl2 is consistent with slow exchange 
between two or more complexes. The broadening and shifting of the aminoethyl peaks 
(the 4 methylene protons originally at 2.8 ppm, and the methyl protons at 2.3 ppm, Figure 
2.9.1B) suggests an undesirable interaction between the metal and the amine, 
presumably in an intermolecular fashion. 
 
 
Figure 2.9.2 1H NMR (CD3NO2, 300 MHz) spectra of Boc-protected PyOX precatalyst 




A 1H NMR spectrum of the Boc-protected precatalyst 2.51 in the presence of 
Pd(CH3CN)2Cl2 was also obtained (Figure 2.9.2). The ligand peaks remain sharp and 
downfield shifts are observed for the pyridyl and oxazoline protons after addition of Pd(II) 
(Figure 2.9.2A), while the aminoethyl and methyl protons at 3.4 and 2.9 ppm are not 
shifted. The noticeable difference in NMR signals between the carbamate 2.51 and 
precatalyst amine 2.20 upon the addition of Pd(II) is consistent with the amine (but not the 
carbamate) participating in undesirable intermolecular coordination with the metal, which 
may also occur under the reaction conditions and preclude substrate binding and 
activation. To the carbamate 2.51 and Pd(CH3CN)2Cl2 (1 eq.) was added AgBF4 (1 eq.) 


















syringe filter, before a stock solution of cyclopentene (1 eq.) in CD3NO2 was added. 
Relative to a control sample without catalyst, there were no observed changes in the 1H 
NMR for the cyclopentene peaks. This indicated that a Pd–alkene complex did not form 
to a significant degree, though reactions on transiently-coordinated ligands are possible. 
 Despite the lack of reactivity from our PyOX or tridentate thiazole bifunctional 
catalysts, we learned valuable information to improve on our precatalyst design. The 
PyOX bifunctional catalyst had observable interactions from 1H NMR between the 
organocatalyst and p-acid, yet demonstrated evidence for Pd(II) coordination when the 
organocatalyst was Boc protected. The N-benzylamine for the tridentate thiazole 
precatalyst also had undesired coordination of the N-benzylamine to the Ag metal as 
evident from the X-ray crystal structure. We thus sought to utilize the tridentate strategy 
from the thiazole precatalyst and apply it to the existing bifunctional PyOX system or 
similar pincer ligands for group 10 metals. We hypothesize a tridentate ligand will establish 
a well-defined 1:1 metal:ligand complex and minimize undesired intermolecular 
interactions between the organocatalyst and p-acid. 
 
 
2.10 DFT Calculations of Tridentate Bifunctional Catalysts 
 
 
Examination of the X-ray structures of several pincer complexes suggested that a 
well-defined tridentate system may be promising scaffolds to contain binding pockets 
selective for smaller alkenes and alkynes over bulkier amines/enamines. The 
“Lockamine”-type NNN-ligands (derivatives of the “Nickamine-type” catalysts) reported by 
Hu,144 phenyl-bis(oxazoline) pincer ligand (PheBOX),145-146 and pyridyl-bis(oxazoline) 
(PyBOX)147-148 pincer ligand are examples of scaffolds that could meet these criteria. Our 
interest in using pincer complexes stemmed from the relevant precedent for alkene 





thus sought to combine such pincer scaffolds with our pendant organocatalyst moiety 
previously designed for the bifunctional PyOX scaffold. 
 
 
Table 2.10.1 DFT calculations of bifunctional PyBOX/PheBOX catalysts for propylene 
coordination (∆G1, 2.61) and C-C bond formation (∆G2, 2.62–2.65) 
 
Entry M Y n (+) ∆G1 (kcal/mol)
a 
2.61 
C-C Bond Formation: ∆G2 (kcal/mol)a 
2.62 2.63 2.64 2.65 
1 Ni N 2 0.6 –21.0 –23.9 –16.8 –16.2 
2 Pd N 2 –4.2 –21.8 –25.2 –21.3 –21.1 
3 Pt N 2 –7.5 –19.7 –23.9 –17.2 –16.2 
4 Ni C 1 10.2 11.6 9.8 17.4 18.2 
5 Pt C 1 9.0 10.6 8.4 15.6 17.2 
aCalculations used the functional B3PW91, basis set LANL2DZ for metals, and basis set cc-pVDZ for all 
other atoms, and DCM as solvent. 
 
 
With these tridentate complexes, either a monocationic (“Lockamine”-type NNN 
ligands and PheBOX ligands) or dicationic (PyBOX ligands) complex intermediate could 
be formed (2.61, Table 2.10.1). Monocationic complexes possess the following 
advantages: they are more functional group tolerant (they should not react with alcohols 
or water) and the intermediate neutral alkyl-metal intermediate will be more susceptible to 
a subsequent protodemetalation that would be required for catalyst turnover. In the 
presence of water, the protodemetalation would ideally occur, but a stoichiometric amount 
of acid as a proton source may be needed. In contrast, an olefin in a dicationic metal 
complex has enhanced electrophilic character and is more activated towards nucleophilic 
addition than the respective monocationic species. However, the biscationic character 
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lead to the soft olefin ligand being displaced by harder ligands and/or nucleophiles in an 
unproductive fashion.58 
DFT calculations were utilized to assist in understanding the impact the electronic 
environment around the Lewis acid has on the energetics for alkene coordination, C-C 
bond formation, and undesired intramolecular quenching in order to prioritize between the 
PyBOX, PheBOX, and Lockamine precatalyst scaffolds. The coordination of propylene to 
Ni(II), Pd(II), and Pt(II) bifunctional PyBOX (entries 1–3) and PheBOX (entries 4 and 5) 
complexes, and the subsequent intramolecular C-C bond formations with enamine 
nucleophiles, were calculated using DFT (Table 2.10.1). Alkene coordination was found 
to be favorable for Pd- and Pt-PyBOX complexes (entries 2 and 3), but significantly 
unfavorable for the PheBOX complexes (entries 4 and 5). Four possible diastereomeric 
adduct intermediates 2.62–2.65 can be formed as a result of linear or branched addition 
to propylene and the formation of a E- or Z-iminium ion. C-C bond formation is consistently 
favorable with bifunctional PyBOX catalysts (entries 1-3) and more exergonic for the 
branched addition (2.62 and 2.63) than linear addition (2.64 and 2.65), while the 
bifunctional PheBOX complexes (entries 4 and 5) are calculated to have unfavorable C-C 
bond formation, suggesting that they may not be suitable catalysts.  
 
 
Table 2.10.2 DFT Calculations of bifunctional Lockamine catalysts for propylene 
coordination (∆G1, 2.67) and C-C bond formation (∆G2, 2.68–2.71) 
 
Entry M ∆G1 (kcal/mol)
a 
2.67 
C-C Bond Formation: ∆G2 (kcal/mol)a 
2.68 2.69 2.70 2.71 
1 Ni 13.3 3.6 –0.1 7.3 7.5 
2 Pt –2.9 10.5 12.6 12.6 12.4 
aCalculations used the functional B3PW91, basis set LANL2DZ for metals, and basis set cc-pVDZ for all 

























The coordination of propylene and subsequent C-C bond formation in Ni(II) and 
Pt(II) bifunctional Lockamine complexes were also calculated (Table 2.10.2). The C-C 
bond formation is slightly favored for 2.69 with Ni (entry 1), but may be irrelevant with 
propylene coordination being extremely unfavorable (13.3. kcal/mol), as observed with the 
Ni-PheBOX monocationic catalyst. In contrast to Ni, the Pt-Lockamine catalyst (entry 2) 
has favorable energetics for propylene complexation (–2.9 kcal/mol), but suffers from the 
same unfavorable C-C bond formation seen with the Pt-PheBOX catalyst. 
 
 
Table 2.10.3 DFT calculations of propylene coordination (∆G1, 2.73) and C-C bond 
formation (∆G2, 2.74–2.77) of Pt in PyBOX- and PheBOX-based complexes with EDGs 
and EWGs 
 
Entry Y X n (+) ∆G1 (kcal/mol)
a 
2.73 
C-C Bond Formation: ∆G2 (kcal/mol)a 
2.74 2.75 2.76 2.77 
1 N H 2 –7.5 –19.7 –23.9 –17.2 –16.2 
2 N OMe 2 –6.6 –17.5 –22.4 –15.6 –14.0 
3 N NMe2 2 –6.2 –14.6 –17.6 –12.3 –12.2 
4 C H 1 9.0 10.6 8.4 15.6 17.2 
5 C Cl 1 NDb 10.9 7.0 15.2 16.2 
6 C NO2 1 9.0 8.1 4.6 12.2 13.4 
aCalculations used the functional B3PW91, basis set LANL2DZ for metals, and basis set cc-pVDZ for all other 
atoms, and DCM as solvent.bDFT energies have not been determined for this entry. 
 
 
The bifunctional PyBOX precatalysts showed the most promise with favorable 
energetics for propylene complexation and C-C bond formation, but these highly 
electrophilic metals may have limited functional group tolerance (i.e. react with alcohols 
or water). To decrease the electrophilicity of the biscationic PyBOX-based complexes, 
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pyridyl ligand (entries 1-3, Table 2.10.3). The EDGs attenuated the energetics of 
propylene complexation and C-C bond formation, but both steps were still exergonic. This 
feature could potentially promote higher turnover frequency if the overall energy profile 
became narrower as a result of these attenuated energetics, and may give improved 
functional group tolerance over the analogous biscationic catalysts without EDGs. 
 In contrast to the bifunctional PyBOX scaffold, monocationic PheBOX and 
Lockamine scaffolds suffered from endergonic C-C bond formation and propylene 
coordination for the bifunctional Ni-Lockamine. To increase the electrophilicity of the 
monocationic Pt in PheBOX complexes, electron withdrawing groups (EWGs) (X = Cl, 
NO2) were placed in the 4-position of the phenyl ligand (entries 4-6, Table 2.10.3). The 
EWGs were calculated to have little impact on propylene coordination, and the C-C bond 
formation is predicted to be less endergonic, but still unfavorable. The monocationic Ni-
Lockamine complex suffered from poor coordination to propylene, while the C-C bond 




Table 2.10.4 Propylene coordination (∆G1, 2.79) and C-C bond formation (∆G2, 2.80–
2.83) calculations on Ni- and Pt-Lockamine complexes with EDGs and EWGs 
 
Entry M X ∆G1 (kcal/mol)
a 
2.79 
C-C Bond Formation: ∆G2 (kcal/mol)a 
2.80 2.81 2.82 2.83 
1 Ni H 13.3 3.6 –0.1 7.3 7.5 
2 Ni OMe 8.9 5.8 3.8 10.7 9.8 
3 Pt NMe2 –2.9 10.5 12.6 12.6 12.4 
4 Pt H –1.2 3.4 1.1 3.7 2.7 
aCalculations used the functional B3PW91, basis set LANL2DZ for metals, and basis set cc-pVDZ for all 
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EDGs (X = OMe) and EWGs (X = NO2) were added para to the central amine in 
an effort to promote propylene coordination and C-C bond formation in the respective 
bifunctional Ni- and Pt-Lockamine complexes (Table 2.10.4). The EDGs (entry 2 vs 1) 
only provided a marginal improvement, although still endergonic, on propylene 
coordination, but had a negative influence on C-C bond formation. The Pt-Lockamine 
complex with EWGs (entry 4 vs 3) resulted in slightly less favorable propylene 




Table 2.10.5 DFT calculations of intramolecular enamine quenching (∆G2) in bifunctional 
PyBOX and PheBOX catalysts 
 




Enamine Quenching: ∆G2 
(kcal/mol) 
2.86 2.87 
1 Ni N 2 0.6 –18.5 –18.5 
2 Pd N 2 –4.2 –24.6 –24.1 
3 Pt N 2 –7.5 –24.9 –26.0 
4 Ni C 1 9.0 6.1 8.7 
5 Pt C 1 10.2 7.0 10.0 
aCalculations used the functional B3PW91, basis set LANL2DZ for metals, and basis set cc-pVDZ for all 
other atoms, and DCM as solvent. 
 
 
 A concern with these bifunctional catalysts is the potential of an enamine to 
irreversibly add to the metal in an intramolecular fashion. This would prevent the 
productive olefin coordination required for the desired reaction. The bifunctional PyBOX 
catalysts, predicted to be the most promising for propylene coordination and C-C bond 
formation, were found to be very exergonic for intramolecular enamine quenching (Table 






























calculated to not be problematic (entries 4–5), but these systems were not predicted to be 
promising catalysts due to unfavorable propylene coordination and C-C bond formation. 
 Bifunctional Lockamine-Ni catalysts exhibited similar results to the bifunctional 
PheBOX catalysts, having both unfavorable intramolecular enamine quenching and 
propylene coordination. Using Pt with the bifunctional Lockamine complex had the benefit 
of favorable energetics of propylene coordination, but the intramolecular enamine 
quenching is slightly favorable in some cases, depending on if it is the E- 2.90 or Z-iminium 
2.91 adduct (Figure 2.10.1). 
 
 
Figure 2.10.1 Intramolecular enamine quenching in bifunctional Lockamine catalysts. 




 A bifunctional catalysts system with calculated favorable energetics for propylene 
coordination and C-C bond formation, but unfavorable intramolecular enamine quenching 
has yet to be found. Intramolecular enamine quenching could be a complication with these 
bifunctional catalysts, but we hypothesize that the enamine (or amine) is too far to complex 
directly with the metal without substantial structural reorganization (i.e. unfavorable 
transition state). When designing these catalysts, our goal was to position the 
organocatalyst far enough away to avoid the amine or enamine from poisoning the metal. 
Examination of the optimized DFT structures does indicate the enamine is substantial 
distance (>6Å) away from the metal center (Figure 2.10.2). In summary, these DFT 
calculations prioritized the bifunctional PyBOX scaffold over the PheBOX or Lockamine 
M = Ni: 9.0 kcal/mol
       Pt: 0.9 kcal/mol
M = Ni:  7.0 kcal/mol
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due to its more favorable energetics for propylene coordination and C-C bond formation. 
The next step was to determine whether the bifunctional PyBOX scaffold would 
experimentally result in desired reactivity, unlike the analogous PyOX scaffold, for the 
addition of an aldehyde/ketone to an alkene or alkyne. Further results and discussion of 
this approach are given in Chapter 3. 
 
 
Figure 2.10.2 Examples of DFT optimized Pt-propylene complexes in bifunctional A) 











Dual Catalysis with Group 10 Metal Complexes for Direct Additions of Carbonyl 
Compounds to Alkenes and Alkynes 
 
 
3.1 Introduction to Dual Catalysis with Group 10 metal-PyBOX Complexes 
 
 
 Our previous unsuccessful attempts at adding aldehydes and ketones to alkenes 
and alkynes using a Pd/Pt(II)-PyOX or Cu(I) systems to activate unsaturated electrophiles 
led us to explore alternatives catalytic systems. A dual catalyst system was originally 
avoided due to the potential for the Lewis acid and Lewis basic catalytic sites to poison 
each other. The desired alkene activation via coordination to the p-acid metal would be in 
competition with direct coordination of the amine co-catalyst or enamine. Initially inspired 
by reports from Gagne65, 149 that utilized a Pt-PyBOX complex for activation of alkenes, we 
hypothesized that it might be possible to adapt this system into a dual catalytic system 
suitable for additions of carbonyl compounds to alkenes or alkynes (Figure 3.1). 
Additionally, our previous DFT studies on tridentate bifunctional scaffolds suggested the 
PyBOX scaffold would result in more exergonic alkene complexation to group 10 metals 
than alternative tridentate scaffolds (“Lockamine” and PheBOX). We hypothesized that a 
dual catalytic approach could be an improvement over our previously tested bifunctional 
PyOX and Cu(I) systems in that 1) tridentate PyBOX ligands have been established to 
form stable rigid structures with group 10 metals, 2) facile synthesis of tridentate ligands 
or utilizing commercially available ligands, 3) variation of the p-acid and organocatalyst 
can be varied and optimized independently from each other. We hypothesize that 
substituents on the oxazoline ligands could be modulated to form a well-defined binding 
pocket in addition to using bulkier organocatalysts could prevent catalyst poisoning of the 





discussed here resulted in a publication titled “Computationally-guided investigation of 
dual amine/pi Lewis acid catalysts for direct additions of aldehydes and ketones to 
unactivated alkenes and alkynes.”150 
 
 
Figure 3.1 Proposed dual catalytic approach for the addition of carbonyl compounds to 




 The proposed dual catalytic reaction as given in Figure 3.1 would proceed very 
similarly to the bifunctional catalyst systems (Chapter 2). An amine co-catalyst would 
activate an aldehyde or ketone via enamine formation (and loss of water), while the 
alkene/alkyne would be activated by the p-acidic metal via coordination. Outer sphere 
attack of the enamine on the coordinated alkene/alkyne would generate an organometallic 
intermediate (Figure 3.1, middle). Subsequent iminium hydrolysis and protodemetalation 
would yield the alkylation product and regenerates the active catalyst. In both the 
bifunctional and dual catalytic systems, we hypothesized that the branched alkylation 
products would be selectively formed, which is consistent with an outer sphere attacks of 
nucleophiles on alkenes coordinated to group 10 metals.151 
In the design of pincer ligands with selective binding pockets, analogs with varied 
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(R’ and R”) would be more selective for binding alkenes and alkynes over amine co-
catalysts or bulkier enamines due to steric constraints. Substituents at R’ and R” could 
also be varied to selectively recognize terminal alkenes or 1,2-disubstituted E-alkenes by 
sterically blocking 2, 3, or 4 quadrants around the coordination site. Ligands with C2-
symmetry or ligands with one open quadrant may have bulky substituents that extend far 
enough out to affect the approach of a prochiral or chiral enamine to permit 
enantioselective reactions. Initially, terminal alkenes and alkynes were tested with ketones 
and aldehydes and several secondary amine co-catalysts, including pyrrolidine, proline,33 
Jørgensen’s pyrrolidine,152 and MacMillan’s imidazolidinone (Figure 3.2).44-46 We 
hypothesize that the bulkier amines, such as Jørgensen’s pyrrolidine or MacMillan’s 
imidazolidinone, will be less prone to direct coordination and poisoning of the metal. 
 
 




The final component to consider with these tridentate systems is the electronics 
around the metal. As previously discussed with the analogous bifunctional pincer 
scaffolds, the PyBOX ligands could be used to form biscationic complexes with an alkene 
or alkyne, which are more active towards nucleophilic addition. However, this enhanced 
electrophilic character and hardness on the metal center can lead to softer alkene and 
alkyne ligands being displaced by harder ligands and/or nucleophiles. Addition of electron 
withdrawing or donating groups to the pyridine moiety of the ligand, or using more electron 
rich pyridyl-bis(imidazoline) ligands, would allow us to tune the electrophilicity and strength 
of the coordinated alkene or alkyne. Syntheses of PheBOX and PyBOX complexes with 
























asymmetric cyclopropanations of olefins were affected by the electronics of 4-substituted 
PyBOX ruthenium catalysts.155  
 Our initial studies focused on a Pt-PyBOX complex to take advantage of the fact 
that platinum-olefin complexes are more stable than with other group 10 metals, which 
would assist with spectroscopic studies (e.g. NMR) on potential intermediates. 
Additionally, the protodemetalation of Pt(II) intermediates is known to be more facile than 
with analogous palladium complexes.156 However, nickel provides the great advantage of 
being approximately 3600x cheaper than platinum at current prices. We additionally 




3.2 DFT Optimization of Dual Catalyst Combinations 
 
 
 In order to study our proposed dual catalytic system before extensive reaction 
screening, we again used DFT calculations to computationally explore ligand, metal, and 
organocatalyst combinations that would minimize the likelihood of the competing Lewis 
acidic and Lewis basic catalysts from poisoning each other. In addition to performing DFT 
calculations on the C-C bond formation step, we also turned our attention towards 
comparing the Gibbs free energies of alkene and alkyne complexation between different 
metals (i.e. Ni, Pt, and Pd) with variable ligands and electronic environments (Figure 
3.2.1). We hypothesized that even if the C-C bond formation was exergonic for a particular 
scaffold, an endergonic alkene or alkyne complexation could also be a factor inhibiting 
catalytic activity, i.e. the complete catalytic cycle should ultimately be considered. 
Complexation to the p-acid in our dual catalyst systems is especially important; the pincer 
complexes needs to have a selective binding pocket favoring coordination of smaller 





Through comparing the Gibbs free energies of alkene, alkyne, aminocatalyst, and 
enamine coordination to the pincer complexes with varying steric and electronic 
environments, we sought to identify suitable catalyst combinations that could promote 
alkene/alkyne coordination and subsequent nucleophilic addition of the enamine to the 
coordinated olefin, while avoiding poisoning of the metal by the organocatalyst. 
 
 




The first set of DFT calculations were performed to predict how changes in the 
electronic environment around the p-acid would effect propylene/acetylene coordination 
and C-C bond formation: the presence of an electron-donating group (EDG) (X = NMe2) 
at the 4-position of the pyridine; flanking oxazoline versus imidazoline ligands; and bis-
methyl or isopropyl substituents on the oxazolines or imidazolines (Table 3.2.1). The 
addition of the enamine derived from acetone and pyrrolidine was used for our initial 
studies, with Ni(II) and Pt(II) catalyst complexes. For our DFT calculations, structures were 
again visualized and underwent a pre-optimization with molecular mechanics in Avogadro 
before geometries were further optimized and energies were calculated using DFT via 
Gaussian 09 software. Propylene complexation was found to be unfavorable with the bulky 
tetramethyl-substituted nickel complexes (entries 1–3), whereas acetylene complexation 
was favorable (entry 2). The relatively less sterically congested isopropyl-substituted 




















































6). With the platinum complexes, propylene complexation was found to be favorable for 
the tetramethyl-, isopropyl-, and tertbutyl-complexes (entries 7–14).  
 
 
Table 3.2.1 DFT calculations of alkene complexation and iminium adduct formation 
 
Entry M R R’ X Y Propylene or (acetylene)
b 
complexation, ΔG1 (kcal/mol) 
Enamine additionb 
ΔG2 (kcal/mol) 
1 Ni Me Me NMe2 O 6.8 –18.0 
2 Ni Me Me H O 5.9 (–2.4) –21.8 (–44.0) 
3 Ni Me Me H NH 7.7 –17.1 
4 Ni i-Pr H NMe2 O –3.6 –14.7 
5 Ni i-Pr H H O –3.2 (–8.0) –20.2 (–42.3) 
6 Ni i-Pr H H NH –1.6 –13.2 
7 Pt Me Me NMe2 O –4.0 –14.2 
8 Pt Me Me H O –3.5 (–9.3) –21.2 (–44.6) 
9 Pt Me Me H NH –2.4 –16.5 
10 Pt i-Pr H NMe2 O –9.6 –15.0 
11 Pt i-Pr H H O –8.6 (–11.0)c –19.7 (–45.8) 
12 Pt i-Pr H H NH –7.1 –15.8 
13 Pt t-Bu H NMe2 O –4.2c –16.5 
14 Pt t-Bu H H O –2.3 –16.1 
aAll calculations used the functional B3PW91 and basis set LANL2DZ for metals, and the basis set cc-pVDZ for all other atoms. 




C-C bond formations to give the iminium adduct intermediates 3.3 were calculated 
to be exergonic for both Ni2+ and Pt2+ in all cases. The electron-donating group (EDG) 
dimethylamine (entries 1, 4, 7, 10, and 13) was found to have a beneficial effect on alkene 
coordination with platinum (e.g. entries 10 vs. 11), which initially led us to prioritize its use 
in our calculations in Table 3.2.1. However, it attenuated the favorable free energy 
changes of the enamine addition (C-C bond formation), which is not surprising considering 




























used the unsubstituted PyBOX complexes in our screening experiments (vide infra). The 
more electron rich pyridine-bis(imidazoline) systems gave relatively less favorable 
energetics for iminium adduct formation and propylene complexation (entries 3, 6, 9, and 
12). 
In the design of PyBOX ligands with selective binding pockets, the substituents (R, 
R') on the oxazolines can be varied to selectively recognize smaller alkenes or alkynes, 
while making bulkier enamine organocatalysts less prone to direct coordination and metal 
poisoning (Figure 3.2.1). Any interaction between the organocatalyst and Lewis acid 
should also be rapidly reversible. Another possible concern is that the metal could also be 
poisoned via aldehyde/ketone binding, instead of the alkene/alkyne; however, we were 
primarily interested in studying Pt or Pd systems, and presumed that this interaction was 
more likely for the harder, more oxophilic Ni(II) salts. This notion is consistent with some 
of DFT calculations that we have performed on coordination of carbonyls to group 10 metal 
complexes. For our subsequent calculations, the 4-NMe2-PyBOX scaffold was selected 
due to its improved energetics for propylene binding. We considered a variety of 
secondary amine co-catalysts, including pyrrolidine, a-methyl-L-proline, Jørgensen’s 
pyrrolidine 3.8,152 and MacMillan’s t-Bu-imidazolidinone 3.9.44 DFT calculations were 
performed on combinations of PyBOX, organocatalyst, alkene (propylene and ethylene), 
and metal (Ni, Pd, Pt) to determine the energetics of alkene coordination versus poisoning 
of the metal via organocatalyst coordination (Table 3.2.2). 
As expected, pyrrolidine was calculated to fit into the binding pocket of all 
complexes and had very favorable (though undesired) metal coordination (Table 3.2.2, 
column 8). While the bulkier a-methyl-L-proline had diminished energetics for 
coordination, it was also predicted to have favorable coordination with every system 





most promising organocatalysts were predicted to be Jørgensen’s pyrrolidine 2.6 and 
MacMillan’s imidazolidinone 2.7. 
 
 
Table 3.2.2 DFT calculations for desired alkene/alkyne vs undesired amine coordination 
 










1 Ni Me Me NMe2 cc-pVDZ –15.8 –5.1 4.3 3.4 1.5 6.8  
2 Ni i-Pr H NMe2 cc-pVDZ –23.5 –19.9 –8.3 –6.9 –3.2 –3.6  
3 Ni i-Pr H NMe2 Def2-
QZVPP 
  –8.1 –3.0 0.3 0.8  
4 Ni t-Bu H NMe2 cc-pVDZ –16.5 –7.2 3.0 5.0 4.1 5.6  
5 Ni t-Bu H NMe2 Def2-
QZVPP 
   9.8 5.4 7.6  
6 Ni i-Bu H NMe2 cc-pVDZ –21.8 –12.4 –7.3 –4.7 –2.6 –1.6  
7 Ni Ph H NMe2 cc-pVDZ –24.1 –16.6 –7.0 –6.9 –5.4 –3.9  
8 Pd Me Me NMe2 cc-pVDZ –16.5 –5.0 2.4 2.0 –1.6 0.2  
9 Pd i-Pr H NMe2 cc-pVDZ –19.6 –17.9 –7.2 –7.0 –6.8 –5.0  
10 Pd t-Bu H NMe2 cc-pVDZ –16.9 –9.2 NA 2.6 –0.4 1.4  
11 Pd i-Bu H NMe2 cc-pVDZ –19.9 –13.2 –4.1 –4.2 –4.1 –4.7  
12 Pd Ph H NMe2 cc-pVDZ –24.2 –16.2 –9.8 –9.2 –8.3 –7.9  
13 Pt Me Me NMe2 cc-pVDZ –17.8 –7.9 0.4 1.3 –6.0 –4.0  
14 Pt i-Pr H NMe2 cc-pVDZ –23.0 –20.5 –9.2 –6.0 –12.3 –9.6 –11.8 (–
13.0) 
15b Pt i-Pr H NMe2 cc-pVDZ    –6.7 –11.5 –12.3  
16 Pt i-Pr H NMe2 Def2-
QZVPP 
   –3.7 –13.8 –10.1  
17c Pt i-Pr H NMe2 cc-pVDZ   –5.7 –4.1  –4.8 –7.1 (–6.5) 
18 Pt t-Bu H NMe2 cc-pVDZ –20.2 –11.5 –2.2 2.0 –7.1 –4.2 –7.4 (–9.0) 
19b Pt t-Bu H NMe2 cc-pVDZ   –2.4 2.1 –7.4 –6.4  
20 Pt t-Bu H NMe2 Def2-
QZVPP 
  5.4 5.3 –8.3 –4.2  
21 c Pt t-Bu H NMe2 cc-pVDZ   0.8 5.0 –1.9 1.1 –2.5 (–3.9) 
22 Pt i-Bu H NMe2 cc-pVDZ –21.8 –14.4 –7.7 –4.7 –9.5 –9.2  
23 Pt Ph H NMe2 cc-pVDZ –26.3 –20.8 –9.7 –9.4 –12.2 –11.1  
24b Pt Ph H NMe2 cc-pVDZ   –
10.0 
–8.4  –13.8  
25 Pt t-Bu H H cc-pVDZ   –0.3 3.9 –6.0 –2.3 –3.7 (–7.5) 
26 c Pt t-Bu H H cc-pVDZ   –0.2 6.0 0.0 3.2 –0.8 (–0.2) 
aCalculations used the functional B3PW91, basis set LANL2DZ for metals, and basis set cc-pVDZ for all other atoms, and DCM 
as solvent, unless otherwise noted. bAn UltraFine integration grid was used instead of the default Gaussian 09 FineGrid. NA = Not 





























































































Lewis acid poisoning by these organocatalysts was calculated to be unfavorable 
with the bulkiest PyBOX systems (i.e. those with bis-t-Bu or tetramethyl substituents: 
entries 1, 4, 5, 8, 10, 13, and 18, columns 10 and 11). Coordination of propylene and 
ethylene in these systems was typically favored, with some exceptions, most notably the 
bulkier Ni complexes (entries 1, 3, and 4). Taking into account both organocatalyst 
poisoning and olefin coordination, the DFT calculations predicted MacMillan’s 
organocatalyst with (4-NMe2-t-Bu-PyBOX)Pt2+ to be the most promising combination, due 
to the calculated endergonic coordination of the organocatalyst 2.9 (+2.0 kcal/mol) and 
the exergonic coordination of propylene (–4.2 kcal/mol) and ethylene (–7.1 kcal/mol) 
(Table 3.2.2, entry 18; Figure 3.2.2).  
 
 
Figure 3.2.2 Optimized structures for optimal combinations from Table 3.2.2 (entry 18). 
Propylene coordination to the Pt2+ complex (left) is calculated by DFT to be favorable, 
and organocatalyst coordination (right) unfavorable. 
 
 
Wheeler recently noted that the default Gaussian09 (75,302) grids can result in 
errors greater than 5 kcal/mol in relative free energies for several systems.157 Thus, we 
repeated our calculations using a finer (99,590) grid size for several intermediates (Table 
3.2.2, entries 15, 19, and 24) and found the grid size to have relatively modest effects; 













MacMillan's organocatalyst for use in the desired reaction (entry 18). The diastereomeric 
"poisoned" complex composed of the enantiomeric (t-Bu-PyBOX)Pt2+ and 2.9 was 
calculated to be insignificantly slightly lower in energy (+2.1 kcal/mol versus +2.0 kcal/mol 
in entry 18). 
For select entries of interest, additional DFT calculations were made by performing 
a single-point correction using the larger basis set Def2-QZVPP in an attempt to increase 
the accuracy of these predicted energies (Table 3.2.2, entries 3, 5, 16, and 20). In the 
case of the (i-Pr-PyBOX)-Ni2+ complex, the complexation of ethylene and propylene was 
no longer exergonic (entry 3). However, the calculations on the i-Pr- and (t-Bu-PyBOX)-
Pt2+ complexes found relatively minor differences between basis sets for ethylene and 
propylene complexation, but organocatalyst 3.8 poisoning of the (t-Bu-PyBOX)-Pt2+ 
complex was now computed to be unfavorable (+5.4 kcal/mol) and similar to poisoning by 
organocatalyst 3.9 (+5.3 kcal/mol) (entry 20). Additionally, DFT calculations were 
performed taking into consideration alternative solvents. This became important since the 
bis-cationic PyBOX-metal complexes were found to have poor solubility in less polar 
solvents. Using NO2Me instead of DCM as the solvent (entries 17 and 21), the energies 
of alkene complexation were computed to be significantly different. Propylene was no 
longer computed to be exergonic for complexation to the (t-Bu-PyBOX)-Pt2+ complex 
(entry 21, column 13). However, complexation of a terminal alkyne (5-phenyl-1-pentyne) 
or internal alkyne (6-phenyl-2-hexyne) to the (t-Bu-PyBOX)-Pt2+ complex were found to 
still be exergonic (Table 3.2.2, column 14). Additionally, coordination of MeCN to the (t-
Bu-PyBOX)-Pt2+ was computed to be –15.3 kcal/mol when using the PCM solvation model 
with DCM. This suggests that using a coordinating solvent could also act as a competing 












In addition to the organocatalysts or solvent acting as competing ligands for the π-
acid, the electron-rich enamine intermediates could also coordinate competitively, as 
observed with our previously reported Cu(I)-phenylacetylene complex (Figure 2.6.2).115 
We hypothesized that a bulkier enamine would coordinate less favorably to the sterically 
congested π-acidic metal than a smaller alkene. To test this hypothesis, we performed 
ground state DFT calculations for the addition of enamines 3.10 or 3.11 to the (t-Bu-
PyBOX)-Pt2+ ethylene complex (Figure 3.2.3). The bulkier enamine derived from 3.9 and 
phenylacetaldehyde (3.10) was calculated to be very endergonic (+11.8 kcal/mol) for the 
displacement of ethylene, while displacement with the smaller pyrrolidine-derived 
enamine (3.11) was found to be exergonic (–2.3 kcal/mol). This result suggested that a 
reaction using the smaller pyrrolidine would be unlikely. However, a catalytic reaction using 
the bulkier imidazolidinone organocatalyst may be feasible as neither the imidazolidinone 
organocatalyst, nor its enamine intermediate, were predicted to have more favorable 
interactions with the Pt2+ complex than ethylene. 
 
 
3.3 Synthesis and NMR Studies of PyBOX-Pt Complexes 
 
 
Based on our DFT calculations, we decided to pursue the synthesis of Pt 
complexes from the tetramethyl- and t-Bu-PyBOX ligands 3.16a–b (Scheme 3.3.1). While 



































exergonic for ethylene complexation and C-C bond formation, we did not see any 
significant advantage of this ligand, which requires a lengthier synthesis. Therefore, we 
proceeded to prepare the parent PyBOX ligands. Treatment of 2,6-pyridinedicarboxylic 
acid with oxalyl chloride afforded 3.14 in excellent yield. Coupling of 3.14 with 2-amino-2-
methyl-1-propanol or L-tert-leucinol yielded 3.15a–b. Oxazoline formation using Deoxo-
Fluor®138-139 proceeded smoothly to yield PyBOX ligands 3.16a–b. The Pt(II) precatalyst 
from ligand 3.17a was prepared according to a protocol adapted from that reported by 
Gagné.65 Treatment of 3.16a with Pt(DMSO)2I2, prepared from a procedure reported by 
Vos,158 and one equivalent of AgBF4 at 70 ºC,  yielded the cationic complex 3.17a in 88% 
yield. Elevated temperatures were found to be crucial for successful complexation. 
Attempts to isolate the cationic Pt(II) precatalyst from ligand 3.16b were unsuccessful. 
 
 




Prior to screening dual catalytic reactions, we wanted to confirm via NMR that the 
optimal organocatalyst 3.9 identified in our DFT calculations (Figure 3.2.3) would not 
effectively compete with ethylene for complexation. For all of our NMR experiments and 
reaction screens, we generated the bis-cationic (t-Bu-PyBOX)Pt2+ ethylene complex in situ 
by heating a solution of 3.17a with one equivalent of AgBF4 in CD3NO2 at 40 ºC for 1 h, 
and filtering off the silver salts using a syringe filter before bubbling ethylene into the 
























3.15a: R = t-Bu, R’ = H
3.15b: R, R’ = Me
DeoxoFluor®



























to 5.47 ppm in CD3NO2, which is consistent with the formation of Pt-ethylene complex 3.18 
(Figure 3.3.1). To the ethylene complex was added one equivalent of organocatalysts 3.8, 
3.9, or MacMillan’s imidazolidinone organocatalyst 3.19 (Figure 3.3.1). Upon the addition 
of 3.8 and 3.19, ethylene shifted back upfield to its original position in the 1H NMR, thus 
suggesting coordination of these organocatalysts is highly favored over ethylene 
coordination. However, when 3.9 was added, the 1H NMR peak for ethylene did not shift 
completely back to its original position and only shifted from 5.47 ppm to 5.44 ppm. This 
is consistent with at least a measurable fraction of ethylene binding to the platinum 
complex in the presence of the bulkier t-Bu imidazolidinone 3.9.  
 
 
Figure 3.3.1 NMR study of the displacement of ethylene with pyrrolidine and 




These findings are in agreement with our DFT calculations, as coordination of 3.8 
to 3.17a was computed to be –0.2 kcal/mol, versus ethylene complexation (defined as 0 
kcal/mol), while coordination of 3.9 to 3.17a was computed to be +6.0 kcal/mol (Table 
3.2.2, entry 26). Therefore, 3.9 could be promising for use as an organocatalyst that does 
not poison the metal center. Additionally, in situ formation of the parent PyBOX-Pt(II) 
complex was confirmed via mass spectroscopy. After heating the solution of 3.17a with 
one equivalent of AgBF4 in nitromethane at 40 ºC for 1 h, excess MeCN was added prior 
to using a direct inject LC-MS method with electrospray ionization. The m/z of 282.60 
corresponds to the PyBOX-Pt(II)-MeCN complex (M2+/2). With the results of these DFT 














2 BF4-A) AgBF4 (1 eq)
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3.4 Dual Catalyst Intermolecular Reaction Screening with t-Bu-PyBOX-Pt Complex 
 
 
With our DFT calculations predicting that the combination of a bulky t-Bu-PyBOX-
Pt metal complex coupled with a bulky imidazolidinone organocatalyst would prevent 
catalyst poisoning and promote alkene/alkyne binding, we set out to screen a variety of 
alkenes/alkynes and carbonyl substrates for an intermolecular addition reaction. Although 
the majority of our calculations were performed on coordination of small alkenes (ethylene 
and propylene) to save on computational time, a selection of larger unsaturated alkyne 
substrates (Table 3.2.2, column 14) and 4-phenyl-1-butene (–6.0 kcal/mol) were also 
computed to have favorable energies of complexation to a t-Bu-PyBOX-Pt metal complex. 
We wished to gather further evidence for alkene or alkyne complexes with these larger 
substrates (Scheme 3.4.1), whose resulting addition products would provide easier UV 
detection and isolation. To accomplish this, reaction screens were set up in CD3NO2 to 
permit observation of alkene/alkyne binding via NMR. We were limited in choice of solvent 
to nitromethane, due to the insolubility of the in situ generated bis-cationic t-Bu-PyBOX-
Pt(II) complex in less polar solvents. 
 
 









A) AgBF4 (1 eq)
    CD3NO2, 30 ºC 1 h
B) Alkene (3.21 bubbled; 3.22: 1eq)
     Alkyne (3.23-3.26: 1 eq)









3.23: R1 = Ph
3.24: R1 = n-propyl
R2
3.25: R2 = Ph












Upon the addition of alkenes/alkynes 3.22–3.26 to the in situ generated (t-Bu-
PyBOX)-Pt(II) complex 3.17a (see chapter 5 for details) in CD3NO2, there were no 
observed 1H NMR shifts for the PyBOX ligand protons or the protons in any of the 
substrates (Scheme 3.4.1). While this result doesn’t rule out the possibility of catalytic 
activity, it does suggest that the abundance of bound alkene or alkyne is small enough 
that it is not detectable by 1H NMR. Following 1H NMR analysis, preformed enamine 3.27 
was added as a solution in CD3NO2 and samples were again analyzed by 1H NMR. After 
the addition of enamine 3.27, no observed displacement of ethylene was observed and 
no chemical shifts were observed in either the ligand or enamine for any of the samples. 
These results align with our DFT calculations (Figure 3.2.3) that predicted enamine 3.27 
to have unfavorable energetics of catalyst poisoning (+11.8 kcal/mol). 
 
 




The samples were heated at 80 ºC for 24 h (50 psi of ethylene with 3.21) and 
analyzed directly via GC-MS, which indicated no detectable alkylation or alkenylation 
reactions. For comparative purposes, analogous reactions were also run with less 
hindered enamine 3.28. The samples immediately turned brown upon addition of enamine 
3.28. We hypothesized that 3.28 underwent a redox reaction with the bis-cationic PyBOX-
Pt(II) complex to generate a stabilized radical cation intermediate. In any regard, enamine 
3.28 was found experimentally to have undesirable interactions with 3.17a, which was 
predicted by our DFT calculations (–2.3 kcal/mol, Figure 3.2.3). We hypothesize that the 
1) 3.17a, AgBF4 (1 eq.)
    CH3NO2, 40 ºC 1 h
2) 3.29 or CH2CH2, 15 min
3) aldehyde/ketone (1 eq.)
     80 ºC, 24 h
Ph
3.29 (1 eq.)















R1 = H; R2 = i-Pr, Et, Ph





lack of reactivity of 3.18 with 3.27 may be due to 3.27 being stabilized by conjugation and 
make C-C bond formation less favorable. Unfortunately, we were unable to isolate less 
stabilized enamines formed from butyraldehyde and the bulky imidazolidinone 
organocatalyst 3.9. 
With the lack of success when using a preformed stabilized enamine, we next 
tested our prioritized dual catalytic system for the direct addition of aldehydes/ketones to 
alkenes and alkynes. Ethylene was selected due to its observed coordination to our 
PyBOX-Pt(II) complex, and 6-phenyl-2-hexyne (3.29) was chosen as a representative 
alkyne substrate (Scheme 3.4.2). The samples were heated at 80 ºC for 24 h (50 psi for 
samples with ethylene) and analyzed directly via GC-MS. Only starting material was 
detected for all samples. The lack of desired products for the reactions with ethylene was 
confirmed by comparison to the GC trace of commercially available 2-ethylhexanal. 
 
 




While our reaction screening afforded no detectable desired alkylation products, 
there was the possibility that we were forming the intermediate PyBOX-Pt-alkyl+ 
complexes and unable to detect these intermediates via GC-MS. Such complexes may 
require an acid or proton shuttle to facilitate protonolysis.65 We screened a range of 
additives, including proton donors and bulky bases, for the addition of n-hexanal to 
ethylene using stoichiometric Pt-complex 3.17a and organocatalyst 3.9 (Table 3.4.1). 
1) 3.17a, AgBF4 (1 eq)
    CH3NO2, 40 ºC 1 h
2) 3.29, 3.30, or CH2CH2 RT 15 min
3) Acetal (1 eq)
    PTSA (10 mol%)
     80 ºC, 20 h
R
Ph
3.29 (R = Me), 3.30 (R = H) (1 eq)









3.9: R’ = t-Bu, R” = H (25 mol%)











After 20 h, the reactions were analyzed via GC-MS. For all of the additives except water, 
only a trace amount of aldol self-condensation byproduct from n-hexanal was detected, in 
addition to unreacted substrates. 
 
 
Table 3.4.1 Additive screening for direct addition of hexanal to ethylene 
 
Entry Additive Resulta 
1 H2O NR 
2 benzoic acid A 
3 pTsO-H2O A 
4 acetic acid A 
5 4-nitrophenol A 
6 Ph2NH A 
7 2,6-di-tert-butylpyridine A 
8 none A 
aNR = no reaction detected by GC-MS. A = trace amount of aldol 
condensation byproduct from n-hexanal was detected. 
 
 
3.5 Dual Catalyst Intramolecular Reaction Screening 
 
 
We next tested our dual catalytic system for the carbocyclization of formyl alkyne 
3.31 to determine whether the C-C bond formation could alternatively proceed in an 
intramolecular fashion (Table 3.5.1). Gratifyingly, reaction screening performed by Jacob 
Porter found that alkyne 3.31 cyclized to afford enal 3.32 in 84% NMR yield when initially 
using 50 mol% of the t-Bu-PyBOX-Pt complex and organocatalyst 3.9 (entry 1). Other less 
hindered organocatalysts were tested and found to have negligible activities (entries 2–
4). This finding was in agreement with our DFT predictions and 1H NMR experiments that 
these would have favorable coordination with the π-Lewis acid and outcompete the 
binding of an alkene/alkyne substrate. 
H2C
CH2
1) 3.17a, AgBF4 (10 mol%)
    CH3NO2, 40 ºC 1 h
2) CH2CH2 RT 15 min,
    hexanal
3) Additive (10 mol%)














Table 3.5.1 Intramolecular reactions with formyl alkyne 3.31 
 
Entrya Lewis acid(s) Lewis acid(s) (mol%) Organocatalyst Yield (%)
c 
1 3.17a, AgBF4 50 3.9 (50 mol%) 84 
2 3.17a, AgBF4 50 3.8 (50 mol%) <5 
3 3.17a, AgBF4 50 
cyclohexylamine 
(50 mol%) <5 
4 3.17a, AgBF4 50 pyrrolidine (50 mol%) <5 
5b 3.16a, Pd(CH3CN)4(BF4)2 
50 3.9 (50 mol%) 13 
6 AgBF4 50 3.9 (50 mol%) <5 
7 none 0 3.9 (50 mol%) NR 
8 3.17a, AgBF4 50 none NR 
9 none 0 none NR 
10 3.17a 50 3.9 (50 mol%) 11 
aReactions were performed with screening procedure A, unless otherwise noted. See Experimental 
Section for details. bReaction screening procedure B was used. cYields measured (n = 1) by 1H NMR 
with pentachloroethane as an internal standard; NR = No desired product detected by GC-MS. 
 
 
This specific cyclization reaction was also reported by Kirsch using (PPh3)AuSbF6 
and diisopropylamine catalysts,82 and we prepared an authentic sample of the product 
3.32 using a Cu(OTf)2, BINAP, and cyclohexylamine catalyst system reported by 
Michelet.124 
Switching to a palladium(II) precatalyst generated in situ from 3.16a and 
Pd(CH3CN)4(BF4)2, was found to be less effective with only a 13% yield (entry 5). 
Additionally, all control reactions had either negligible (<5%) or no detectible 3.32 when 
any combination of precatalyst 3.17a or organocatalyst 3.9 were omitted from the reaction 
mixture (entries 6–9). Interestingly, the reaction still produced some desired product when 
run without the addition of AgBF4 to pre-form the bis-cationic platinum complex (entry 10). 
We presume that the alkyne is capable of displacing the iodide ligand (or the iodide binding 
is quite reversible), allowing the reaction to proceed to some extent (11% NMR yield). With 
a positive intramolecular reaction in hand, we next chose to test lower catalyst loadings to 
1) Lewis acid(s)
2) Organocatalyst






















optimize the reaction (Table 3.5.2). For these studies, reactions were run in CD3NO2 in 
order to measure NMR yields in situ to achieve the most accurate measurement of yield 
without potentially degrading the enal product. Yields were measured by 1H NMR using 
penatchloroethane as an internal standard. 
 
 
Table 3.5.2 Catalyst loading studies for intramolecular reaction with formyl alkyne 3.31 
 
Entry a Catalyst loading (mol%) 32 (%)
b 33 (%)b 32+33b (%) 
1 1 29 5 34 
2 5 32 7 39 
3 10 46 5 51 
4 20 79 0 79 
aReactions were performed using intramolecular reaction screening procedure C. bYields 
measured (n = 1) by 1H NMR using pentachloroethane as an internal standard. 
 
 
This procedure differs from our initial studies (Table 3.5.1) where samples were 
filtered through a silica plug before adding the internal standard and subsequent 
measurement of the yield by 1H NMR. These in situ measurements showed peaks 
consistent with exocyclic alkene 3.33, which isomerized to the more stable alkene 3.32 
over the 24 h reaction time. Exocyclic alkene 3.33 was never observed when crude 
reaction mixtures were first filtered through a silica plug before analysis. Yields are 
reported as the sum of products of the desired C-C bond formation (3.32 + 3.33). Lower 
catalyst loadings of 1 and 5 mol% (entries 1 and 2) produced similar results (34 and 39% 
yields respectively). Raising the catalyst loading to 10% (entry 3) produced a significant 
increase in yield to 51%. The optimal result came from a metal catalyst loading of 20 mol% 
(entry 4, 79% yield of enal 3.32), which is comparable to the 84% yield when using a 50 










1) AgBF4, 60 °C 1 h
2) 3.9 (20 mol%)


















Up to this point, all reactions were run at elevated temperatures with an in situ 
generated bis-cationic complex generated from Pt complex 3.17a. We next explored the 
effect of temperature on reactions using either the bis- or mono-cationic Pt complexes that 
previously showed reactivity (Table 3.5.1). The reaction run at ambient temperature with 
Pt complex 3.17a (20 mol%) and organocatalyst 3.9 (20 mol%) resulted in only trace 
formation of enal 3.32 and exocyclic alkene 3.33 (Table 3.5.3, entry 1). However, raising 
the temperature to 70 ºC gave a 62% yield for the sum of both isomers (entry 2). When 
3.17a was treated with 1 equivalent of AgBF4 to generate the bis-cationic complex in situ 
prior to the addition of formyl alkyne 3.31, the reaction proceeded to quantitative yield at 
ambient temperature (entry 3). 
 
 
Table 3.5.3 Temperature and counterion study for intramolecular reaction with 3.31 
 
Entry X Temperature (ºC) 3.32 (%)b 3.33 (%)b 3.32+3.33 (%)b 
1 BF4, I 22 <5 <5 <5 
2 BF4, I 70 50 12 62 
3a (BF4)2 22 63 37 100 
4a (BF4)2 70 79 0 79 
aPrior to the addition of formyl alkyne 3.31, complex 3.17a was dissolved in CD3NO2 (0.250 mL). This 
solution was transferred to an aluminum foil wrapped 1.5 mL HPLC vial containing AgBF4. The solution was 
placed in an oil bath heated to 60 ºC before being syringe filtered into another 1.5 mL HPLC vial. Addition 
of the substrate 3.31 and organocatalyst 3.9 followed. bYields measured (n = 1) by 1H NMR using 
pentachloroethane as an internal standard. 
 
 
Reacting the pre-formed bis-cationic complex at 70 ºC led to full conversion of 
alkyne 3.31 exclusively to enal 3.32 (entry 4). Formation of the more stable alkene 3.32 
after 24 h was presumably due to isomerization of 3.33 at the elevated temperature. This 
study demonstrated that catalyst turnover was possible, and pre-generation of the highly 










1) AgBF4, 60 °C 1 h
2) 3.9 (20 mol%)



















We had previously limited our choice of solvent to the polar non-coordinating solvent 
nitromethane due to the lack of solubility of the bis-cationic platinum complex formed after 
treatment with AgBF4. 
 
 
Table 3.5.4 Solvent study for intramolecular reaction with 3.31 
 
Entry Solvent 32 (%)c 33 (%)c 32+33 (%)c 
1a CD2Cl2 <5 <5 <5 
2d THF-d8 14(33) 7 (0) 21 (33) 
3d CD3CN 7 (14) 5 (6) 12 (20) 
4a DMSO-d6 <5 <5 <5 
5d CDCl3 34 (46) 13 (14) 47 (60) 
6a,b CD3NO2 50 12 62 
aReaction only run for 24 h. bReaction heated to 70 ºC. cYields measured (n = 
1) by 1H NMR using pentachloroethane as an internal standard. dYields in 
parenthesis measured after 48 h. 
 
 
Given our observed catalytic activity of mono-cationic Pt complex 3.17a, Jacob 
Porter screened the intramolecular reaction in alternative deuterated solvents to allow 
direct measurement of 1H NMR yields (Table 3.5.4). Interestingly, the reaction was found 
to tolerate a variety of less polar and/or coordinating solvents (entries 2, 3, and 5). 
Chloroform was demonstrated to be a promising solvent (entry 5) as a yield of 60% could 
be achieved after 48 h, which was comparable to nitromethane (62%) after 24 h. Jacob 
also explored the effect of changing the steric bulk on the alkyl substituents of the PyBOX 
ligand (Table 3.5.5). The t-Bu-PyBOX ligand (entry 1) gave a yield of 53%. This was 
slightly lower than previously observed (Table 3.5.3, entry 4) perhaps due to the decrease 
in reaction time. Less sterically hindered i-Pr- and Ph-PyBOX complexes also promoted 
productive reactions at 71% and 54% yields respectively (entries 2 and 3). Although our 










1) AgBF4, 60 °C 1 h
2) 3.9 (20 mol%)


















Bu-PyBOX)-Pt(II) complex 3.17a would be preferred for favorable ethylene binding, in this 




Table 3.5.5 PyBOX ligand study for intramolecular reaction on 3.31 
 
Entry R 32 (%)b 33 (%)b 32+33 (%)b 
1 t-Bu 40 13 53 
2 i-Pr 50 21 71 
3 Ph 42 12 54 
aPrior to the addition of formyl alkyne 3.31, the Pt-PyBOX complex was dissolved in CD3NO2 
(0.250 mL). This solution was transferred to an aluminum foil wrapped 1.5 mL HPLC vial 
containing AgBF4. The solution was placed in an oil bath heated to 60 ºC before being syringe 
filtered into another 1.5 mL HPLC vial. Addition of the substrate 3.31 and organocatalyst 3.9 
followed. bYields measured by 1H NMR using pentachloroethane as an internal standard, as 
an average of two runs. 
 
 
3.6 Intermolecular Direct Alpha Alkenylation of Aldehydes with Terminal Alkynes 
 
 
With new evidence that in situ pre-formation of the bis-cationic Pt-PyBOX complex 
was not necessary for catalytic activity in an intramolecular reaction (Table 3.5.3), we 
decided to revisit whether a direct intermolecular alpha alkenylation of an aldehyde could 
be achieved. We hypothesized that the monocationic Pt2+ complex could be more tolerant 
and less readily poisoned in our intermolecular reaction system. To directly compare to 
the intramolecular reaction, nitromethane was selected as a solvent for initial testing. A 
non-alpha branched aldehyde, hexanal 3.34, compatible with organocatalyst 3.9 and 
terminal alkyne, 5-phenyl-1-pentyne 3.35, were chosen for our model system. We 
hypothesized alkyne coordination to the Pt-PyBOX complex would be favored for a 
terminal over internal alkyne. Jacob Porter discovered that when aldehyde 3.34 and 
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presence of organocatalyst 3.9, enal 3.36 was obtained in 19% yield as determined by 1H 
NMR (Scheme 3.6.1). Isolation and characterization of the resulting enal gave 1H/13C 
NMR, HMBC, and HR-MS spectral data consistent with the structure 3.36. A 1H–1H NOE 
experiment is still pending to support the alkene isomer depicted. We were surprised to 
find that the carbon-carbon bond formation had occurred at the terminal carbon of the 
alkyne to give the anti-Markovnikov product, which rapidly isomerized to afford 3.36. There 
were no observable proton peaks for the unisomerized b,g-unsaturated aldehyde when 
monitoring the reaction by 1H NMR. We postulate that the bulky alkyl groups on the ligand 
and organocatalyst prevent addition to the internal alkyne carbon. 
 
 




With enal 3.36 in hand, we were elated to have identified an intermolecular direct 
addition of an unactivated aldehyde to an unactivated alkyne. However, Jacob Porter’s 
preliminary solvent screen did not result in any yields above that of the catalyst loading, 
even after extended reaction time (72 h). We presumed these non-catalytic reactions may 
be due to the active catalyst not turning over after the first cycle, or catalyst degradation 
during the reaction. In an effort to generate catalytic turnover, we performed a screen of a 
wide variety of additives (Table 3.6.1). Acetonitrile was initially chosen as the solvent for 
the additive study due to its optimal yield in Table 3.6.3. CDCl3 was selected as the solvent 































turnover would be enhanced with an acid additive in a less polar solvent. For these 
intermolecular reaction screens, 3.17 and chloroform were added to 1.5 mL HPLC vials 
before the addition of alkyne 3.35, aldehyde 3.34, organocatalyst, and NMR or GC 
standard as stock solutions. Vials were sealed and heated in an oil bath. In situ 1H NMR 
analysis was performed on crude mixtures. Prior to GC-MS analysis, samples were sent 
through a silica plug and eluted with DCM.  Both the organocatalyst and p-Lewis acid were 
necessary to achieve an appreciable yield (Table 3.6.1, entries 9, 11, and 12). In the 
absence of the organocatalyst, the detectable yield may be attributed to addition via the 
enol tautomer of n-hexanal. Testing of several protic acid additives (entries 3–5, 10, and 
14–16) showed that mild acids such as AcOH (entries 3 & 14) or benzoic acid (entry 15) 
were not found to promote catalyst turnover (Table 3.6.1). 
Triflate containing additives were tested (entries 7 and 22–24), yet these additives 
were found to have no beneficial effects. Use of the stronger acid TFA gave NMR yields 
of 41% and 71% in MeCN and chloroform respectively (entries 4 and 10). Unfortunately, 
these reactions were found to generate a mixture of the desired product 3.36 and the aldol 
condensation byproduct 3.37, with alkene and aldehyde protons overlapping in the 1H 
NMR spectra (within 0.01 ppm), necessitating the use of GC to determine product ratios. 
In several reaction mixtures, there was a third aldehyde peak observed in 1H NMR not 
attributed to the starting material 3.34 or enal 3.36. This trace product was typically 
observed in <1%. When using TFA and the organocatalyst without Pt catalyst 17a, this 
byproduct was observed in 17% yield (entry 14). Attempted isolation of this unknown 
aldehyde afforded exclusively the self-aldol condensation byproduct 3.37. We hypothesize 
that the third aldehyde peak observed during our reaction monitoring was the aldol 







Table 3.6.1 Additive screening for direct intermolecular addition of aldehyde 3.34 to 3.35 
 
Entrya Additive (1 eq) Solvent 3.34 (%) 3.36 + 3.37 (%) 24 h (48 h)d 
GC Ratio 
3.36:3.37 
1 none CD3CN  16 (29) 6.2:1 
2b none CD3CN  6 1.6:1 
3 AcOH CD3CN  20  
4 TFA CD3CN  41  
5 pTsOH CD3CN  <5  
6 TBAI CD3CN  7  
7 Ga(OTf)3 CD3CN  15  
8 none CDCl3 54 (36) 8 (13) 99:1 
9c none CDCl3  3  
10 TFA CDCl3 8 (0) 71 (85) 0.1:1 
11c TFA CDCl3  29  
12d TFA CDCl3  13  
13c,d TFA CDCl3  <1  
14 AcOH CDCl3 47 17 1.2:1 
15 benzoic acid CDCl3 45 16  
16 4-nitrobenzoic acid CDCl3 43 19 2.1:1 
17 NaTFA CDCl3 23 (16) 31 (30)  
18a NaTFA CDCl3 39 21  
19b NaTFA CDCl3 83 0  
20 pTsOH CDCl3 69 <5  
21 TBAI CDCl3 100 0  
22 Ga(OTf)3 CDCl3 36 <5  
23 In(OTf)3 CDCl3 5 <5  
24 N(nBu)4OTf CDCl3 82 11  
25 H2O CDCl3 89 10  
26 t-BuOH CDCl3 83 7  
27 PhOH CDCl3 82 10  
28 4-nitrophenol CDCl3 80 12  
29 HFIP CDCl3 80 9  
aComplex 3.17a was dissolved in solvent (0.2 mL) in a 1.5 mL HPLC vial before 3.35 was added via 
microsyringe. 3.34, organocatalyst 3.9, additive, and pentachloroethane were added as individual 
solutions in solvent (50 µL). The reactions were heated at 55 ºC for 48 h bHexanal in CD3CN was added 
via syringe pump at 8 uL/h for 24 h. cNo t-butyl-imidazolidinone organocatalyst added. dNo tBu-PyBOX-



































Key entries were repeated and analyzed using GC-MS to determine the ratios 
between enals 3.36 and 3.37, as 1H NMR could not easily provide that information. GC 
yields with these additives will also be acquired and those experiments are in progress. In 
the absence of an acid additive, the reaction in CD3CN without an additive (entry 1) gave 
a 6.2:1 ratio of desired product 3.36 to 3.37, while chloroform (entry 8) gave exclusively 
enal 3.36. The acid additives (entries 3–5,10, and 14–16)  promoted the formation of aldol 
byproduct 3.37, with the strongest acid, TFA (entry 10), having the greatest effect. The 
increase in combined yield of both enals is attributed to the increase in conversion to the 
aldol condensation enal 3.37. In an effort to diminish the formation of enal 3.37, n-hexanal 
was added to the reaction via slow addition over the 24 h. This method was found to 
neither be beneficial for overall yield nor increase selectivity towards the desired product 
(entry 2). 
In an effort to avoid promotion of the aldol condensation byproduct, alternative 
additives were explored. We hypothesized that an iodide source, such as TBAI (entries 6 
and 21), would assist in regeneration of the stable complex 17a after protodemetalation. 
However, this additive did not produce an increase in reaction yield in MeCN and 
completely shut down the reaction in chloroform. Interestingly, H2O and alcohol additives 
(entries 25–29) also did not promote a catalytic reaction. 1H NMR yields for both enals 
combined were 7–12% for with these alcohols, compared to the control yield of 8% in the 
absence of any additive (entry 8). It is currently inconclusive whether these additives are 
tolerated for the intermolecular reaction, and the determined 1H NMR yields are attributed 
to exclusively the aldol product. GC yields will be obtained to determine the composition 










Table 3.6.2 Organocatalyst studies with intermolecular reaction 
 
Entrya Organocatalyst 3.36 + 3.37 (%)
b 
24 h (48 h) 
GC Ratio 
3.36:3.37c 
1 none 2  
2 3.9 16 (29) 6.2:1 
3 3.8 8 (10) 3.7:1 
4 N-ethylaniline 10 (11) 3.3:1 
5 N-i-Pr-cyclohexylamine <1  
6 indoline 3 (5)  
7 cyclohexylamine 3  
8 pyrrolidine 5  
aComplex 3.17a was dissolved in solvent (0.25 mL) in a 1.5 mL HP-LC vial before 3.35 was 
added via microsyringe. 3.34, organocatalyst, and pentachloroethane were added as 
individual solutions in solvent (50 µL). The reactions were heated at 55 ºC for 48 h bReaction 
yields (n = 1) measured by 1H NMR using pentachloroethane as an internal standard. cGC 
ratios determined using hexamethylbenzene as an internal standard. 
 
 
We next sought to determine the effect of the organocatalyst on both the reaction 
yield and selectivity for the direct addition product 3.36. Prior to identification of the aldol 
condensation product, an organocatalyst screen had been performed and analyzed by 1H 
NMR (Table 3.6.2). Less bulky indoline, cyclohexylamine, and pyrrolidine organocatalysts 
(entries 6–9) were found to give no measurable improvement over the control reaction 
without an organocatalyst (entry 1). Interestingly, N-ethylaniline (entry 4) was found to 
facilitate the reaction and gave a 10% combined yield, while the bulkier secondary amine 
N-i-Pr-cyclohexylamine (entry 5) gave no appreciable yield. MacMillan’s t-Bu-
imidazolidinone was found to still produce the highest yield amongst all screened 
organocatalysts (entry 2). After identification of enal 3.37, the most promising 
organocatalysts (entries 2–4) were rescreened and analyzed via GC-MS to determine the 
ratio between enals 3.36 and 3.37. While there was some observed variation in yield 






























variability can be attributed to the modest solubility of 17a in MeCN. MacMillan’s t-Bu-
imidazolidinone (entry 2) gave the highest yield of direct addition product 3.36, while not 
promoting the formation of the aldol condensation product 3.37 to a greater degree than 
either Jorgensen’s pyrrolidine 3.8 or N-ethylaniline (entries 3–4). 
 
 
Table 3.6.3 Solvent study for direct addition of aldehyde 3.34 to alkyne 3.35 
 
Entrya Solvent Yieldb 
1c DCM 4 
2 DCE 6 
3 THF 3 
4 chloroform 2 
5 toluene 4 
6 MeCN 6 
7 NO2Me 4 
aComplex 3.17a was dissolved in solvent (0.25 mL) in a 1.5 mL HP-LC vial before 3.35 was added 
via microsyringe. 3.34, organocatalyst 3.9, and pentachloroethane were added as individual 
solutions in solvent (50 µL). The reactions were heated at 55 ºC for 48 h bYields (n = 1) measured 
by GC-MS using hexamethylbenzene as an internal standard. cReaction run at 22 ºC. 
 
 
We also repeated the solvent screen to accurately determine the yield of direct 
addition product 3.36 using GC-MS, in contrast to our preliminary screen that was 
monitored via 1H NMR. All solvents gave lower yields (2–6 %) than the previous screen, 
but the overall trend was similar with MeCN and DCE (entries 2 and 6) affording the 
highest yields of 6%, though the reactions were not repeated to determine if these 
differences are statistically significant (Table 3.6.3). Interestingly, CDCl3 (entry 4) gave 
minimal reactivity for the intermolecular reaction but was a suitable solvent for the 
intramolecular reaction. 
We most recently performed a combinatorial metal salt and ligand study with our 
lead organocatalyst 3.9 in an effort to identify alternative lead catalyst systems. Several 
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platinum metal salts were tested in combination with a variety of bidentate and tridentate 
ligands (Table 3.6.4), and analyzed by GC-MS. The coordinating solvents acetonitrile and 
tetrahydrofuran were chosen for reactions in an effort to create homogenous solutions 
with many of the more poorly soluble metal salts.  
 
 
Table 3.6.4 Combinatorial screen of Pt salts and ligands for intermolecular reaction 
 
Entrya Ligand 
Pt(DMSO)2Cl2b Pt(DMSO)2I2b Ziese’s Dimerb PtI2b 
MeCN THF MeCN THF CPMEc MeCN THF MeCN THF 
1 None 7.2 7.6 5.1 6.9 0.2 0.6 0.9 4.4 0.6 
2 (S)-iPrQuinox 3.7 8.3 3.3 7.1 0.2 0.4 1 4.1 0.1 
3 BIPY 0.1 1.0 5.6 2.5  0.2 0.1 2.5 0.4 
4 4,4’-dimethoxyBIPY 0.3 0.9 6.7 0.9  <0.1 0 0.2 0.4 





0.8 1.8 7.5 5.8  <0.1 0 1.2 0 
7 (R)-BINAP 2.4 5.4 8.0 5.6 1.0 0.4 1.2 1.0 0 
8 Xantphos <0.1 2.6 0.8 2.9  0.5 0 0.7 0 
9 (S,S)-DACH-phenyl Trost 0.6 0.6 0.9 0.3  0.4 0 <0.1 0 
10 iPr-PyBOX 11.2 10.5 19.0 13.9  1.0 4.8 3.7 0 
11 tBu-PyBOX 6.6 8.9 8.9 9.0  0.8 0.7 5.9 0 
aMetal salt, ligand, and solvent (0.3 mL) were heated at 55 ºC for 1 h before 3.35 was added via syringe. Then 3.34, 3.9, 
and hexamethylbenzene were added as stock solutions in solvent (25 µL) and the solutions were heated at 55 ºC for 24 
h. bGC yields determined using hexamethylbenzene as an internal standard. cReactions were heated to 100 ºC. 
 
 
Interestingly, reactions with all metal salt/ligand combinations resulted in nearly 
exclusive formation of desired product 3.36. No detectable aldol condensation byproduct 
3.37 and only a trace amount of a GC peak with a mass corresponding to the aldol addition 
product 3.38 were observed. Overall, Ziese’s dimer was only found to facilitate the direct 
addition product and gave a 5% yield when using i-Pr-PyBOX as a ligand in THF. 
Oxazoline-based ligands (entries 6, 10, and 11) and BINAP (entry 7) with Pt(DMSO)2I2 





























The direct addition reaction was found to not tolerate elevated temperature as a selection 
of ligands screened in cyclopentylmethyl ether (CPME) at 100 ºC all had negligible yields. 
The analogous metal salt Pt(DMSO)2Cl2 afforded consistently lower yields, which was 
expected due to the presence of the stronger coordinating chloride and DMSO ligands. 
Interestingly, the i-Pr-PyBOX ligand gave better yields than t-Bu-PyBOX with most of the 
platinum salts and the highest yield of 19% with Pt(DMSO)2I2 (entry 10, column 5).  
Although a labile platinum source, such as Pt(DMSO)2I2, has been reported as 
being necessary when pre-forming Pt-PyBOX complexes,65 we hypothesized that the 
DMSO may be a source of catalyst poisoning when the catalyst is formed in situ. PtI2 and 
Pt(MeCN)2Cl2 were screened as alternative metal salts to omit DMSO. Pt(MeCN)2Cl2 gave 
<1% yield of desired product 3.37 and no ligand combination with PtI2 improved upon the 
control sample in the absence of a ligand (entry 1). We presumed that the decrease in 
reactivity of PtI2 from Pt(DMSO)2I2 was the result of its extremely poor solubility. In an 
effort to combat this issue, Pt(PhCN)2I2 (3.39) was prepared and screened in acetonitrile 
with or without i-Pr-PyBOX and found to only have a 5% yield for both reactions. 
[Rh(COD)Cl]2, Rh(COD)2BF4, [Rh(C2H4)Cl]2, and [Ir(COD)Cl]2 were also screened in 
combination with the t-Bu- and i-Pr-PyBOX in MeCN and afforded no desired direct 
addition product. Co and Ru metal salts will also be considered for future screens. 
With i-Pr-PyBOX, Pt(DMSO)2I2, and organocatalyst 3.9 identified as our lead 
combination for the direct addition reaction, preliminary studies were performed to further 
explore the reaction dependence on the Lewis acid and organocatalyst. Several control 
reactions were performed varying the loading of each catalyst (Table 3.6.5). The variability 
between the 19% yield achieved in Table 3.6.4 (entry 10) and the 6% yield achieved here 
in Table 3.6.5 (entry 3) demonstrates the variability with this reaction. The direct addition 






Table 3.6.5 Catalyst loading screen for direct addition of aldehyde 3.34 to alkyne 3.35 
 
Entrya Pt(DMSO)2I2/iPr-PyBOX (mol%) 3.9 (mol%) Additive Yield
b 
1 0 20 – 0 
2 25 0 – 0 
3 25 20 – 6 
4c 25 20 – 2 
5 100 20 – 9 
6 25 100 – 34 
7 100 100 – 47 
8 25 20 4 Å mol sieves 1 
aPt(DMSO)2I2, i-Pr-PyBOX, and solvent (0.3 mL) were heated at 55 ºC for 1 h before 3.35 was added via 
syringe. Then 3.34, 3.9, and hexamethylbenzene were added as stock solutions in solvent (25 µL) and the 
solutions were heated at 55 ºC for 24 h. bYields (n = 1) measured by GC-MS using hexamethylbenzene as 
an internal standard. cReaction run at 80 ºC. 
 
 
 As previously observed when heating samples in CPME at 100 ºC (Table 3.6.4, 
column 7), the reaction yield decreased to 2% at 80 ºC in MeCN (Table 3.6.5, entry 4). 
Increasing the metal/ligand loading to 1 equivalent resulted in a marginal increase to 9% 
(entry 5). However, increasing the organocatalyst loading to 1 equivalent gave a 34% yield 
(entry 6). This result was promising as a catalytic reaction was promoted with respect to 
the metal salt, albeit with limited turnover. We hypothesized that enamine formation and/or 
reactivity could be problematic or could be rate-limiting. In an effort to combat this, 4 Å mol 
sieves were added to the reaction, but resulted in only a 1% yield (entry 8). 
 
 
3.7 Current/Future Work with Intermolecular Additions of Aldehydes to Alkynes 
 
 
 It was initially believed to be promising that TFA promoted some catalytic turnover, 
however that system has now been identified to instead promote the aldol condensation 




















complex was found to afford higher yields than when using a t-Bu-PyBOX ligand. Ligand 
screening has been mostly limited to commercially available ligands. In order to fully 
explore the dependence on the steric environment of the ligand, more extensive PyBOX 
ligand screening is required, specifically a Me-PyBOX scaffold (Figure 3.7.1). If these less 
sterically demanding ligands are shown to still be tolerated, then internal alkynes may be 
reactive. However, this could pose a new challenge to control the regioselectivity for the 
new C-C bond formation. 
 
 




Although the PyBOX ligand sterics have been shown to affect the yield, the 
dependence on the organocatalyst was demonstrated to be a limiting factor on catalytic 
turnover. A wider range of amines will be explored in an attempt to optimize the reaction 
and generate substantial catalytic turnover. The bulky t-butyl imidazolidinone 
organocatalyst currently used restricts the substrate scope to non-alpha branched 
aldehyde substrates. An alternative organocatalyst capable of enamine formation with 
ketones and alpha-branched aldehydes is highly desirable. With chiral metal complexes 
and/or organocatalysts, asymmetric additions to alpha-branched aldehydes/ketones could 
be performed to generate a chiral all carbon quaternary center, and the resulting b,g-
unsaturated alkene would not be able to isomerize. Additionally, the reaction tolerance to 








































will be examined. Preliminary data from the additive screen already suggests that alcohols 
may be tolerated. 
Once catalytic turnover can be achieved, lower catalyst and substrate loadings will 
be explored. In order for these reactions to be broadly useful, it will be necessary to reduce 
the amount of expensive platinum catalyst needed. Additionally, initial studies used 5 
equivalents of alkyne substrate, and the effect of reducing the amount of alkyne has yet 
to be explored. A reaction that only requires one equivalent of alkyne would of course be 
desirable, and might be critical if performing a macrocyclization reaction. 
After obtaining optimized conditions for catalytic turnover with a more versatile 
organocatalyst that can facilitate enamine formation with a wider range of carbonyl 
substrates for additions to alkynes, our ideal reaction would facilitate the addition of 
carbonyl compounds to alkenes. We presume that the addition to alkenes will be more 
challenging than to alkynes, thus leading us to focus first on the optimization for additions 
to alkynes. Once we have an optimized system in hand, these conditions will be used to 
study an intramolecular addition to alkene substrates prior to attempting an intermolecular 
reaction. Additionally, we will attempt to transfer these conditions over to our bifunctional 
PyBOX system that will be further discussed in chapter 4. With these goals in mind, we 
are elated to report what is, to our knowledge, the first direct intermolecular anti-
Markovnikov addition of an unactivated aldehyde to an unactivated terminal alkyne. 
 
 
3.8 Future Work with Bifunctional PyBOX Catalyst 
 
 
 Although we had identified a dual catalyst system that promoted the intermolecular 
addition of an aldehyde to terminal alkyne, we still sought to develop a bifunctional catalyst 
system. If the dual catalyst approach remains restricted to the use of a bulky 





branched aldehydes. We hypothesized that a bifunctional catalyst utilizing a PyBOX ligand 
moiety may be capable of enamine formation with alpha-branched aldehydes and 
ketones, while still preventing undesired coordination of the organocatalyst to the p-acid. 
We designed a PyBOX bifunctional catalyst based on our analogous design discussed in 
Chapter 2 (Figure 3.8.1).  
 
 
Figure 3.8.1 Dual vs bifunctional catalysis for intermolecular addition of carbonyl 




We hypothesized that a tridentate system would create a more well-defined 
binding pocket and undesired intermolecular interactions may be precluded due to 
incorporation of a third ligand around the Lewis acid. With the promising DFT calculations 
performed on propylene complexation and C-C bond formation, Jacob Porter and I 
successfully synthesized bifunctional PyBOX precatalyst 3.42 (Scheme 3.8.1).159 This 
synthesis utilized the key amino alcohol 2.57 previously synthesized for the PyOX-based 
precatalyst. The synthesis of the PyBOX-based precatalyst began with Fischer 
esterification of 2,6-pyridinedicarboxylic acid to afford monoester 3.37. EDC amide 
coupling with 2-amino-2-methyl-1-propanol gave amide 3.38 in 70% yield. Ester hydrolysis 
followed by EDC amide coupling of carboxylic acid 3.39 with amino alcohol 2.57 yielded 
bis-amide 3.40. As seen previously with the PyOX precatalyst synthesis, the alcohol of 
































ester byproduct was performed with the crude mixture using LiOH in 1:1 H2O:THF to 
regenerate exclusively bis-amide 3.40. Oxazoline formation with Deoxo-Fluor®138 and 
subsequent Boc deprotection with TFA afforded the desired PyBOX precatalyst 3.42. 
 
 




A single crystal of the PyBOX bifunctional ligand with Pd(MeCN)4(BF4)2 was 
obtained via slow diffusion in a 1:1 nitromethane:benzene solution by Jacob Porter. The 
structure of the X-ray crystal structure showed the precatalyst binding to Pd in a tridentate 
fashion along with a molecule of MeCN to give a square planar Pd complex (Figure 3.8.2). 
This X-ray structure gave evidence that complexation of the PyBOX precatalyst 3.42 to 
the Lewis acid occurred in a fashion consistent with our models, and there was no 
evidence for organocatalyst coordination to the Lewis acid. With this result, Jacob 
screened the bifunctional PyBOX catalyst for the intermolecular addition of aldehyde 3.34 
to alkyne 3.35 (Scheme 3.8.2). In situ 1H NMR analysis indicated the desired product had 
formed in 5% yield in CD2Cl2 at 30 ºC, although GC-MS analysis needs to be performed 
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Figure 3.8.2 X-ray crystal structure of precatalyst 3.42 bound to Pd 
    
   BF4- counterions not shown 
 
 
Overall, this suggests that the N-methylamine moiety on the bifunctional catalyst 
may be functioning to some degree as an organocatalyst. Due to the extremely limited 
supply of this bifunctional catalyst due to its challenging and lengthy synthesis, further 
screening will only be performed after further studies with the dual catalyst system. One 
pertinent control reaction to confirm that the catalyst is operating in a bifunctional manner 
is to test the Boc-protected PyBOX 3.41. 
 
 
Scheme 3.8.2 Intermolecular addition of aldehyde 3.34 to alkyne 3.35 using in situ 




Additionally, results from the combinatorial Lewis acid and ligand screen for the 
dual catalyst system suggest that it may not be necessary to use AgBF4 to form 
monocationic PyBOX complexes. Depending on results from the dual catalyst screening, 
several variations of the bifunctional system will be considered (Figure 3.8.3). The lack of 











































organocatalyst moiety combinations to be used. This may permit an increased substrate 
scope that may not be otherwise possible with our dual catalytic systems. 
 
 








O 1) Pt(DMSO)2I2, AgBF4











































Route Exploration and Synthesis of the Reported Structure of the Pyridone-based 
PDI Inhibitor STK076545 
 
 
4.1 Introduction to Protein Disulfide Isomerase 
 
 
Protein disulfide isomerase (PDI) is a key enzyme that catalyzes the oxidation-
reduction and isomerization of disulfide bonds and serves as a necessary chaperone for 
protein folding.160 PDI is composed of four thioredoxin domains a, b, b’, and a’ and a 19 
amino acid linker termed x between domains b’ and a’ (Figure 4.1.1) that are all attached 
in a U-shaped confirguration. Thioredoxins are proteins that facilitate the reduction of other 
proteins. Both domains a and a’ contain an active site Cys-Gly-His-Cys motif responsible 
for the oxidoreductase activity. Oxidized PDI exists in an open state with a more exposed 
hydrophobic area with potential substrate binding at the non-catalytic b and b’ domains, 
the b’ domain being the principle substrate binding domain. 
 
 
Figure 4.1.1 Crystal structure of oxidized hPDI (4EL1)161 
 
 
Although primarily localized in the endoplasmic reticulum with its ER-retaining 
KDEL sequence at its C-terminus, PDI can be released onto the surface of endothelial 


















under study. For these reasons, PDI inhibitors are of significant interest both for the 
treatment of cancer162 and the prevention of thrombosis.163 Several animal models of 
thrombosis have demonstrated that targeting cell surface PDI with antibodies or small 
molecules blocks both platelet accumulation and fibrin generation.164-168 Previously 




4.2 Identification and Activity of Novel Inhibitors of PDI 
 
 
In an effort to identify novel inhibitors of PDI with more suitable therapeutic 
properties, a high-throughput screen was performed by Flaumenhaft and co-workers on 
approximately 5,000 bioactive small molecules.166 From their insulin-based turbidimetric 
assay, they identified 18 PDI inhibitory compounds representative of 13 separate chemical 
scaffolds, including 3 flavonols. Flavonols are a class of flavonoids found in high 
abundance in various fruits and vegetables. Of the identified flavonols, quercertin-3-
rutinoside (rutin) was the most potent and inhibited PDI in a dose-dependent manner. 
Rutin was found to bind and reversibly inhibit PDI, while showing minimal activity towards 
other extracellular thiol isomerases present in the vasculature. 
To further understand the structure activity relationship of rutin, common 
metabolites and other analogs were evaluated on their ability to inhibit PDI (Table 4.2.1). 
This study demonstrated that inhibitory activity against PDI for these flavonols was 
restricted to those with a 3-O-glycoside linkage. From this class, isoquercertin advanced 
to a phase II clinical trial to evaluate its efficacy to reduce hypercoagulability in cancer 
patients. There were 28 patients (cohort A) who received 500 mg of isoquercertin daily, 
while 29 patients (cohort B) took 1000 mg daily (Figure 4.2.1).After 56 days, isoquercertin 





thromboembolic disease, by a median of 22% in cohort B, while cohort A (500 mg) had a 
nonsignificant median change in D-dimer of +9.90%.173 However, the high dose and highly 
variable patients responses are drawbacks of isoquercertin. 
 
 





To seek additional PDI inhibitors, a second high-throughput screen was performed 
on 348,505 compounds from the Molecular Libraries Small Molecule Repository.174 Two 
series of PDI inhibitors, represented by bepristats 1a and 2a (Figure 4.2.2) were found to 
bind to the hydrophobic pocket of the b’ domain.168 A commercial compound called 
STK076545 was also identified from the high-throughput screen to be a reasonably potent 
hit for the inhibition of PDI, and had an attractive structure for medicinal chemistry studies 
















Quercertin H OH OH OH >100 
Tamarixetin H OH OCH3 OH >100 
Isorhamnetin H OCH3 OH OH >100 
Diosmetin H OH OCH3 H >100 
Hyperoside H OH OH Galactose 5.9 (2.9–12.5) 
Isoquercertin H OH OH Glucose 7.1 (4.3–12.0) 
Quercertin-3-glucuronide H OH OH Glucuronic acid 5.9 (3.5–10.1) 
Rutin H OH OH Rutinose 6.1 (1.1–10.7) 










The commercial supply of STK076545 was soon depleted, and we were unable to 
secure additional quantities, so we immediately endeavored to synthesize it. The work 
described here has been submitted for publication with the title “Route exploration and 
synthesis of the reported pyridone-based PDI inhibitor STK076545.” Its structure proved 
to be deceptively simple, and this chapter describes several pitfalls that were encountered 
prior to its successful synthesis.  
 
 




4.3 Conventional Routes for Accessing b-Keto Amides 
 
 
Methods for preparing b-keto amides have been pursued for at least a century.175 
The most obvious approach to b-keto amides is via amide couplings between b-keto acids 
and amines, which also permits late stage diversification for medicinal chemistry studies 




















IC50 = ~1.2 µM
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stability of the b-keto acid starting materials, which can undergo decarboxylation (step 'b'). 
Alternatively, Meldrum’s acid can be C-acylated, then aminolysis affords a b-keto amide, 
but limited to a-unsubstituted substrates.176 Direct aminolysis of b-keto esters177 or b-keto 
thioesters178 at high temperature is possible (approach 'c'), but can be compromised by 
competing enamine formation. Aminolysis reactions catalyzed with DMAP,179 enzymes,180 
or transition metals181-182 have also been reported. Alternatively, addition of a ketone or 
enamine to an isocyanate have also been reported (approach 'd'). Cross Claisen-like 
condensations of esters with amide enolates have been reported (approach 'e'),183-184 or 
alternatively an aldol reaction between a pyridone-containing amide and a benzaldehyde 




Figure 4.3.1 Retrosynthetic strategies for accessing the b-keto amide in STK076545 (Ar 







































































Other approaches involving a late stage addition of the pyridone are possible, but 
these were not initially considered since we were first interested in exploring amide 
structure-activity relationships (SARs), and the presence of a basic tertiary amine on the 
amide side chain of STK076045 could complicate a late stage halogenation/pyridone N-
alkylation reaction. It remained to be determined how the presence of an a-pyridone could 
affect the steps outlined in Figure 4.3.1. Herein, we report our explorations of these routes, 
culminating in a successful 5-step synthesis of the reported structure of STK076545. 
 
 
4.4 Synthesis of the reported structure of STK076545 
 
 
4.4.1 Proceeding via a b-Keto Carboxylic Acid 
 
 
The initial synthetic route we envisioned to access STK076545 (Figure 4.3.1, 
approach ‘a’) involved N-alkylation of 2-pyridone with bromo-b-keto ester 4.2, followed by 
ester hydrolysis and amide coupling (Scheme 4.4.1). Alkylation of 2-pyridone with 4.2 
proceeded smoothly using conditions previously reported using a bromomalonate.185 Both 
the N-alkylated 4.3 and O-alkylated 4.4 products were isolated, in 47% and 9% yield 
respectively. 4.3 and 4.4 were readily distinguishable based on their 13C NMR chemical 
shifts for the a-carbon, with the O-alkylated product 4.4 being assigned based on the more 
downfield a-carbon peak at 75.9 ppm. In this paper, all alkylations of 2-pyridone gave N-
alkylation as the major product, though the O-alkylated products were sometimes 
observed in trace amounts. Unfortunately, the hydrolysis of ester 4.3 under acidic (H2SO4) 
or basic conditions (NaOH, LiOH, or Me3SnOH186) all resulted in decarboxylation of 
carboxylic acid intermediate 4.6 to yield ketone 4.5, despite careful attempted isolations 





Direct coupling of alkali metal carboxylate salts has been shown by Batey and 
coworkers to be a useful strategy with unstable carboxylic acids.187 Attempts at a tandem 
ester hydrolysis of 4.3 with NaOH or LiOH followed by peptide coupling with carboxylate 
4.7 were not fruitful. Alternatively, the decarboxylation product 4.5 was synthesized on a 
larger scale via N-alkylation of 2-pyridone with 2-bromoacetophenone. Subsequent 
carboxylation using MgCl2 and NaI with CO2 also gave no detectable amount of 
carboxylate 4.8 or carboxylic acid 4.6 after an acidic workup.188 
 
 




In an effort to access carboxylic acid 4.6 under milder conditions, the analogous 
benzyl ester intermediate 4.13 was synthesized in four steps (Scheme 4.4.2). First, 1,3-
dicarbonyl 10 was prepared from acetophenone and dimethylcarbonate using NaH in 98% 
yield.189 ZnO-catalyzed transesterification of 4.10 afforded benzyl alcohol 4.11.190 Next, 
monohalogenation of 4.11 with NBS catalyzed by Amberlyst-15®, followed by reaction with 
2-pyridone yielded a-substituted-b-keto ester 4.13 in 66% yield over two steps.191 Benzyl 
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decarboxylation. In addition, 1H NMR analysis of the crude product indicated the ketone 
was reduced to afford benzyl alcohol 4.14. Efforts to reduce the ketone prior to ester 
hydrolysis were not successful (Scheme 4.4.8). 
 
 




4.4.2 Enolate Formation and Reactivity of Benzylic Ketone Intermediate 
 
 
Instead of proceeding through a carboxylic acid intermediate, we envisioned 
installation of the amide via reaction of an enolate with a suitable isocyanate, or CDI 
followed by addition of an amine to the intermediate acylimidazole (Figure 4.3.1, approach 
‘d’). To identify suitable conditions for enolate formation with ketone 4.5, LDA, LiHMDS, 
and NaH were screened as bases (Table 4.4.1). Reactions were quenched at –78 ºC or 
20 ºC using D2O, and crude samples were analyzed via 1H NMR. Based on our screen, it 
was found that all reactions occurring at 20 ºC facilitated enolate formation (entries 3-5), 
while no deuterium incorporation occurred when quenching the samples at –78 ºC (entries 
1-2). The observed deuterium incorporation over 100% is within the systematic error 
associated with 1H NMR analysis, the scale used to weigh NaH, and microsyringe in 
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Table 4.4.1 Enolate formation from ketone 4.5 
 
Entry Base Base (eq.) T (ºC) Addition of Base 
T (ºC) 
Addition of D2O 
% Deuterium 
Incorporationa 
1 LDA 1.05 –78 –78 0 
2 LiHMDS 1.05 –78 –78 0 
3 LDA 1.05 –78 20 117 
4 LiHMDS 1.05 –78 20 92 
5 NaH 1.2 20 20 134 
a Deuterium incorporation was determined via 1H NMR. 
 
 
The enolate from ketone 4.5 was next formed using LDA at 20 ºC and reacted with 
CDI or urea intermediate 4.16, synthesized from CDI and N,N-diethylethylenediamine 
(Scheme 4.4.3). There was no observable reaction with either electrophile, even after 
heating at 70 ºC. We then tested commercially available tert-butyl isocyanate as a model 
isocyanate for reaction screening. When LDA was used as a base, no desired product 
was observed. Rather, urea byproduct 4.18 formed from the addition of diisopropylamine 
to tert-butyl isocyanate was detected via LC-MS.  
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Switching to NaH as the base and heating the reaction at 100 ºC for 2 h in toluene 
yielded amide 4.19 in 15% yield. Efforts to synthesize the desired isocyanate from N,N-
diethylethylenediamine and triphosgene, or reacting diethylamine with 2-bromoethyl 
isocyanate, were both troublesome. With this synthetic route being low yielding and having 
the limitation of only producing secondary amides, we chose to seek an alternative route. 
 
 
4.4.3 Direct Aminolysis of b-Keto Ester 
 
 
Another common synthetic approach to access amides is via direct aminolysis of 
esters (Figure 4.3.1, approach ‘c’). Starting from b-keto ester 3, we first tested a Ag(I)-
catalyzed aminolysis (Scheme 4.4.4).182 Rather than observing conversion to the desired 
b-keto amide, reaction monitoring via LC-MS when using condition A showed masses 
associated with ester 4.21 and amide 4.24 (Scheme 4.4.5). Similarly, when heating ester 
4.3 with N,N-diethyethylenediamine in toluene at 80 ºC with or without DMAP, the same 
decomposition peaks were present. Ester 4.21 was isolated when using conditions B and 
correlated with the mass peak observed via LC-MS. Ag(I)/DBU and DMAP were found to 
both accelerate the conversion to 4.21 in a few hours, in comparison to the reaction heated 
in toluene that proceeded slowly over 24 h. We hypothesize that the b-keto ester 
decomposes via a retro Claisen-like condensation mechanism. The amine (or nucleophilic 
catalyst) could add to the ketone, followed by collapse of the tetrahedral intermediate 4.22 
and cleavage of the C-C bond to produce ester 4.21 (Scheme 4.4.5).  
Štefane and Polanc reported a method to prepare b-keto amides from b-keto 
esters that proceeds via a 1,3,2-dioxaborinane intermediate.192 Reacting b-keto ester 4.3 











Unfortunately, subsequent treatment of 4.20b with N,N-diethylethylenediamine 
also resulted in decomposition to ester 4.21 after only 1 h, and complete decomposition 
after 24 h. Interestingly, when starting from b-keto ester 4.10 which does not have the 
pyridone substituent in the a position, the preparation of the boron complex 4.20a and 
treatment with N,N-diethylethylenediamine cleanly afforded b-keto amide 4.22. 
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4.4.4 Late Stage Pyridone Formation 
 
 
Incorporation of the pyridone at the end of the synthesis was briefly considered. 
Attempts at a-bromination of 4.22 were found to be unsuccessful, which we hypothesized 
would be challenging due to the presence of the basic tertiary amine. Alternatively, we 
proposed synthesizing a-amino-ketone 4.30 and performing a condensation reaction with 
2H-pyran-2-one to access the pyridone (Scheme 4.4.6), a strategy that has been 
previously reported for the preparation of N-substituted pyridones.193 First, oxime 4.25 was 
synthesized from diethylmalonate.194 Palladium-catalyzed hydrogenation of 4.25 and 
subsequent Boc protection of the intermediate amine afforded 4.27. Direct aminolysis of 
diester 4.27 with N,N-diethylethylenediamine yielded diamide 4.28. Then, acylation of 4.28 
with benzoyl chloride in the presence of magnesium ethoxide provided b-keto-amide 4.29 
in 44% yield.195 
Boc removal from 4.29 proceeded smoothly; unfortunately, the resulting a-amino-
ketone 4.30 was not isolatable and underwent intermolecular condensation to form 4.31 
as evident from LC-MS analysis and crude 1H NMR. Due to the instability of 4.30 and our 



















































































4.4.5 Late Stage C-C Coupling 
 
 
Inspired by our observed retro Claisen-like reaction that occurred with a b-keto 
ester substrate, we examined the feasibility of performing an aldol addition, Claisen-like 
condensation, or acylation with intermediates 4.34a-b (Scheme 4.4.7). Thus, installation 
of the C2-C3 bond would occur after amide formation and minimize the possibility of 
decarboxylation. Synthesis of 4.34a-b began with N-alkylation of 2-pyridone with ethyl 
bromoacetate followed by ester hydrolysis, affording the previously reported carboxylic 
acid 4.32.196 Amide coupling with either N,N-diethylethylenediamine 4.32a or PMB-
protected amine 4.33b yielded amides 4.34a-b. We prepared the PMB-protected amide 
4.27b in an effort to avoid competitive deprotonation of the amide proton during enolization 
reactions. Extensive efforts with various electrophiles (aldehyde, ester, or acid chloride 








Identification of the aldol adduct as a possible intermediate provided inspiration to 
access alcohol 4.39, which would not undergo decarboxylation during ester hydrolysis 
(Scheme 4.4.8). Starting from benzyl esters 4.12 or 4.13, we attempted to either protect 
or reduce the benzylic ketone. Efforts to protect the ketone using ethylene glycol and 
catalytic p-TsOH with triethyl orthoformate and 4 Å mol sieves or a Dean–Stark trap 
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resulted in pyridone reduction, as suggested by the crude 1H NMR spectrum. Switching to 
NaBH4 produced benzyl ester 4.38, which we presume proceeds via a similar retro-aldol 
reaction as observed previously. 
 
 
Table 4.4.2 C2-C3 coupling screening on amide 4.33-b 
 
Entry Amide R Base Solvent Temperature (ºC) Yielda 
1 4.34a H NaOMe PhMe 111 0 
2 4.34a H NaH PhMe 111 0 
3 4.34a H NaOMe none 140 – 160 0 
4 4.34b H NaH none 130 0 
5 4.34b H LDA THF -78 → RT 0 
6 4.34b OMe LDA THF 0 → RT 0 
7 4.34b Cl LDA THF 0 → -78 → 40 0 
aAll reactions were monitored via LCMS and 1H NMR. 
 
 




4.4.6 Protected Benzylic Alcohol Route  
 
 
To access benzylic alcohols that could be converted to ketones late in the 
synthesis, we prepared bromohydrins 4.42a-b from the respective methyl and benzyl 
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halides for pyridone alkylations. Under standard 2-pyridone alkylation conditions, epoxide 
4.43 was exclusively formed. To circumvent this issue, the TBS- or MOM-protected 
bromohydrins 4.44a-b were synthesized. It was found that the use of 2,6-lutidine as base 
was critical, as alternative bases such as DIPEA favored epoxidation over alcohol 
protection. However, subjecting the TBS- or MOM-protected bromohydrin to pyridone 
alkylation conditions afforded only alkene 4.45 in <20% yield. Alternatively, the acetyl-
protected alcohol 4.46 was synthesized using acetic anhydride and catalytic DMAP. N-
alkylation of 2-pyridone using 4.46 afforded what was initially presumed to be the desired 
product 4.47a and alkene 4.48a in 18% and 9% yield respectively (Scheme 9). Due to the 
low yields, we screened alternative solvents (acetone) and bases (Cs2CO3) in an effort to 
increase the yield and selectivity; however, the yield of 4.47 was not improved. 
 
 




Moving forward with the synthesis, methyl ester and acetate hydrolysis proceeded 
smoothly to yield the presumed carboxylic acid 4.49a (Scheme 4.4.10). At that time, we 
did not suspect any issues and completed the synthetic sequence to yield 4.57, which was 
initially thought to be STK076545 (Scheme 4.4.11). N,N-diethylethylenediamine was used 
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oxidation was unsuccessful when using DMP, PDC, IBX, or Bobbitt’s salt under basic (2,6-
lutidine) or acidic (silica gel) conditions.198 
 
 




Instead, ethanolamine was TBS-protected to afford 4.51 and then used in an amide 
coupling using HATU with carboxylic acid 4.49 to yield 4.53 in 91% yield. DMP oxidation 
of the alcohol proceeded smoothly to afford ketone 4.54, followed by TBS removal using 
HCl. In a one-pot reaction, alcohol 4.55 underwent a mesylation followed by a substitution 
with diethylamine. The final product was treated with HCl to furnish the HCl salt 4.57 in 
28% yield over 2 steps. 
 
 




However, analogs 4.55 and 4.57 were both found to be inactive in a PDI activity 
assay measuring the reduction of insulin (cleavage of its disulfide bonds). Obtained X-ray 
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position (Scheme 4.4.10). A distinct difference between 4.49a and the X-ray structure of 
4.49b is the relative stereochemistry between the hydroxyl and pyridone substituents. We 
propose that cyclic acetoxonium ion intermediate 4.50 is formed, similar to that proposed 
for the Prévost199 and Woodward200 dihydroxylation reactions, and 2-pyridone then attacks 
the benzylic carbon. Since we started with (E)-methyl cinnamate, the anti addition of water 
to the intermediate rac-bromonium ion results in a racemic mixture of bromohydrins 4.46. 
Formation of the proposed acetoxonium ion intermediate 4.50 and subsequent pyridone 
alkyation would result in inversion of both stereocenters and generate 4.47b. Ester 
hydrolysis of 4.47b then yielded acid 4.49b, with its relative stereochemistry confirmed by 
the X-ray crystal structure (Scheme 4.4.10). 
 
 




4.4.7 Aldol Addition to Ethyl and Allyl Esters 
 
 
To circumvent the unexpected rearrangement through the acetoxonium ion 
intermediate, we planned to perform the N-alkylation prior to installation of the 
alcohol/ketone functionality. Inspired by Easton and co-workers' use of NBS and AgNO3 
to generate hydroxy-a-amino acid derivatives,201 we sought to access a benzylic bromide 
intermediate from 4.58 (Scheme 4.4.12). Ester 4.21 was reacted with LiHMDS to generate 
an enolate, followed by alkylation with benzyl bromide to afford 4.58. Subsequent 
treatment with NBS and AIBN in MeCN yielded no bromination at the benzylic position. 
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Alternatively, benzaldehyde was used instead of benzyl bromide to react with the 
enolate generated from ester 4.21 to access the benzylic alcohol directly (Scheme 
4.4.13). Using identical conditions (LiHMDS and 0 ºC), the elimination product 4.60 was 
generated. Hydrolysis of ester 4.60 yielded carboxylic acid 4.61, which X-ray 
crystallography confirmed to be the alkene to be the Z alkene. With LDA being more 
commonly used in the literature for aldol addition reactions with esters, we switched our 
base to LDA (Scheme 4.4.13). Quenching the reaction at –78 ºC was found to be critical 
to avoid generation of the elimination product and give the desired alcohol 4.62. 
Unfortunately, ester hydrolysis with LiOH yielded the elimination product 4.60 again. In an 
effort to avoid generation of this undesired alkene, we synthesized the TBS-protected 
alcohol 4.63. This route was unfruitful as ester hydrolysis or cleavage using LiOH, 
Me3SnOH, or LiI all resulted in the generation of 4.60. 
In order to access the carboxylic acid under milder conditions, we instead 
synthesized allyl ester 4.64 (Scheme 4.4.14). First, 2-pyridone was alkylated with allyl 
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afforded alcohol 4.65. By increasing the amount of benzaldehyde from 1 to 2 equivalents, 
we were able to nearly double the yield to 82% for this reaction. Allyl removal with 
Pd(PPh3)4 produced carboxylic acid 4.66. Amide coupling and subsequent DMP oxidation 
of alcohol 4.67 successfully produced the final b-keto-amide product 4.68 with the reported 
structure of STK076545. Alcohol analog 4.67 and the final compound 4.68 were both 
tested in the insulin reduction assay and found to be inactive. We obtained an X-ray crystal 
structure corroborating the structure of 4.68 (Figure 5.6.1). Interestingly, the 1H and 13C 
NMR spectra do not match that of the batch received from the commercial supplier. This 
confirms that the structure of the active PDI-inhibiting compound was misassigned. 
 
 




In conclusion, several conventional methods for forming b-keto amides resulted in 
fragmentation of pyridone-containing intermediates, such as retro-Claisen-like and retro-
aldol reactions. Efforts to instead proceed via an acetyl protected bromohydrin resulted in 
a rearrangement that we propose proceeds via an acetoxonium ion intermediate. 
Alternatively, we successfully synthesized the reported structure of STK076545 via a 5-
step synthetic route proceeding through allyl ester 4.64. This strategy should prove to be 
broadly useful in accessing b-keto amides, particularly with an electron-withdrawing a-
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several of its precursors were found to inhibit protein disulfide isomerase, and its 1H and 
13C NMR spectra do not match those of the active commercial compound STK076545. It 
is not uncommon for complex natural products to have misassigned structures which 
require correction after more detailed synthetic and spectroscopic studies.202 However, it 
is often taken for granted that simpler commercial small molecules are provided in high 
purity and with structures as advertised, which is not always the case.203 Our results here 
highlights the importance of resynthesis and structure validation of active compounds prior 
to embarking on medicinal chemistry campaigns. Current efforts in our lab are ongoing to 
elucidate the correct structure of the commercially supplied compound that may have 









Experimental Procedures and Characterization of Compounds 
 
 
5.1 General Information: Synthesis, Characterization, and Reaction Screening 
 
 
All reagents and solvents were purchased from commercial vendors and used as 
received, unless otherwise noted. Nitromethane was distilled and stored over 4 Å 
molecular sieves prior to use. A Vacuum Atmospheres Co. Omni-Lab glovebox was used 
for weighing out air sensitive materials, as noted in the detailed protocols. NMR spectra 
were recorded on Varian 300 MHz or 400 MHz spectrometers as indicated.  Proton and 
carbon chemical shifts are reported in parts per million (ppm; δ) relative to 
tetramethylsilane (1H δ 0), CDCl3, (13C δ 77.16), CD3CN (1H δ 1.94), CD3OD (1H δ 3.31, 
13C δ 49.00), or CD3NO2 (1H δ 4.33). NMR data are reported as follows: chemical shifts, 
multiplicity (obs = obscured, app = apparent, br = broad, s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet); coupling constant(s) in Hz; integration.  Unless otherwise 
indicated, NMR data were collected at 25 °C. NMR data was processed using 
MestReNova software. Flash chromatography was performed using Biotage SNAP 
cartridges filled with 40–60 µm silica gel, or C18 reverse phase columns (Biotage® SNAP 
Ultra C18 or Isco Redisep® Gold C18Aq) on Biotage Isolera systems, with photodiode 
array UV detectors. Analytical thin layer chromatography (TLC) was performed on Agela 
Technologies glass plates with 0.25 mm silica gel with F254 indicator. Visualization was 
accomplished with UV light (254 nm) and aqueous potassium permanganate (KMnO4) 
stain followed by heating, unless otherwise noted. Tandem liquid chromatography/mass 
spectrometry (LC-MS) was performed on a Shimadzu LCMS-2020 with autosampler, 
photodiode array detector, and single-quadrupole MS with ESI and APCI dual ionization, 





method was used to analyze reactions and reaction products: Phenomenex Gemini C18 
column (100 x 4.6 mm, 3 µm particle size, 110 A pore size); column temperature 40 °C; 5 
µL of sample in MeOH or CH3CN at a nominal concentration of 1 mg/mL was injected, and 
peaks were eluted with a gradient of 25−95% CH3CN/H2O (both with 0.1% formic acid) 
over 5 min., then 95% CH3CN/H2O for 2 min. Purity was measured by UV absorbance at 
210 or 254 nm. Gas chromatography/mass spectrometry (GC-MS) was performed with 
either an Agilent Technologies 6850 GC with 5973 MS detector, and Agilent HP-5S or 
Phenomenex Zebron ZB-5MSi Guardian columns (30 m, 0.25 mm ID, 0.25 µm film 
thickness), or a Shimadzu 2010 Plus GC with an AOC-20i auto injector and QP2010 SE 
MS detetector, and Shimadzu SH-5Rxi-4SiMS column (30 m, 0.25 mm ID, 0.25 µm film 
thickness). High-resolution mass spectra were obtained at the University of Wisconsin-
Milwaukee Mass Spectrometry Laboratory with a Shimadzu LCMS-IT-TOF with ESI and 
APCI ionization, or at the University of Cincinnati Environmental Analysis Service Center 
with an Agilent 6540 LCMS with accurate mass Q-TOF. IR spectra were obtained as a 
thin film on ZnSe plates using a Thermo Scientific Nicolet iS5 spectrometer. Optical 
rotations were measured with a Perkin Elmer 341 polarimeter at = 589 nm, with a 10 mL 
cell with 10 cm path length. Specific rotations are reported as follows: [a]DTºC (c = g/100 
mL, solvent). A VWR® Analog vortex mixer fitted with a 5 x 5” sample box with divider was 
used to shake reaction screening samples at 20 ºC. Cis-[Pt(DMSO)2I2] was prepared using 
a previously reported procedure.158  
 
 
5.2 General Information: Density Functional Theory Calculations 
 
 
Initial complexes were drawn within the Avogadro204 molecular visualization 
program and subjected to preliminary optimization with molecular mechanics using the 





algorithm). For alkene and alkyne complexes, as well as enamine and amine poisoned 
structures, conformational sample was utilized by submitting multiple starting point 
coordinates of the same complex varying tether positions and/or complexation 
orientations. This was utilized to ensure a higher probability of obtaining an optimized 
geometry for the global minimum. The resulting coordinates were added to the Gaussian 
09 input file. All reported geometries were then optimized and energies were calculated 
by DFT using the B3PW91 functional31 and the basis sets LANL2DZ32 for all metals and 
cc-pVDZ for other atoms, using the PCM solvation model with dichloromethane, and the 
default FineGrid integration grid unless otherwise noted. Enthalpies and free energies 
were calculated at 298.15 K using unscaled harmonic vibrational frequencies. Subsequent 
calculations performed of different precatlaysts/substrates used previously obtained 
optimized coordinates as starting points when performing variations and preoptimizations 
in Avogadro. All calculations were performed with Gaussian09 on the Père cluster at 
Marquette University.  
 
 
5.3 Bifunctional Catalyst Reaction Screening Protocols 
 
 
5.3.1 General Procedure for Cu(I) Intramolecular Carbocyclization Screens 
 
 
The procedure used was adopted from the protocol reported by Michelet.124 First, 
a stock solution was made by adding formyl alkyne 2.1 (200 mg, 0.790 mmol) and 
cyclohexylamine (0.018 mL, 0.16 mmol) to a 4 mL vial with stir bar containing DCE (2.0 
mL). After 10 min., 0.2 mL of this solution which contained formyl alkyne 2.1 (0.020 g, 
0.079 mmol) and cyclohexylamine (1.8 !L, 0.016 mmol), was added to a 1.5 mL HPLC 
vial, which contained a solution of the ligand (0.012 mmol) and metal salt (0.012 mmol) in 
DCE (0.15 mL). The vials were capped and shaken for 16 h. The reaction mixtures were 





Yields of 2.2 were measured by 1H NMR in CDCl3 using pentachloroethane as an internal 
standard. Reactions using Cu(I) metal salts followed the same general procedure, 
however sample vials were set up in the glovebox and shaken on the benchtop. 
 
 
5.3.2 General Procedure for Cu(I) Intermolecular Reaction Screens 
 
 
Alkyne and carbonyl stock solutions were made first by mixing the alkyne (0.65 
mmol) with solvent (0.75 mL) in a 1.5 mL HPLC vial. Carbonyl compounds (0.155 mmol) 
were mixed with solvent (0.6 mL) in a 1.5 mL HPLC vial. The vials were sealed and Ar 
was bubbled through the solutions for 10 min before they were brought into the glovebox. 
In the glovebox, a ligand 2.25a and (CH3CN)4CuBF4 stock solution was made by 
weighing (CH3CN)4CuBF4 (0.035 g, 0.109 mmol) into a 20 mL scintillation vial, followed 
by addition of 2.25a (0.042 g, 0.109 mmol) as a solution in solvent (10.5 mL). To separate 
HPLC vials, 0.5 mL of this stock solution containing 2.25a (2.0 mg, 0.005 mmol) and 
(CH3CN)4CuBF4 (1.7 mg 0.005 mmol) was added followed by the respective addition of 
the alkyne stock solution (0.15 mL, 0.130 mmol) and carbonyl stock solution (0.10 mL, 
0.026 mmol). If additives (0.005 mmol) were used, they were added at this point as a stock 
solution in solvent (0.1 mL). The reaction vials were removed from the glovebox, sealed 
with parafilm, and heated in a sand bath at 50 °C without stirring for 16 h. After heating, 
the samples were directly analyzed by GC-MS. GC-MS method (see General Information 
for further details): 50 °C to 100 °C over 2 min., then hold at 100 °C for 2 min, ramp to 280 












5.3.3 General Procedure for PyOX Intermolecular Reaction Screens 
 
 
 Complex 2.28 (2 mg, 0.0070 mmol) and metal salt (0.0070 mmol) were dissolved 
in NO2Me (0.3 mL) in an oven-dried 1.5 mL HPLC vial. The alkene (0.070 mmol) and 
carbonyl (0.070 mmol) substrates were added as individual stock solutions in NO2Me (0.1 
mL). Vials were then capped and heated at 50 ºC for 24 h. Reactions using ethylene were 
bubbled with ethylene and stirred at 50 ºC for 24 h under ethylene (50 psi) in a pressure 
flask. After heating, all samples were directly analyzed by GC-MS. 
 
 
5.4 Dual Catalyst Reaction Screening Protocols 
 
 
5.4.1 General Procedures for Intramolecular Reactions 
 
 
Procedure A: Complex 3.17a (2.0 mg, 0.003 mmol) was dissolved in CH3NO2 (250 
µL) in a 1.5 mL HPLC vial. This solution was transferred to a separate aluminum foil 
wrapped 1.5 mL HPLC vial containing AgBF4 (1.0 mg, 0.0046 mmol). The vial was capped 
and placed in an oil bath heated to 50 °C for 30 min. The solution was filtered through a 
22 µM PTFE syringe filter into another 1.5 mL HPLC vial containing substrate 3.31 (2.0 
mg, 0.006 mmol) dissolved in CH3NO2 (100 µL). Lastly, organocatalyst (3.8, 3.9, 
cyclohexylamine, or pyrrolidine) (0.003 mmol) was added as a solution in CH3NO2 (100 
µL). The reaction was placed in an oil bath and heated at 70 °C for 16 h. The crude reaction 
mixtures were loaded onto silica gel plugs made from Pasteur pipettes containing ~4 cm 
silica gel and eluted with EtOAc (5 mL), then condensed and redissolved with CDCl3. 
Analyses were performed by 1H NMR using pentachloroethane as an internal standard. 
 
 
Procedure B: Ligand 3.16a (5.0 mg, 0.015 mmol) was dissolved with CH3NO2 





vial containing (CH3CN)4Pd(BF4)2 (7.0 mg, 0.030 mmol). The solution turned yellow and 
homogeneous before being transferred to a 1.5 mL HPLC vial containing substrate 3.31 
dissolved in CH3NO2 (200 µL). Lastly, organocatalyst 3.9 (4.0 mg, 0.015 mmol) was added 
as a solution in CH3NO2 (200 µL). The reaction was placed in an oil bath and heated at 70 
°C for 16 h. The crude reaction mixture was loaded onto a silica gel plug made from a 
Pasteur pipette containing ~4 cm silica gel and eluted with EtOAc (5 mL), then condensed 
and redissolved with CDCl3. Analysis was performed by 1H NMR using pentachloroethane 
as an internal standard. 
 
 
Procedure C: Complex 3.17a (5 mg, 0.008 mmol), was added to a 1.5 mL HPLC 
vial followed by CD3NO2 (0.5 mL). This solution was transferred to a separate aluminum 
foil-wrapped 1.5 mL HPLC vial containing AgBF4 (2 mg, 0.012 mmol). The solution was 
placed in an oil bath heated to 50 °C for 1 h, then filtered through a 22 µm PTFE syringe 
filter into a 1.5 mL HPLC vial. The solution of the metal complex (1, 5, 10, and 20 mol%) 
was added to separate 1.5 mL HPLC vials, then diluted up to 0.4 mL with CD3NO2. A 
solution of 3.31 (5 mg, 0.022 mmol) and pentachloroethane (3 µL, 0.022 mmol) in 0.1 mL 
CD3NO2 was then added. Lastly, the samples were transferred to a final 1.5 mL HPLC vial 
containing the organocatalyst 3.9 (1 mg, 0.004 mmol). The samples were placed in an oil 
bath heated to 70 °C for 24 h before being directly analyzed by 1H NMR to measure yield 
using pentachloroethane as an internal standard. 
 
 
Procedure D:  Complex 3.17a (0.003 mmol) were added to 1.5 mL HPLC vials 
followed by CD3NO2 (0.250 mL). The solutions were transferred to separate aluminum foil-
wrapped 1.5 mL HPLC vials containing AgBF4 (1 mg, 0.004 mmol). The reactions were 
placed in an oil bath heated to 60 °C for 1 h before being syringe filtered. Formyl alkyne 





together as a solution in CD3NO2 (0.1 mL). Lastly, organocatalyst 3.9 (0.001 g, 0.003 
mmol) was added as a solution in CD3NO2 (0.1 mL). The reactions were placed in an oil 
bath heated to 70 °C or left at 20 ºC for 24 h before being analyzed by 1H NMR using 
pentachloroethane as an internal standard. 
 
 
5.4.2 Intermolecular Reaction Screening with Pre-formed Bis Cationic Pt Complex 
 
 
Complex 3.17a (1.0 mg, 0.0014 mmol) was dissolved in NO2Me (0.3 mL) in an 
oven-dried 1.5 mL HPLC vial under N2. Next, a 0.028 M solution of AgBF4 in nitromethane 
(50 µL, 0.0014 mmol) was added via syringe. The vial was wrapped in aluminum foil and 
heated at 30–40 ºC for 1 h. The white precipitate was filtered off by passing the solution 
through a PTFE syringe filter into another oven dried 1.5 mL HPLC vial. If ethylene was 
used, ethylene gas was bubbled through the solution for 5 min. The alkene/alkyne (0.014 
mmol), aldehyde/ketone/acetal (0.0014–0.014 mmol), organocatalyst/enamine 3.9, 3.19, 
3.27, or 3.28 (0.00035–0.0014 mmol), and additive (0.00035 mmol) were respectively 
added as solutions in NO2Me (50 µL). Vials were either sealed and heated in a sand bath 
at 80 ºC or placed in a pressure tube and stirred under ethylene (50 psi) at 80–90 ºC for 
20–24 h. Crude reaction mixtures were analyzed directly by GC-MS. 
 
 
5.4.3 General Screening Procedure for Intermolecular Direct Addition Reaction of 
Aldehyde 3.34 to Alkyne 3.35 
 
 
Complex 3.17a (4.1 mg, 0.00677 mmol) or the combination of a ligand (0.00677 
mmol) plus metal salt (0.00677 mmol) were dissolved/suspended in solvent (0.3 mL) in an 
oven-dried 1.5 mL HPLC vial. If the metal plus ligand mixture was not homogenous, the 
mixture was heated at 55 ºC for 1 h and allowed to cool to 20 ºC. 5-phenyl-1-pentyne 3.35 





in solvent (25 uL, 0.0271 mmol), organocatalyst in solvent (25 uL, 0.00542 mmol), and 
pentachloroethane in solvent (25 uL, 0.0271 mmol) were respectively added. The vials 
were capped, sealed with parafilm wax, and heated in an oil bath at 55 ºC for 24 h. After 
24 h, the reactions were analyzed by 1H NMR using pentachloroethane as an internal 
standard. Then solutions were sent through a silica plug (~2 cm) in a pipette, eluted with 
DCM (4 mL), diluted to a total volume of 10 mL and analyzed by GC-MS. Samples 




5.5 Synthetic Experimental Procedures 
 
 







1-carboxylate (2.10). N-Boc-L-proline (2.8) (5.38 g, 24.5 mmol) and L-threonine methyl 
ester, HCl salt 2.9 (4.16 g, 24.5 mmol) were added to a 1.0 L flask with stir bar and sealed 
under N2. DCM (400 mL), HOBt (4.13 g, 27.0 mmol), TEA (8.60 mL, 61.7 mmol), and EDC 
HCl (5.17 g, 27.0 mmol) were sequentially added and the reaction was stirred for 20 h. 
LC-MS analysis confirmed complete conversion. The reaction was washed with half 
saturated NaHCO3 (2 x 200 mL) and 0.2 N HCl (2 x 200 mL). The combined aqueous 
washes were extracted with DCM (2 x 100 mL). The combined organics were washed with 
brine, dried over anhydrous Na2SO4, filtered, and concentrated to afford amide 2.10 as a 











purification. This compound has been previously reported and characterized (CAS# 
80897-23-0). 1H NMR (300 MHz, CDCl3) δ 4.58 (dd, J = 9.0, 2.6 Hz, 1H), 4.36–4.26 (m, 
2H), 3.77 (d, J = 1.7 Hz, 3H), 3.48–3.39 (m, 2H), 1.80–2.35 (m, 4H), 1.47 (s, 9H), 1.19 (d, 







carboxylate (2.11). Alcohol 2.10 (5.91 g, 17.9 mmol) was added to a 1 L round bottom 
flask with stir bar followed by DCM (300 mL) and Dess-Martin periodinane (8.35 g, 19.7 
mmol). The flask was sealed with a septum, flushed with N2, and stirred for 3 h. H2O (0.322 
mL, 17.9 mmol) was added and the reaction stirred for an additional 3 h. LC-MS analysis 
confirmed complete conversion. The reaction was poured on to a 10% Na2S2O3 solution 
(400 mL) and stirred for 45 min until both layers turned clear. The organic layer was 
separated, washed with saturated NaHCO3 (2 x 100 mL) and brine, dried over anhydrous 
Na2SO4, filtered, and concentrated. The crude yellow oil was dissolved in DCM and 
purified via flash chromatography (100 g SiO2 cartridge; 0–80 % EtOAc/hexanes) to afford 
ketone 2.11 as a yellow oil (4.60 g, 78%). This compound has been previously reported 
























carboxylate (2.12). Ketone 2.11 (4.59 g, 14.0 mmol) was added to a 250 mL flask with 
stir bar followed by anhydrous THF (150 mL). The headspace was purged with N2 before 
Lawesson's Reagent (8.46 g, 20.9 mmol) was added. The flask was fitted with a reflux 
condenser and sealed under N2 before being heated to reflux for 18 h. LC-MS analysis 
confirmed complete conversion. The reaction was condensed to an oil, dissolved in EtOAc 
(250 mL) and washed with saturated NaHCO3 (2 x 250 mL). The aqueous washes were 
extracted with EtOAc (100 mL), and the combined organics were washed with brine, dried 
over anhydrous Na2SO4, filtered, and concentrated. The crude red oil was adsorbed onto 
SiO2 (25 g) and purified via flash chromatography (100 g SiO2 cartridge; 0–40% 
EtOAc/hexanes) to afford 2.12 as an orange oil (3.46 g, 76%). This compound has been 
previously reported and characterized (CAS# 838853-22-8): 1H NMR (300 MHz, CDCl3) δ 
5.15 (d, J = 13.8 Hz, 1H), 3.93 (s, 3H), 3.65–3.37 (m, 2H), 2.45–2.12 (m, 2H), 2.00–1.84 







(2.13). Ester 2.12 (3.43 g, 10.5 mmol), sodium triacetoxyborohydride (0.112 g, 0.525 
mmol), and sodium borohydride (0.898 g, 23.1 mmol) were added to a 100 mL oven-dried 

















reaction stirred for 5 min, then anhydrous methanol (1.70 mL, 42.0 mmol) was added over 
15 min. The reaction was heated to 35 °C for 16 h. LC-MS analysis confirmed complete 
conversion. The reaction was diluted with EtOAc (30 mL) and quenched with saturated 
NH4Cl. The layers were separated and the aqueous layer was extracted with 10% MeOH 
in DCM (3 x 50 mL). The combined organic layers were washed with brine and 
concentrated to afford alcohol 2.13 as a yellow oil (2.65 g, 85%). The crude material was 
moved forward without purification. [#]%&' -78.36 (0.573, DCM); TLC Rf: 0.57 (90:10 
DCM:MeOH); 1H NMR (300 MHz, CDCl3) δ 5.15–5.03 (m, 1H), 4.62 (s, 3H), 3.56–3.39 
(m, 2H), 2.40–2.37 (m, 2H), 2.28–2.17 (m, 1H), 1.94–1.89 (m, 2H), 1.47–1.34 (m, 9H); 13C 
NMR is complicated due to rotamers. 13C NMR (75 MHz, CDCl3) 172.4, 171.5, 154.8, 
154.4, 150.8, 150.7, 128.7, 128.5, 80.2, 59.4, 58.9, 58.1, 47.0, 46.6, 34.1, 32.9, 28.5, 28.4, 
24.0, 23.2, 11.1; IR (film) 3377, 2975, 1698, 1388, 1366, 1165, 770 cm−1; HRMS (ESI+) 







(2.14). Alcohol 2.13 (2.12 g, 7.11 mmol) was added to a 250 mL oven-dried flask with stir 
bar and sealed under N2. Anhydrous DCM (50 mL) was added followed by mesyl chloride 
(0.660 mL, 8.53 mmol) and triethylamine (1.12 mL, 8.61 mmol). The reaction was stirred 
at room temperature for 24 h. LC-MS analysis confirmed complete conversion. The DCM 
was removed under vacuum and the crude oil dissolved with anhydrous DMF (50 mL). 
Sodium azide (0.544 g, 8.53 mmol) was added in one portion and the reaction stirred for 











The aqueous layers were extracted with ether (2 x 100 mL). The combined organics were 
washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated. The crude 
orange oil was dissolved with minimal DCM and purified via flash chromatography (25 g 
SiO2 cartridge; 0–20% EtOAc/hexanes) to afford azide 2.14 as a yellow oil (1.73 g, 75%). 
[#]%&' -86.52 (0.620, DCM); TLC Rf: 0.40 (80:20 hexane:EtOAc); 1H NMR (300 MHz, 
CDCl3) δ 5.12–5.03 (m, 1H), 4.33 (s, 2H), 3.55–3.44 (m, 2H), 2.42 (s, 3H), 2.26–2.21 (m, 
2H), 1.94–1.92 (m, 2H), 1.48–1.36 (m, 9H); 13C NMR is complicated due to rotamers. 13C 
NMR (100 MHz, CDCl3) δ 172.3, 171.2, 154.6, 154.2, 146.0, 145.7, 131.0, 130.8, 80.1, 
80.0, 59.3, 58.8, 47.5, 46.9, 33.8, 32.5, 28.4, 28.3, 23.9, 23.1, 11.2; IR (film) 2976, 2093, 








(2.15). Azide 2.14 (1.63 g, 5.05 mmol) was added to a 250 mL pressure flask with stir bar 
followed by methanol (50 mL). The flask was purged with Ar then 10% Pd/C (0.537 g, 
0.505 mmol) was added. The reaction flask was attached to a Parr hydrogenator, 
evacuated, and backfilled with hydrogen x 3. The reaction was stirred vigorously under 3 
bar of hydrogen for 16 h. LC-MS analysis confirmed complete conversion. The reaction 
mixture was passed through a pad of Celite, then concentrated to afford amine 2.15 as a 
colorless oil (1.30 g, 87%). The crude product was used directly without further purification. 
[#]%&' -83.71 (0.653, DCM); TLC Rf: 0.39 (90:10 DCM:MeOH); 1H NMR (300 MHz, CDCl3) 











2.37 (s, 3H), 2.28–2.21 (m, 2H), 1.95–1.92 (m, 2H), 1.67 (br s, 2H), 1.49–1.35 (m, 9H); 
13C NMR is complicated due to rotamers. 13C NMR (100 MHz, CDCl3) d 171.7, 171.1, 
154.8, 154.4, 152.8, 152.5, 126.6, 126.5, 80.1, 59.5, 59.0, 47.0, 46.5, 39.8, 34.0, 32.9, 
28.6, 28.4, 23.9, 23.2, 11.1; IR (film) 3356, 3301, 2974, 1694, 1385, 1164, 1113, 770 cm−1; 







(2.16a). Amine 2.15 (0.200 g, 0.576 mmol) was added to a 25 mL oven-dried flask with 
stir bar followed by glacial acetic acid (5.0 mL). Next, quinoline-8-carbaldehyde (0.128 g, 
0.777 mmol) and sodium triacetoxyborohydride (0.180, 0.847 mmol) were added. The vial 
was purged with N2 and allowed to stir for 16 h. LC-MS analysis confirmed complete 
conversion. The reaction was neutralized with saturated NaHCO3 and brought to pH ~9. 
The aqueous solution was extracted with EtOAc (2 x 20 mL). The combined organic layers 
were washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated. The 
crude dark orange oil was dissolved with DCM (50 mL), and Amberlyst® 15 ion exchange 
resin (4 g) was added. The solution was stirred with the resin for 16 h. Analysis by LC-MS 
confirmed that the desired product had completely bound to the resin. The resin was 
filtered and washed with DCM (50 mL) and MeOH (50 mL). The washed resin was placed 
in a 50 mL round bottom flask with 3.5 N ammonia in methanol (30 mL) and stirred for 16 
h. After 16 h, the resin was filtered and washed with 3.5 N ammonia in MeOH until no 












and the crude oil dissolved in DCM and purified via flash chromatography (5 g SiO2; 0–
27% 0.5N NH3 in MeOH:DCM) to afford 2.16a as a pale yellow oil (75 mg, 32%). [#]%&' -
37.73 (0.273, DCM); TLC Rf = 0.16 (90:10 MeOH:DCM); 1H NMR (400 MHz, CDCl3) δ 
8.91 (dd, J = 4.2, 1.8 Hz, 1H), 8.14 (dd, J = 8.3, 1.8 Hz, 1H), 7.75–7.67 (m, 2H), 7.49 (dd, 
J = 8.3, 6.9 Hz, 1H), 7.40 (dd, J = 8.3, 4.2 Hz, 1H), 4.49–4.39 (m, 3H), 3.85 (s, 2H), 3.10 
(ddd, J = 10.0, 7.2, 5.3, 1H), 3.01 (ddd, J = 10.0, 7.6, 6.5 Hz, 1H), 2.53 (br s, 2H), 2.32 (s, 
3H), 2.29–2.18 (m, 1H), 1.99–1.72 (m, 3H); 13C NMR (100 MHz, CDCl3) d 173.7, 150.4, 
149.5, 147.0, 138.4, 136.4, 128.9, 128.4, 127.9, 127.0, 126.4, 121.0, 49.9, 50.4, 47.0, 
33.9, 25.6, 11.3; IR (film) 3301, 2919, 1498, 1445, 828, 792 cm−1; HRMS (ESI+) calcd for 







(2.16b). Amine 2.15 (0.195 g, 0.655 mmol) was added to a 100 mL oven-dried flask with 
stir bar followed by anhydrous THF (30 mL). Next, salicylaldehyde (0.088 g, 0.720 mmol) 
and sodium triacetoxyborohydride (0.167 g, 0.786 mmol) were added. The vial was purged 
with N2 and stirred for 16 h. LC-MS analysis confirmed complete conversion. The reaction 
was quenched with saturated NH4Cl and basified with saturated NaHCO3. The aqueous 
layer was extracted with EtOAc (2 x 20 mL) and the combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, filtered, and concentrated. The crude yellow oil 
was dissolved with DCM (50 mL), and Amberlyst® 15 ion exchange resin (4 g) was added. 












desired product had completely bound to the resin. The resin was filtered and washed with 
DCM (50 mL) and MeOH (50 mL). The washed resin was placed in a 50 mL round bottom 
flask with 3.5 N ammonia in methanol (30 mL) and was stirred for 16 h. After 16 h, the 
resin was filtered and washed with 3.5 N ammonia in MeOH until no further material was 
eluted, as determined by TLC. The combined washes were concentrated to give a brown 
oil, dissolved in DCM, and purified via flash chromatography (10 g SiO2; 0–12% 0.5N NH3 
in MeOH/DCM) to afford 2.16b as a colorless oil (119 mg, 60%). [#]%&' -45.04 (2.280, 
DCM); TLC Rf = 0.19 (90:10 DCM:MeOH); 1H NMR (400 MHz, CDCl3)  δ 7.16 (td, J = 8.0, 
1.7 Hz, 1H), 6.94 (dd, J = 7.4, 1.5 Hz, 1H), 6.83 (dd, J = 8.1, 1.1 Hz, 1H), 6.76 (td, J = 7.4, 
1.2 Hz, 1H), 4.45 (dd, J = 8.0, 5.4 Hz, 1H), 3.93 (s, 2H), 3.74 (s, 2H), 3.17–2.97 (m, 2H), 
2.26–2.22 (m, 4H), 1.98–1.74 (m, 3H); 13C NMR (100 MHz, CDCl3) d 174.8, 158.3, 148.4, 
128.9, 128.7, 128.6, 122.3, 119.0, 116.4, 49.8, 51.4, 47.0, 45.0, 3.9, 25.6, 11.0; IR (film) 
3290, 2920, 1589, 1490, 1474, 1456, 1256, 754 cm−1; HRMS (ESI+) calcd for C16H21N3OS 







phenol (2.16c). Prepared as described for 2.16b. Compound purified via flash 
chromatography (10 g SiO2; 0–12% 0.5N NH4 in MeOH/DCM) to afford 2.16c as a yellow 
oil (101 mg, 43%). [#]%&' -39.46 (0.147, DCM); TLC Rf = 0.33 (90:10 DCM:MeOH); 1H NMR 
(400 MHz, CDCl3) δ 6.81 - 6.87 (m, 2H), 6.73 (dd, J = 8.0, 2.0 Hz, 1H), 5.52 (br s, 2H), 












4H), 1.99–1.81 (m, 3H); 13C NMR (100 MHz, CDCl3) d 174.1, 159.2, 148.0, 133.9, 129.4, 
129.2, 120.8, 119.0, 116.7, 59.7, 50.8, 46.9, 44.8, 33.9, 25.5, 11.1; IR (film) 2923, 1585, 








methyl]phenol (2.16d). Prepared as described for 2.16b. Compound purified via flash 
chromatography (10 g SiO2; 0-7% 0.5N NH4 in MeOH/DCM) to afford 2.16d as a colorless 
oil (91 mg, 48%). [#]%&' -30.41 (1.207, DCM); TLC Rf = 0.48 (90:10 DCM:MeOH); 1H NMR 
(300 MHz, CDCl3) δ 7.22 (d, J = 1.8 Hz, 1H), 6.82 (d, J = 1.8 Hz, 1H), 4.46 (dd, J = 7.7, 
5.4 Hz, 2H), 3.91 (s, 2H), 3.75 (s, 2H), 3.17–3.01 (m, 2H), 2.28–2.20 (m, 4H), 1.90 (m, 
3H), 1.42 (s, 9H), 1.28 (s, 9H); 13C NMR (75 MHz, CDCl3) d 174.5, 154.8, 148.7, 140.4, 
135.9, 128.9, 123.6, 123.0, 121.7, 59.7, 52.4, 47.0, 45.1, 35.0, 34.2, 34.0, 31.8, 29.7, 25.6, 
11.2; IR (film) 3276, 2951, 1480, 1485, 1443, 1236, 877, 820 cm−1; HRMS (ESI+) calcd for 





















2-(3-bromophenyl)ethanamine (2.45). This was prepared using a procedure described 
by Saha and coworkers.132 LiAlH4 (3.04 g, 80.0 mmol) was added to a 250 mL oven-dried 
flask with stir bar and sealed under N2. Anhydrous THF (100 mL) was added, and the flask 
was cooled to –5 ºC in an ice/salt bath. Concentrated H2SO4 (3.9 g, 40 mmol) was added 
dropwise by syringe, and the resulting mixture was stirred at –5 ºC for 1 h. A solution of 3-
bromo-benzeneacetonitrile (9.80 g, 50.0 mmol) in dry THF (5.0 mL) was added dropwise, 
the flask was removed from the ice bath when the addition was complete, and the reaction 
was stirred at room temperature for 1 h. The reaction was then cooled back to –5 ºC and 
quenched by the addition of 1:1 THF:H2O (12.4 mL). Et2O (50 mL) was added, followed 
by aqueous NaOH (3.6 M, 24.4 mL). The mixture was filtered through Celite, and the solids 
were washed well with additional Et2O (6 x 50 mL). Water (100 mL) was added and the 
phases were separated, and the organic phase was dried over anhydrous Na2SO4, 
filtered, and concentrated to afford amine 2.45 as a yellow oil (8.97 g, 90%). This 
compound has been previously reported and characterized (CAS# 58971-11-2). IR (thin 
film): 3363, 3284, 2932, 2863, 1656, 1592, 1565, 1472, 1425, 1372, 1323, 775, 690, 664 
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36–7.29 (m, 2H), 7.20–7.10 (m, 2H), 2.96 (t, J = 6.9 
Hz, 2H), 2.72 (t, J = 6.9 Hz, 2H), 1.19 (br s, 2H); 13C NMR (75 MHz, CDCl3) δ 142.3, 131.9, 












tert-butyl N-[2-(3-bromophenyl)ethyl]carbamate (2.46). Amine 2.45 (8.93 g, 44.6 
mmol) was added to a 250 mL oven-dried round bottom flask with stir bar and sealed 
under N2. Anhydrous THF (70 mL) and TEA (12.4 mL, 89.0 mmol) were added and the 
reaction mixture was stirred for 15 min at 0 ºC before Boc anhydride (10.7 g, 49.1 mmol) 
was added. The reaction mixture was warmed to room temperature and stirred for 2 h, 
then it was diluted with DCM (100 mL) and H2O (100 mL). The organic layer was separated 
and the aqueous layer was extracted with DCM (3 x 100 mL). The combined organic 
extracts were washed with brine (100 mL), dried over Na2SO4, filtered, and concentrated. 
The crude yellow oil dissolved in DCM and purified via flash chromatography (340 g SiO2 
column, 0–20% EtOAc/hexanes) to afford 2.46 as a clear yellow oil (11.0 g, 82%). This 
compound has been previously reported and characterized (CAS# 153732-25-3). TLC Rf 
= 0.70 (50:50 EtOAc:Hexanes); IR (thin film): 3343, 2976, 2931, 1687, 1596, 1567, 1508, 
1474, 1426, 1365, 1343, 1269, 1247, 1162, 777, 692, 670 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 7.37–7.34 (m, 2H), 7.20–7.10 (m, 2H), 4.59 (br s, 1H), 3.36 (q, J = 6.9 Hz, 2H), 2.77 (t, 
J = 7.0 Hz, 2H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 155.9, 141.5, 132.0, 130.2, 






2,4,6-trivinylcyclotriboroxane-pyridine. To an oven dried 1.0 L round bottom flask, 














addition funnel was attached, and the solution was purged with N2 and cooled to -78 ºC. 
Vinylmagnesium bromide (310 mL of a 0.7 M solution in THF, 0.217 mmol) was cannula 
transferred to the addition funnel, added dropwise over the course of 3 h, and the reaction 
was stirred at –78 ºC for an additional 2 h. An aqueous 1M HCl solution (109 mL) was 
added dropwise over the course of 20 min. The solution was allowed to warm to 20 ºC. 
Brine (100 mL) was added, and the solution was extracted with Et2O (3 x 100 mL), and 
the combined extracts were washed with water (100 mL), brine (100 mL), dried over 
Na2SO4, filtered, and concentrated under vacuum to 250 mL. The Et2O solution was 
treated with pyridine (44.0 mL, 0.546 mmol) and stirred at 20 ºC for 16 h. The solvents 
were evaporated under reduced pressure to give a pale yellow oil. Kugelrohr distillation 
under reduced pressure (100-135 ºC, 0.5 Torr) gave the desired product as a pale yellow 
solid (5.65 g, 33%). The 1H NMR data obtained was in agreement with that reported in the 
literature.133 1H NMR (300 MHz, CDCl3) δ 8.82–8.79 (m, 2H), 8.02–7.97 (tt, J =1.6 Hz, J = 






tert-butyl N-[2-(3-ethenylphenyl)ethyl]carbamate (2.44). A 250 mL oven-dried flask 
with stir bar was covered in tin-foil was equipped with a reflux condenser and sealed under 
Ar. Aryl bromide 2.46 (5.27 g, 17.6 mmol), ethylene glycol dimethyl ester (100 mL), 
tetrakis(triphenylphosphine)palladium(0) (406 mg, 0.351 mmol), potassium carbonate 
(2.91 g, 21.1 mmol), H2O (25 mL), and 2,4,6-trivinylcyclotriboroxane-pyridine complex 
(2.00 g, 8.33 mmol) were sequentially added. The reaction mixture was stirred and heated 









was added, and the resulting mixture was filtered. The filtrate was extracted with Et2O (4 
x 25 mL). The combined organic extracts were dried over anyhydrous Na2SO4, filtered, 
and concentrated. The crude product was dissolved in DCM and purified via flash 
chromatography (100 g SiO2 column, 0–50% EtOAc/hexanes) to afford 2.44 as a clear 
yellow oil (3.75 g 86%). 1H NMR (300 MHz, CDCl3) δ 7.28–7.23 (m, 3H), 7.10–7.08 (m, 
1H), 6.69 (dd, J = 17.6, 10.9 Hz, 1H), 5.74 (dd, J = 17.6, 0.8 Hz. 1H), 5.24 (dd, J = 10.9, 







carbamate (2.47); benzyl N-[(2R)-2-[3-(2-{[(tert-butoxy)carbonyl]amino}ethyl) 
phenyl]-2-hydroxyethyl] carbamate (2.48). In a 500 mL flask with stir bar, a solution of 
tert-butyl carbamate (6.14 g, 40.6 mmol) in nPrOH (55 mL) was sequentially treated with 
a freshly prepared solution of NaOH (1.70 g, 42.5 mmol) in H2O (110 mL) and tert-
butylhypochlorite (4.42 g, 40.7 mmol). After stirring for 30 min, the solution was cooled to 
0 ºC and a solution of (DHQD)2PHAL (467 mg, 0.600 mmol) in nPrOH (55 mL) was added. 
Then, a solution of the 2.44 (3.30 g, 13.3 mmol) in nPrOH (110 mL) was added followed 
by the addition of K2OsO2(OH)4 (147 mg, 0.400 mmol). After stirring at 0 ºC for 7 h, the 
green solution became a pale yellow. Saturated aqueous sodium sulfite (50 mL) was 
added, and the reaction was stirred for 20 min. The two layers were separated and the 
aqueous layer was extracted with EtOAc (3 x 100 mL). The combined organic extracts 
were washed with brine (50 mL), dried over anhydrous Na2SO4, filtered, and concentrated. 



















SiO2 column, 35–45% EtOAc/hexanes) to afford the desired regioisomer 2.48 as a white 
solid (2.21 g, 40%) and the undesired regioisomer 2.47 as a white solid (2.22 g, 40%). 
2.48: 1H NMR (400 MHz, CDCl3) δ 7.33–7.23 (m, 6H), 7.13–7.07 (m, 3H), 5.86 (br s, 1H), 
5.08 (s, 2H), 4.79 (br s, 1H), 4.67 (br s, 1H), 3.81–3.77 (m, 2H), 3.37–3.31 (m, 2H), 2.94 
(br s, 1H), 2.78–2.68 (m, 2H), 1.37 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 156.5, 156.1, 
139.7, 139.5, 136.4, 128.9, 128.6, 128.5, 128.4, 128.3, 127.1, 124.8, 79.4, 67.0, 66.4, 
57.0, 41.6, 36.4, 28.9, 28.5. 2.47: 1H NMR (400 MHz, CDCl3) δ 7.37–7.29 (m, 6H), 7.23–
7.20 (m, 2H), 7.13–7.11 (m, 1H), 5.23 (br s, 1H), 5.11 (s, 2H), 4.84–4.83 (m, 1H), 4.57 (br 






tert-butyl N-(2-{3-[(1R)-1-amino-2-hydroxyethyl]phenyl}ethyl)carbamate (2.43). In a 
250 mL flask with stir bar, 2.47 (2.10 g, 5.07 mmol) and MeOH (100 mL) were added. The 
headspace was flushed with N2 before Pd/C (539 mg, 0.507 mmol) was added. The flask 
was sealed, and evacuated under house vacuum and flushed three times with H2. The 
reaction mixture was stirred at 20 ºC for 3 hours under H2 (3.5 bar). The reaction mixture 
was filtered through a Celite plug, and the filtrate was condensed down under vacuum to 
afford amino alcohol 2.43 as a yellow oil (1.41 g, 99%). 1H NMR (400 MHz, CDCl3) δ 7.31–
7.27 (m, 1H), 7.20–7.15 (m, 2H), 7.12–7.10 (m, 1H), 4.58 (br s, 1H), 4.03 (dd, J = 7.9, 4.5 
Hz), 3.74 (dd, J = 10.8 Hz, 4.5 Hz), 3.56 (dd, J = 10.8, 7.9 Hz), 3.39-3.36 (m, 2H), 2.80 (t, 
















ethyl)carbamate (2.49b). Amino alcohol 2.43 (0.305 g, 1.09 mmol) and 4-chloropicolinic 
acid (0.156 g, 0.990 mmol) were added to a 50 mL oven-dried flask with stir bar sealed 
under N2. Anhydrous DCM (30 mL), HOBT (0.161 g, 1.219 mmol), DIPEA (207 uL, 1.19 
mmol), and HATU (0.452 g, 1.19 mmol) were sequentially added. The reaction mixture 
was stirred under N2 for 16 h. A 50% saturated NaHCO3 solution (20 mL) was added. The 
organic layer was separated and the aqueous layer was extracted with DCM (2 x 20 mL) 
and EtOAc (2 x 20 mL). The organic extracts were combined, dried over anhydrous 
Na2SO4, filtered, and concentrated. The crude oil was taken up in DCM and purified via 
flash chromatography (50 g SiO2, 20–100% EtOAc/hexanes) to afford amide 2.49b as a 
yellow oil (0.345 g, 83%). 1H NMR (400 MHz, CD3CN) δ 8.68 (d, J = 8.1 Hz, 1H), 8.56–
8.53 (m, 1H), 7.59–7.55 (m, 1H), 7.27–7.17 (m, 3H), 7.11–7.09 (m, 1H), 5.35 (br s, 1H), 
5.11–5.05 (m, 1H), 3.88–3.78 (m, 2H), 3.46–3.41 (m, 1H), 3.25–3.17 (m, 2H), 2.27–2.22 
(m, 1H), 1.37–1.34 (m, 9H). 13C NMR (100 MHz, CD3CN) δ 163.6, 156.8, 152.5, 150.7, 





















ethyl)carbamate (2.50b). Alcohol 2.49b (0.329 g, 0.784 mmol) was added to a 25 mL 
with stir bar under N2. Anhydrous DCM (10 mL) was added, the solution was cooled to –
20 ºC in a dry ice/MeOH/H2O bath, and Deoxofluor® (163 uL, 0.885 mmol) was added 
dropwise over 5 min. The reaction mixture was stirred at –20 ºC for 2 h. The reaction was 
allowed to warm to 20 ºC before quenching with saturated NaHCO3 (10 mL). The aqueous 
layer was extracted with DCM (3 x 15 mL), and the combined organic extracts were dried 
over anhydrous Na2SO4, filtered, and concentrated. The crude yellow oil was taken up in 
DCM and purified via flash chromatography (10 g SiO2, 3–10% MeOH/DCM) to afford 
oxazoline 2.50b as a clear and colorless oil (205 mg, 65%). 1H NMR (400 MHz, CDCl3) δ 
8.64 (dt, J = 5.3, 0.6 Hz, 1H) 8.20 (dt, J = 2.0, 0.6 Hz, 1H), 7.45 (ddd, J = 5.3, 2.0, 0.6 Hz, 
1H), 7.33–7.29 (m, 1H), 7.19–7.14 (m, 3H), 5.45 (dd, J = 10.3, 9.7 Hz, 1H), 4.92 (dd, J = 
10.3, 8.6 Hz, 1H), 4.66 (br s, 1H), 4.40 (dd, J = 9.7, 8.6 Hz, 1H), 3.40–3.31 (m, 2H), 2.82–
2.78 (m, 2H), 1.42 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 162.9, 155.9, 150.6, 147.9, 144.9, 






tert-butyl N-[2-(3-bromophenyl)ethyl]-N-methylcarbamate (2.53). Carbamate 2.45 















dried flask with stir bar and sealed under N2. Anhydrous DMSO (20 mL) was added and 
the solution was stirred at 20 ºC for 5 min. Then methyl iodide (3.34 mL, 53.7 mmol) was 
slowly added and the reaction mixture was stirred at 20 ºC for 48 h. Aqueous NH4Cl (25%, 
450 mL) was added and the product was extracted with EtOAc (4 x 150 mL). The 
combined organic layers were washed with brine (100 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated. The crude yellow oil was taken up in DCM and purified via flash 
chromatography (340 g SiO2 column, 0–20% EtOAc/hexanes) to afford carbamate 2.53 
as a clear yellow oil (9.8 g, 87%). This compound has been previously reported and 
characterized (CAS# 153732-25-3). TLC Rf = 0.84 (50:50 EtOAc:Hexanes); IR (thin film): 
2974, 2929, 1688, 1596, 1568, 1475, 1424, 1390, 1364, 1214, 1232, 772, 693, 664 cm-1; 
Note: some peaks are broadened/doubled due to carbamate rotamers. 1H NMR (300 MHz, 
CDCl3) δ 7.35–7.33 (m, 2H), 7.18–7.09 (m, 2H), 3.42 (t, J = 6.9 Hz, 2H), 2.87–2.78 (m, 
5H), 1.44–1.38 (m, 9H); 13C NMR (75 MHz, CDCl3) δ 155.6, 141.7, 131.9, 130.1, 129.4, 






tert-butyl N-[2-(3-ethenylphenyl)ethyl]-N-methylcarbamate (2.54). A solution of 
potassium vinyltrifluoroborate (2.10 g, 15.7 mmol), PdCl2 (53.2 mg, 0.30 mmol), PPh3 (236 
mg, 0.90 mmol), Cs2CO3 (14.7 g, 45.0 mmol), and aryl bromide 2.53 (4.71 g, 15.0 mmol) 
in THF/H2O (9:1) (30 mL) was heated at 85 ºC under an Ar atmosphere in a 15 mL sealed 
pressure tube. The reaction mixture was stirred at 85 ºC for 22 h, then cooled to 20 ºC 
and diluted with H2O (45 mL) followed by extraction with DCM (3 x 150 mL). The combined 








and concentrated. The crude product was taken up in DCM and purified via flash 
chromatography (100 g SiO2, 0–10% EtOAc/hexanes) to afford olefin 2.54 as a clear 
yellow oil (3.51 g, 90%). Rf = 0.70 (50:50); IR (thin film): 2975, 2930, 1690, 1632, 1602, 
1582, 1480, 1451, 1422, 1391, 1364, 1163, 1133, 905, 878, 798, 771, 713 cm-1; Note: 
some peaks are broadened/doubled due to carbamate rotamers. 1H NMR (300 MHz, 
CDCl3) δ 7.33–7.07 (m, 4H), 6.69 (dd, J = 17.6, 10.9 Hz, 1H), 5.74 (d, J = 17.6 Hz, 1H), 
5.21 (d, J = 10.9 Hz, 1H), 3.42 (t, J = 7.0 Hz, 2H), 2.84–2.79 (m, 5H), 1.44–1.39 (m, 9H); 
13C NMR (75 MHz, CDCl3) δ 155.7, 139.6, 137.8, 136.9, 128.7, 128.5, 126.9, 124.3, 113.9, 







tert-butyl N-methyl-N-{2-[3-(oxiran-2-yl)phenyl]ethyl}carbamate (2.55). Olefin 2.54 
(1.03 g, 3.92 mol) was added to a 25 mL oven-dried flask with stir bar and sealed under 
N2. Anhydrous DCM (15 mL) was added and the solution was cooled to 0 ºC. mCPBA 
(1.26 g, 5.11 mmol) was slowly added, and the reaction mixture was stirred at 0 ºC for 3 
h. The solution was allowed to warm to 20 ºC and stirred for an additional 16 h. The 
reaction mixture was diluted with hexanes (200 mL), washed with 50% saturated NaHCO3 
(3 x 50 mL) and brine (50 mL), dried over anhydrous Na2SO4, filtered, and concentrated. 
The crude pale yellow oil was taken up in DCM and purified via flash chromatography (100 
g SiO2, 0–20% EtOAc/hexanes) to afford epoxide 2.55 as a colorless oil (940 mg, 75%). 
TLC Rf = 0.77 (50:50 EtOAc:Hexanes); IR (thin film): 2975, 2930, 1687, 1480, 1451, 1391, 









due to carbamate rotamers. 1H NMR (300 MHz, CDCl3) δ 7.30–7.25 (m, 1H), 7.14–7.08 
(m, 3H), 3.84 (dd, J = 4.1, 2.6 Hz, 1H), 3.42 (t, J = 7.6 Hz, 2H), 3.14 (dd, J =5.5, 4.1 Hz, 
1H), 2.83–2.78 (m, 6H), 1.44–1.39 (m, 9H). 13C NMR (75 MHz, CDCl3) δ 155.7, 139.6, 
137.8, 136.9, 128.7, 128.5, 126.9, 124.3, 113.9, 79.3, 50.9, 35.0, 34.6, 28.5. HRMS (ESI+): 






tert-butyl N-{2-[3-(1-azido-2-hydroxyethyl)phenyl]ethyl}-N-methylcarbamate (2.56). 
Epoxide 2.55 (715 mg, 2.58 mmol) and H2O (12 mL) were added to a 25 mL flask. To the 
stirred suspension was added sodium azide (504 mg, 7.75 mmol) and the reaction mixture 
was heated at 60 ºC for 32 h. The flask was cooled to 20 ºC, and H2O (10 mL) was added. 
The aqueous phase was extracted with EtOAc (3 x 40 mL) and the combined organic 
extracts were washed with brine (40 mL), dried over Na2SO4, and concentrated. The crude 
product was taken up in DCM and purified via flash chromatography (100 g SiO2, 0–60% 
EtOAc/hexanes) to afford azide 2.55 as a colorless oil (533 mg, 71%). TLC Rf = 0.62 
(50:50 EtOAc:Hexanes); IR (thin film): 3425, 2976, 2931, 2868, 2096, 1667, 1482, 1451, 
1428, 1393, 1365, 1249, 1161, 1134, 876, 792, 771, 706 cm-1; Note: some peaks are 
broadened/doubled due to carbamate rotamers. 1H NMR (300 MHz, CDCl3) δ 7.32–7.30 
(m, 1H), 7.23–7.12 (m, 3H), 4.63 (t, J = 6.2 Hz, 1H), 3.75 (m, 2H), 3.44–3.42 (m, 2H), 
2.83–2.78 (m, 5H), 2.66–2.51 (br s, 1H), 1.38 (br s, 9H) 13C NMR (75 MHz, CDCl3) δ 155.8, 
140.0, 136.8, 129.3, 129.1, 129.0, 127.8, 125.3, 79.5, 67.7, 66.5, 50.8, 50.1, 34.5, 34.0, 














tert-butyl N-{2-[3-(1-amino-2-hydroxyethyl)phenyl]ethyl}-N-methylcarbamate (2.57). 
Azide 8 (503 mg, 1.57 mmol) and MeOH (100 mL) were added to a 50 mL flask with stir 
bar. The headspace was flushed with N2 for 5 minutes before Pd/C (167 mg, 0.157 mmol) 
was added. The flask was sealed and purged with H2. The reaction mixture was stirred at 
20 ºC for 4 h under a positive pressure of H2 using a balloon. The reaction mixture was 
filtered through a Celite plug, and the filtrate was concentrated to afford amine 2.57 as a 
colorless oil (442 mg, 96%). IR (thin film): 3355, 3297, 2974, 2929, 2865, 1686, 1481, 
1451, 1392, 1364, 1305, 1248, 1215, 1162, 1133, 1049, 877, 823, 794, 771, 706 cm-1; 
Note: some peaks are broadened/doubled due to carbamate rotamers. 1H NMR (300 MHz, 
CDCl3) δ 7.30–7.09 (m, 5H), 4.02 (dd, J = 7.9, 4.4 Hz, 1H), 3.72 (dd, J = 10.7, 4.4 Hz, 1H), 
3.55 (dd, J = 10.7, 7.9 Hz, 1H), 3.44 –3.41 (m, 2H), 2.83–2.80 (m, 5H), 1.38 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 155.8, 143.2, 139.6, 128.9, 128.1, 127.2, 124.5, 79.4, 68.2, 57.4, 








methylcarbamate (2.58). Amine 2.57 (450 mg, 1.53 mmol) was added to a 100 mL oven-


















mg, 1.53 mmol), HOBt (370 mg, 2.29 mmol), EDC-HCl (440 mg, 2.29 mmol), and DIPEA 
(523 μL, 3.06 mmol) were sequentially added and the reaction mixture was stirred at 20 
ºC for 16 h. After 16 h, the reaction was concentrated under reduced pressure and taken 
up into EtOAc (100 mL) before being washed with H2O (2 x 30 mL), saturated NaHCO3 (2 
x 30 mL), and brine (50 mL). The organic layer was dried over Na2SO4, filtered, and 
concentrated. The crude oil was taken up in DCM and purified via flash chromatography 
(50 g SiO2, 0-8% MeOH:DCM) to yield a mixture of amide 2.58 and an ester byproduct 
formed from additional reaction of the primary alcohol with picolinic acid. This byproduct 
was easily converted back to 2.58 by redissolving the crude mixture in H2O:THF (1:3) (32 
mL) and adding LiOH-H2O (25.7 mg, 0.613 mmol), then stirring at 20 ºC for 30 min. The 
aqueous layer was extracted with DCM (4 x 20 mL), and the combined organic layers 
were dried over Na2SO4, filtered, and concentrated to afford exclusively amide 2.58 as a 
pale yellow oil (432 mg, 71% over 2 steps). TLC Rf = 0.78 (90:10 DCM:MeOH); IR (thin 
film): 3385, 2974, 2930, 1665, 1591, 1570, 1516, 1484, 1465, 1433, 1393, 1365, 1164, 
1135 cm-1; Note: some peaks are broadened/doubled due to carbamate rotamers. 1H 
NMR (300 MHz, CDCl3) δ 8.77 (br s, 1H), 8.57 (d, J = 4.7 Hz, 1H), 8.19 (dd, J = 7.8 Hz, 
0.8 Hz, 1H), 7.85 (t, J = 7.8 Hz, 1H), 7.44 (dd, J = 7.6 Hz, 4.8 Hz, 1H), 7.30–7.04 (m, 5H), 
5.22 (dt, J = 7.6, 4.8 Hz, 1H), 3.99 (t, J = 4.8 Hz, 2H), 3.41–3.39 (m, 2H), 2.84–2.81 (m, 
7H), 1.38–1.34 (m, 9H); 13C NMR (75 MHz, CDCl3) δ 164.7, 149.8, 148.3, 139.7, 139.5, 
137.5, 129.2, 128.9, 128.6, 127.5, 126.4, 125.0, 122.5, 79.5, 66.8, 56.1, 50.8, 49.9, 34.5, 











ethyl)carbamate (2.59). Amide 10 (413 mg, 1.03 mmol) was added to a 50 mL oven-dried 
flask with stir bar and sealed under N2. Anhydrous DCM (15 mL) was added and the 
solution was cooled to –20 ºC in a dry ice/MeOH/H2O bath. Deoxofluor® (226 μL, 1.23 
mmol) was added dropwise, and the mixture was stirred at –20 ºC for 1 h. After 1 h, the 
reaction mixture was allowed to warm up to 20 ºC and the mixture was stirred for an 
additional 1 h. The reaction was quenched with saturated NaHCO3(10 mL) and water (10 
mL), and the aqueous layer was extracted with DCM (3 x 10 mL). The combined organic 
layers were washed with brine (20 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated. The crude oil was taken up in DCM and purified via flash chromatography 
(25 g SiO2, 0–6% MeOH/DCM) to afford oxazoline 2.59 as an orange oil (346 mg, 88%). 
TLC Rf = 0.62 (90:10 DCM:MeOH); IR (thin film): 2974, 2929, 1687, 1640, 1477, 1441, 
1391, 1363, 1308, 1248, 1164, 1134, 1099, 1043, 964, 878, 799, 772, 744, 706 cm-1; Note: 
some peaks are broadened/doubled due to carbamate rotamers. 1H NMR (400 MHz, 
CDCl3) δ 8.76–8.74 (m, 1H), 8.17, (d, J = 7.9 Hz, 1H), 7.81 (td, J = 7.9, 1.7 Hz, 1H), 7.44 
(ddd, J = 7.4, 5.0, 1.0 Hz, 1H), 7.31–7.29 (m, 1H), 7.19–7.10 (m, 3H), 5.44 (dd, J = 10.1, 
8.7 Hz, 1H), 4.90 (dd, J = 10.1, 8.7 Hz, 1H), 4.38 (t, J = 8.7 Hz, 1H), 3.41 (m, 2H), 2.9–2.7 
(m, 5H), 1.43–1.39 (br s, 9H); 13C NMR (75 MHz, CDCl3) δ 164.0, 155.7, 149.9, 146.8, 
142.1, 140.0, 136.8, 129.1, 128.4, 127.4, 125.9, 124.9, 124.4, 79.4, 75.4, 70.4, 51.0, 34.7, 
















Carbamate 2.59 (157 mg, 0.142 mmol) was added to a 50 mL oven-dried flask with stir 
bar and sealed under N2. Anhydrous DCM (15.0 mL) was added, followed by dropwise 
addition of TFA (15.0 mL, 20.6 mmol). The reaction mixture was stirred for 10 min at 20 
ºC. After 10 min, the reaction mixture was added dropwise into saturated NaHCO3 (400 
mL). The aqueous layer was extracted with DCM:MeOH (9:1) (5 x 100 mL). The combined 
organic layers were dried over anhydrous Na2SO4, filtered, and concentrated. The crude 
oil was taken up in DCM and purified via flash chromatography (12 g C18 cartridge, 0–
80% 0.5 N NH3 in MeOH/H2O) to afford amine 2.28 as a colorless oil (64 mg, 55%). TLC 
Rf = 0.04 (90:10 DCM:MeOH); IR (thin film): 3394, 3056, 2934, 2801, 1640, 1583, 1570, 
1471, 1441, 1362, 1248, 1102, 1043, 958, 801, 745, 706; 1H NMR (300 MHz, CDCl3) δ 
8.75 (d, J = 4.8 Hz, 1H), 8.18 (d, J = 7.9 Hz, 1H), 7.81 (t, J = 7.9 Hz, 1H), 7.46–7.42 (m, 
1H), 7.32–7.27 (m, 1H), 7.19-7.14 (m, 3H), 5.44 (dd, J = 10.1, 8.7 Hz, 1H), 4.90 (dd, J = 
10.1, 8.7 Hz, 1H), 4.44 (t, J = 8.7 Hz, 1H), 2.84–2.80 (m, 4H), 2.42 (s, 3H), 1.11 (br s, 1H); 
13C NMR (75 MHz, CDCl3) δ 163.9, 149.9, 146.8, 142.1, 140.8, 136.8, 129.0, 128.2, 127.3, 
125.9, 124.8, 124.4, 75.4, 70.4, 53.3, 36.5, 36.6; HRMS (ESI+): m/z [M+H]+ calcd for 























Pyridine-2,6-dicarbonyl dichloride (3.14): 2,6-pyridinedicarboxylic acid (5.00 g, 29.9 
mmol) was added to a 100 mL oven-dried flask with stir bar and sealed under N2. 
Anhydrous DCM (45.0 mL) was added via syringe and the suspension was cooled to 0 
ºC. Then oxalyl chloride (5.6 mL, 66.2 mmol) and anhydrous DMF (2 drops, ~20 µL) were 
sequentially added via syringe. The reaction mixture was warmed to 20 ºC and stirred for 
24 h vented into a saturated NaHCO3, at which point the solution became a homogenous 
pale yellow solution. Excess oxalyl chloride and solvent were removed under vacuum to 
afford 3.14 as an off-white solid (6.07 g, 99%). This compound has been previously 
reported and characterized (CAS# 3739-94-4). 1H NMR (300 MHz, DMSO-d6) δ 8.25–8.14 







tert-leucinol (398 mg, 3.40 mmol) and TEA (0.50 mL, 3.59 mmol) were added to a 25 mL 
oven-dried flask with stir bar and sealed under N2. Anhydrous DCM (15 mL) was added 
and the solution was cooled to 0 ºC in an ice bath before a solution of 3.14 (0.330 g, 1.62 
mmol) in anhydrous DCM (3.0 mL) was added via syringe dropwise over 5 min. The 
reaction mixture was removed from the ice bath and stirred for 16 h at 20 ºC. The reaction 




















and H2O (10 mL). The organic layer was dried over anhydrous Na2SO4, and concentrated. 
The crude off-white solid was taken up in DCM and purified via flash chromatography (25 
g SiO2 column, 0–10% i-PrOH/DCM) to afford 3.15a as a white solid (514 mg, 87%). This 
compound has been previously reported and characterized (CAS# 1112149-02-6). 1H 
NMR (300 MHz, CDCl3) δ (8.29 d, J = 7.9 Hz, 2H), 8.06 (d, J = 9.2 Hz, 2H), 8.01 (t, J = 
7.9 Hz, 1H), 4.01–3.95 (m, 4H), 3.78–3.70 (m, 2H), 2.96 (t, J = 4.6 Hz, 2H), 1.05 (s, 18H); 







amino-2-methyl-1-propanol (6.00 mL, 62.9 mmol) and TEA (9.20 mL, 66.0 mmol) were 
added to a 250 mL oven-dried flask with stir bar and sealed under N2. Anhydrous DCM 
(50 mL) was added, an addition funnel was attached, the apparatus was purged with N2 
for 10 min, and cooled to 0 ºC in an ice bath. A solution of 3.14 (6.10 g, 29.9 mmol) in 
anhydrous DCM (45 mL) was added dropwise to the reaction via the addition funnel over 
the course of 1 h at 0 ºC. The reaction was diluted with DCM (100 mL), and washed with 
saturated NaHCO3 (3 x 50 mL) and H2O (50 mL). The organic layer was dried over 
Na2SO4, filtered, and concentrated. The crude yellow oil was taken up in DCM and purified 
via flash chromatography (100 g SiO2 column, 0–10% i-PrOH/DCM) to afford 3.15b as a 
pale yellow oil (1.88 g, 20%). This compound has been previously reported and 
characterized (CAS# 211050-32-7). 1H NMR (300 MHz, CDCl3) δ 8.31 (d, J = 7.8 Hz, 2H), 
8.08 (br s, 2H), 8.04 (t, J = 7.8 Hz, 1H), 4.23 (t, J = 6.1 Hz, 2H), 3.71 (d, J = 6.1 Hz, 4H), 



















2,6-Bis[(4R)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine (3.16a): Diol 15a (490 
mg, 1.34 mmol) was added to a 25 mL oven-dried flask with stir bar and sealed under N2. 
Anhydrous DCM (15 mL) was added and the solution was cooled to –20 ºC in a dry 
ice/MeOH:H2O bath. Deoxo-Fluor® (519 uL, 2.82 mmol) was added dropwise over 5 min. 
The reaction mixture was stirred at –20 ºC for 2 h, removed from the bath, and stirred an 
additional 10 h at 20 ºC. The reaction was monitored via TLC (9:1 DCM:MeOH), which 
indicated complete conversion. The reaction was quenched with saturated NaHCO3 (5 
mL) and water (5 mL). The aqueous layer was extracted with DCM (3 x 10 mL). The 
combined organics were washed with brine (20 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated. The crude residue was taken up in DCM and purified via flash 
chromatography (25 g SiO2 column, 0–1% MeOH/EtOAc) to afford 3.16a as a white solid 
(320 mg, 73%). This compound has been previously reported and characterized (CAS# 
118949-63-6). Rf = 0.86 (9:1 DCM:MeOH); 1H NMR (300 MHz, CDCl3) δ 8.25 (d, J = 7.9 
Hz, 2H), 7.86 (t, J = 7.9 Hz, 1H), 4.48 (dd, J = 8.8, 10.3 Hz, 2H), 4.33 (dd, J = 8.4, 8.8 Hz, 
2H), 4.11 (dd, J = 8.4, 10.3 Hz, 2H), 0.97 (s, 18H); 13C NMR (75 MHz, CDCl3) 162.3, 147.0, 














2,6-Bis(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-pyridine (3.16b): Diol 15b (410 mg, 1.33 
mmol) was added to a 20 mL oven-dried vial with stir bar and sealed under N2. Anhydrous 
DCM (10.0 mL) was and the solution was cooled to -20 ºC in a dry ice/MeOH/H2O bath. 
Deoxo-Fluor® (527 uL, 2.72 mmol) was added dropwise over 2 min, removed from the 
bath, and stirred an addition 2 h at 20 ºC. LC-MS analysis indicated complete conversion. 
The reaction was quenched with saturated NaHCO3 (10 mL) and diluted with EtOAc (70 
mL). The phases were separated, and the aqueous layer was extracted with EtOAc (15 
mL). The combined organics were washed with brine (20 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated. The crude yellow oil was taken up in DCM and purified 
via flash chromatography (10 g SiO2 column, 0–100% EtOAc/hexanes) to afford 3.16b as 
a yellow oil (0.260 g, 72%). This compound has been previously reported and 
characterized (CAS# 131864-69-2). 1H NMR (300 MHz, CDCl3) δ 8.20 (d, J = 7.9 Hz, 2H), 






(t-Bu)-PyBOX-PtI(BF4) (3.17a): PyBOX ligand 3.16a (25.0 mg, 0.0721 mmol), 
Pt(DMSO)2I2 (41.0 mg, 0.0685 mmol), and anhydrous DCM (10 mL), were sequentially 
added to a 25 mL oven dried pressure tube with stir bar. The tube was sealed and the 
solution was heated to 70 ºC in an oil bath for 15 min to give a red homogenous solution. 

















heated to 70 ºC for 12 h. After 12 h, a white precipitate had formed and the solution was 
filtered through a PTFE syringe filter and concentrated to give a red oil. The oil was taken 
up into DCM (1.0 mL), and diethyl ether (15.0 mL) was rapidly added to precipitate the 
product. The supernatant was removed via pipette and the solid was dried under vacuum 
to afford 3.17a as an orange solid (47.0 mg, 88%). 1H NMR (400 MHz, CDCl3) δ 8.80 (t, J 
= 8.1 Hz, 1H), 8.14 (d, J = 8.1 Hz, 2H), 5.22 (dd, J = 2.1, 9.6 Hz, 2H), 4.95 (dd, J = 8.3 Hz, 
9.6 Hz, 2H), 4.31 (dd, J = 2.1, 8.3 Hz, 2H), 1.11 (s, 18H). 13C NMR (100 MHz, CD2Cl2) δ 
175.5, 143.4, 142.9, 128.6, 77.2, 71.4, 35.6, 26.9; Anal. calcd (found) for 
C19H27BF4IN3O2Pt, 1: C, 30.91 (27.57); H,3.69 (3.44); N, 5.69 (4.46). LC-MS (direct 






(5S)-2,2,3-Trimethyl-5-(phenylmethyl)-4-imidazolidinone (3.19): To a 4 mL vial, (5S)-(-
)-2,2,3-trimethyl-5-(phenylmethyl)-4-imidazolidinone hydrochloride (104.4 mg, 0.410 
mmol) was dissolved in H2O (0.5 mL) and DCM (3 mL) was added. Then a 5 w/w% solution 
of NaOH was added until the solution was basic (pH 14). The mixture was shaken, the 
organic layer was separated, and the aqueous layer was extracted with DCM (4 x 3 mL). 
The combined organic layers were dried over anhydrous sodium sulfate, filtered, and 
condensed under vacuum to afford 3.19 as a colorless oil (76.2 mg, 85%). This compound 
has been previously reported and characterized (CAS# 132278-63-8). 1H NMR (300 MHz, 
CD3NO2) δ 7.34-7.21 (m, 5H), 3.70 (dd, J = 8.7, 3.9 Hz, 1H), 3.13 (dd, J = 14.1, 3.9 Hz, 















(3.27): In a 5 mL oven-dried flask with stir bar, 2-phenylacetaldehyde (27.5 mg, 0.217 
mmol) was added to a solution of (2S,5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-
one (47.4 mg, 0.217 mmol) in anhydrous toluene (2.00 mL) in the presence of pTsOH (0.4 
mg, 1 mol%). 4 Å mol sieves were added, a simple distillation apparatus was attached, 
and the system was purged with N2 for 10 min. The mixture was heated at reflux for 4 h 
under a positive pressure of N2, and approximately 1 mL of toluene was allowed to distill 
over. After 4 h, the reaction mixture turned a yellow color and the solution was cooled to 
room temperature. The reaction mixture was filtered through a cotton plug into an oven 
dried 20 mL scintillation vial and concentrated to yield a yellow oil. The crude oil was 
purified using flash chromatography (10 g SiO2 column, 0–40% EtOAc/hexanes w/ 1% 
TEA) to afford 3.27 as a white solid (40.0 mg, 57%). This compound has been previously 
reported and characterized (CAS# 1289555-78-7). 1H NMR (400 MHz, CD3NO2) δ 7.46 
(d, J = 7.5 Hz, 2H), 7.38 (t, J = 7.2 Hz, 2H), 7.30 (t, J = 7.0 Hz, 1H), 7.13 (t, J = 7.2 Hz, 
2H), 6.95 (m, 3H), 6.69 (d, J = 14.3 Hz, 1H), 4.83 (d, J = 14.3 Hz, 1H), 4.50 (s, 1H), 3.91 
(dd, J = 8.0, 4.5 Hz, 1H), 3.27 (dd, J = 13.8, 4.5 Hz, 1H), 2.99 (m, 4H), 1.09 (s, 9H); 13C 
(100 MHz, CD3NO2) δ 173.4, 141.4, 141.0, 140.6, 131.6, 130.3, 130.2, 128.5, 126.0, 














Styrylpyrrolidine (3.28): Phenylacetaldehyde (390 mg, 3.25 mmol) and 4 Å molecular 
sieves (3.9 g) were added were added to a 25 mL oven-dried flask with stir bar and sealed 
under N2. Anhydrous CHCl3 (8.0 mL) was added and the solution was cooled to 0 ºC in 
an ice bath before pyrrolidine (320 uL, 3.90 mmol) was added dropwise. The reaction 
mixture was stirred at 0 ºC for 2 h. After 2 h, the reaction mixture was allowed to warm to 
room temperature and stirred at room temperature for 24 h. After 24 h, the solution was 
filtered through a PTFE syringe filter into an oven dried 25 mL round bottom flask and 
condensed under vacuum to yield a pale yellow oil. The crude oil was distilled using a 
Kugelrohr apparatus under high vacuum to afford 3.28 as an orange oil (323 mg, 57%), 
bp 190-200 ºC/ 0.1 mmHg. This compound has been previously reported and 
characterized (CAS# 6908-73-2). 1H NMR (300 MHz, CDCl3) δ 7.19-7.16 (m, 4H), 7.04 (d, 
J = 13.8 Hz, 1H), 6.92 (m, 1H), 5.08 (d, J = 13.8 Hz, 1H), 3.24-3.20 (m, 4H), 1.92-.188 (m, 























Ethyl 3-oxo-2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylpropanoate (4.3); ethyl 3-oxo-
3-phenyl-2-(pyridin-2-yloxy)propanoate (4.4). A suspension of 2-hydroxypyridone (163 
mg, 1.72 mmol), tetrabutylammonium bromide (59.5 mg, 0.184 mmol), and potassium 
carbonate (765 mg, 55.3 mmol) in acetone (6.0 mL) was heated to 40 ºC and stirred for 
30 min. Ethyl-2-bromo-3-oxo-3-phenylpropanoate (500 mg, 1.84 mmol) was added and 
the suspension was stirred at 40 ºC for 30 min before being cooled to 20 ºC. A solution of 
acetic acid (160 uL, 2.79 mmol) in water (2.0 mL) was added slowly, and the mixture was 
stirred for 15 min. The resulting mixture was diluted with H2O (2.0 mL) and extracted with 
DCM (3 x 15 mL). The combined organic layers were dried over anhydrous Na2SO4, 
filtered, and concentrated. The crude orange oil was dissolved in DCM and purified via 
flash chromatography (25 g SiO2 column, 0–60% EtOAc/hexanes) to afford pyridone 4.3 
as a yellow oil (229 mg, 47%) and 4.4 as a yellow oil (44 mg, 9%). 4.3: Rf = 0.25 (50:50 
EtOAc:hexanes); 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 7.3 Hz, 2H), 7.64–7.58 (m, 
2H), 7.51–7.46 (m, 3H), 7.37–7.33 (m, 1H), 6.62 (d, J = 8.7 Hz, 1H), 6.22–6.18 (m, 1H), 
4.31–4.28 (m, 2H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 191.9, 166.6, 
161.4, 140.6, 136.4, 134.8, 134.0, 129.4, 129.2, 120.2, 106.4, 62.8, 59.2, 14.1; LC-MS tR 
= 3.96; m/z = 285.75 (M+H); 4.4: 1H NMR (400 MHz, CDCl3) δ 8.11–8.05 (m, 3H), 7.63–
7.58 (m, 2H), 7.51–7.46 (m, 2H), 6.98–6.92 (m, 2H), 6.68 (s, 1H), 4.27 (q, J = 7.1 Hz, 2H), 
1.22 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 191.7, 166.6, 161.3, 146.5, 139.3, 



















1-(2-Oxo-2-phenylethyl)-1,2-dihydropyridin-2-one (4.5). 2-hydroxypyridine (0.263 g, 
2.76 mmol) and Cs2CO3 (1.63 g, 5.02 mmol) were added to a 15 mL oven-dried flask with 
stir bar and sealed under N2. Anhydrous DMF (5.0 mL) was added and the suspension 
was stirred at 20 ºC for 30 min before 2-bromoacetophenone (0.500 g, 2.51 mmol) was 
added and the suspension was stirred for an additional 1 h at 20 ºC. A solution of glacial 
acetic acid (210 uL, 3.77 mmol) in H2O (2 mL) was slowly added and the mixture was 
stirred until it turned clear and stopped bubbling (~10 min). The mixture was diluted with 
H2O (5 mL) and EtOAc (40 mL) and the layers were separated. The organic layer was 
washed with water (3 x 15 mL) and the combined aqueous layers were extracted with 
EtOAc (10 mL). The combined organic layers were washed with brine (10 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated. The crude yellow solid was dissolved in 
DCM and purified via flash chromatography (50 g SiO2 column, 0–100% EtOAc/hexanes) 
to afford pyridone 4.5 as a white crystalline solid (0.411 g, 77%). This compound has been 
previously reported and characterized (CAS# 952-75-0).205 1H NMR (400 MHz, CDCl3) δ 
8.02–8.00 (m, 2H), 7.62 (tt, J = 7.4, 1.2 Hz, 1H), 7.51–7.47 (m, 1H), 7.40–7.35 (m, 1H), 
7.23–7.21 (m, 1H), 6.59 (d, J = 9.2 Hz, 1H), 6.21 (td, J = 6.7, 1.3 Hz, 1H), 2.21 (s, 2H); 
13C NMR (100 MHz, CDCl3) δ 192.4, 162.5, 140.2, 138.4, 134.7, 134.1, 129.0, 128.2, 












Methyl 3-oxo-3-phenylpropanoate (4.10). NaH (3.7 g, 60% in mineral oil, 92 mmol) and 
dimethyl carbonate (5.9 g, 66 mmol) were added to a 250 mL oven-dried flask with stir 
bar. A reflux condenser and addition funnel were attached, the apparatus was sealed and 
flushed with N2, and anhydrous toluene (33 mL) was added under N2. After the mixture 
was heated to reflux, a solution of acetophenone (3.80 mL, 32.4 mmol) in toluene (17 mL) 
was added dropwise over 0.5 h. The reaction solution turned orange with the formation of 
a white precipitate. After the evolution of hydrogen ceased (~15 min), the reaction was 
cooled to 20 ºC. Glacial acetic acid (10 mL) was added dropwise and a heavy pasty solid 
separated. Ice-cold water was slowly added until the solid dissolved completely, and the 
reaction mixture was diluted with EtOAc (200 mL). The organic layer was separated, 
washed with H2O (200 mL) and brine (200 mL), dried over anhydrous Na2SO4, filtered, 
and concentrated. The residue was dissolved in DCM and purified via flash 
chromatography (100 g SiO2 column, 0–25% EtOAc/hexanes) to afford ester 4.10 as an 
orange oil (5.65 g, 98%). This compound has been previously reported and characterized 
(CAS# 614-27-7).206 1H NMR (300 MHz, CDCl3) δ 12.51 (s, 0.22 H), 7.94 (m, 2H), 7.78 
(m, 0.44 H), 7.76-7.58 (m, 0.44 H), 7.62-7.58 (m, 1 H), 7.50-7.40 (m, 2.7 H), 5.68 (s, 0.22 
H), 4.01 (s, 2H), 3.80 (s, 0.65 H), 3.75 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 192.5, 173.6, 















Benzyl 3-oxo-3-phenylpropanoate (4.11). A 25 mL round bottom flask was charged with 
methyl 3-oxo-3-phenylpropanoate (1.05 g, 5.91 mmol), benzyl alcohol (6.10 mL, 59.1 
mmol), ZnO (96.0 mg, 1.18 mmol) and anhydrous toluene (5 mL). The flask was fitted with 
a short-path distillation head and heated in an oil bath set at 110 °C, distilling the methanol 
formed during the reaction. After 24 h, LC-MS analysis of the reaction mixture showed 
complete consumption of the starting material. The reaction mixture was filtered through 
a plug of Celite and concentrated. The crude residue was dissolved in DCM and purified 
via flash chromatography (100 g SiO2 column, 0–20% EtOAc/hexanes) to afford benzyl 
ester 4.11 as a light orange oil (1.43 g, 95%). This compound has been previously reported 
and characterized (CAS# 63888-22-2).207 This compound exists as a mixture of tautomers 
in CDCl3 (10:1 keto:enol). 1H NMR (300 MHz, CDCl3) δ 12.50 (s, enol), 7.94 (d, J = 8.0 
Hz, enol), 7.90 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 7.9 Hz, enol), 7.59 (t, J = 7.5 Hz, 1H), 7.48 
– 7.28 (m, 7H), 5.73 (s, enol), 5.25 (s, enol), 5.19 (s, 2H), 4.04 (s, 2H); 13C NMR (75 MHz, 






Benzyl 2-bromo-3-oxo-3-phenylpropanoate (4.12). In a 100 mL flask with stir bar, ester 
11 (1.00 g, 3.93 mmol), N-bromosuccinimide (0.735 g, 4.13 mmol), and Amberlyst-15 (2.89 
g) in ethyl acetate (30 mL) were stirred at 20 ºC for 2.5 h. After completion of the reaction, 
as indicated by LC-MS, the reaction mixture was filtered and washed with EtOAc (2 x 20 
















concentrated. The crude product was dissolved in DCM and purified via flash 
chromatography (50 g SiO2 column, 0–20% EtOAc/hexanes) to afford alkyl bromide 4.12 
as a light yellow oil (1.20 g, 92%). This compound has been previously reported and 
characterized (CAS# 845733-96-2).191 1H NMR (400 MHz, CDCl3) δ 7.94–7.92 (m, 2H), 
7.58 (m, 1H), 7.43 (m, 2H), 7.30–7.23 (m, 5H) 13C NMR (100 MHz, CDCl3) δ 188.0, 165.1, 






Benzyl 3-oxo-2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenyl-propanoate (4.13). A 
suspension of 2-hydroxypyridone (212 mg, 2.23 mmol), tetrabutylammonium bromide 
(65.4 mg, 0.203 mmol), and potassium carbonate (0.841 g, 6.09 mmol) in acetone (4.0 
mL) was heated to 40 °C and stirred for 30 min. Then, bromide 4.12 (676 mg, 2.03 mmol) 
in acetone (0.5 mL) was added. The suspension was stirred at 40 °C for 30 min and cooled 
to 20 ºC before a solution of acetic acid (232 uL, 4.06 mmol) in water (2.0 mL) was added 
slowly. The resulting mixture was stirred for 15 min before it was diluted with H2O (5.0 mL) 
and extracted with DCM (3 x 15 mL). The combined organic layers were dried over 
anhydrous Na2SO4, filtered, and concentrated. The crude dark orange oil was dissolved 
in DCM and purified via flash chromatography (50 g SiO2, 0–50% EtOAc/hexanes) to 
afford pyridone 4.13 as a colorless oil (496 mg, 70%). 1H NMR (400 MHz, CDCl3) δ 8.07–
8.04 (m, 2H), 7.64 (s, 1H), 7.60 (tt, J = 7.4, 1.2 Hz, 1H), 7.48–7.44 (m, 3H), 7.35–7.26 (m, 
6H), 6.61 (d, J = 9.2 Hz, 1H), 6.18 (td, J = 6.8 Hz, 1.3 Hz, 1H), 5.25 (s, 2H). 13C NMR (100 
MHz, CDCl3) δ 191.7, 166.5, 161.4, 140.7, 136.4, 134.8, 134.6, 133.9, 129.4, 129.2, 128.7, 














1-(2-Hydroxy-2-phenylethyl)-1,2-dihydropyridin-2-one (4.14). To a 15 mL flask with stir 
bar, 4.13 (33.5 mg, 0.096 mmol) and MeOH (3.0 mL) were added. The flask headspace 
was flushed with N2 before 10% Pd/C (10.3, 0.0096 mmol) was added. The flask was 
flushed with H2 and stirred under H2 (1 atm) at 20 °C for 1 h. After 1 h, the reaction mixture 
was filtered through Celite, condensed under vacuum and analyzed via LC-MS and 1H 
NMR, which indicated conversion to alcohol 4.14. 1H NMR of the crude product showed 
signals for alkyl protons at 4.36, 3.89, and 5.01 ppm, consistent with published data. This 
compound has been previously reported and characterized (CAS# 69914-21-2).208 1H 
NMR (400 MHz, CD3OD) δ 7.43–7.39 (m, 2H), 7.39–7.33 (m, 3H), 7.29–7.26 (m, 2H), 6.56 
(d, J = 8.5 Hz, 1H), 6.30 (td, J = 6.7, 1.2 Hz, 1H), 5.01 (dd, J = 8.8, 3.8 Hz, 1H), 4.36 (dd, 







N-[2-(Diethylamino)ethyl]-1H-imidazole-1-carboxamide (4.16). In a 4 mL oven-dried 
vial, 1,1-carbonyl diimidazole (205 mg, 1.26 mmol) was added with stir bar and sealed 
under N2. Anhydrous THF (1.2 mL) was added and the solution was cooled to 0 °C in an 
ice bath. A solution of N,N-diethylethylenediamine (97.9 mg, 0.842 mmol) in anhydrous 
DCM (0.6 mL) was added dropwise over 10 min and the solution was stirred at 20 ºC for 















Celite and purified via flash chromatography (12 g C18, MeOH/H2O gradient) to afford 
urea 4.16 as a yellow oil (93.7 mg, 53%). This compound has been previously reported 
(CAS# 698388-51-1).209 1H NMR (300 MHz, CDCl3) δ 8.18 (s, 1H), 7.45–7.42 (m, 1H), 
7.09–7.07 (m, 2H), 3.46 (t, J = 6.1 Hz, 2H), 2.66 (t, J = 5.6 Hz, 2H), 2.61–2.51 (m, 4H), 
1.06–0.97 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 149.1, 136.1, 130.3, 130.1, 116.1, 51.3, 






N-Tert-butyl-3-oxo-2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenyl propanamide (4.19). 
In a 4 mL oven-dried vial with a stir bar, t-butylisocyanate (7.0 mg, 0.071 mmol) and NaH 
(60% w/w in mineral oil, 4.7 mg, 0.118 mmol) were mixed in anhydrous toluene (0.5 mL) 
under N2 at 20 °C. Then, ketone 4.5 (10.0 mg, 0.047 mmol) was added in one portion and 
the mixture was heated at 100 °C for 2 h. After 2 h, the reaction was quenched by the 
addition of saturated ammonium chloride. The aqueous layer was extracted with DCM (3 
x 10 mL). The combined organic extracts were washed with brine (10 mL), dried over 
anhydrous Na2SO4, filtered, and condensed to a yellow residue. The crude product was 
purified via flash chromatography (10 g SiO2, 0–100% EtOAc/hexanes) to afford amide 
4.19 as a yellow oil (2.2 mg, 15%) and recovered ketone 4.5 (8.0 mg, 80%). 1H NMR (300 
MHz, CDCl3) δ 7.98 (d, J = 8.0 Hz, 2H), 7.74–7.72 (m, 1H), 7.56–7.52 (m, 1H) 7.43–7.36 
(m, 3H), 7.31 (s, 1H), 6.85 (br. s., 1H), 6.61 (d, J = 9.0 Hz, 1H), 6.29 (t, J = 6.8 Hz, 1H). 















2,2-Difluoro-6-methoxy-4-phenyl-2H-1λ³,3,2λ⁴-dioxaborinine (4.20a). To an oven-
dried 20 mL vial, 10 (0.420 g, 2.36 mmol) and a stir bar were added and the vial was 
purged with N2 for 10 min. Then, anhydrous toluene (10 mL) and boron trifluoride etherate 
(0.58 mL, 4.71 mmol) were sequentially added. The reaction mixture was stirred at 20 ºC 
for 20 h. The reaction mixture was then concentrated to ~1/3 of its volume and cooled to 
–30 °C in a dry ice MeOH/H2O cooling bath. The precipitated material was filtered off and 
washed with 5:1 petroleum ether/EtOAc (5 mL), yielding the boron complex 4.20a as a 
yellow solid (307 mg, 58%). 1H NMR (300 MHz, CDCl3) δ 7.96–7.92 (m, 2H), 7.63–7.57 
(m, 1H), 7.51–7.46 (2H), 6.03 (s, 1H), 4.12 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 179.6, 






Ethyl 2-(2-oxo-1,2-dihydropyridin-1-yl)acetate (4.21). To an oven-dried 1.0 L round 
bottom flask charged with a stir bar, NaH (60% in mineral oil, 1.99 g, 49.9 mmol) was 
suspended in anhydrous DMF (100 mL) and cooled to 0 °C in an ice bath under N2. To the 
NaH suspension, a solution of 2-hydroxypyridine (4.07 g, 42.1 mmol) in anhydrous DMF 
(200 mL) was slowly added. The resulting solution was stirred for 1 h at 0 °C before ethyl 
bromoacetate (4.3 mL, 38 mmol) was added and the mixture was stirred at 20 ºC for 1.5 















extracted with DCM (3 x 150 mL). The combined organic extracts were washed with water 
(7 x 200 mL), dried over anhydrous Na2SO4, filtered, and concentrated. The crude product 
was dissolved in DCM and purified via flash chromatography (100 g SiO2, 0–100 % 
EtOAc/hexanes) to yield ester 4.21 as a pale yellow oil (3.62 g, 53%). This compound has 
been previously reported and characterized (CAS# 80056-43-5).196 Rf: 0.74 (DCM/MeOH 
9:1). 1H NMR (300 MHz, CDCl3) δ 7.40–7.34 (m, 1H), 7.24–7.21 (m, 1H), 6.61–6.58 (m, 
1H), 6.23–6.18 (m, 1H), 4.64 (s, 2H), 4.24 (q, 2H, J = 7.1 Hz), 1.29 (t, 3H, J = 7.1 Hz). 13C 







N-[2-(Diethylamino)ethyl]-3-oxo-3-phenylpropanamide (4.22). In a 15 mL oven-dried 
flask with stir bar, N,N-diethylethylenediamine (167.0 mg, 1.438 mmol) was added and 
sealed under N2. Anhydrous MeCN (5.0 mL) and 4.20a (250 mg, 1.11 mmol) were added, 
and the reaction mixture was stirred at 20 ºC for 4 h. After 4 h, an aliquot was removed, 
condensed under reduced pressure, and dissolved in CDCl3 to monitor the reaction via 1H 
NMR. The reaction mixture was condensed under vacuum, dissolved in EtOAc (30 mL), 
washed with H2O (2 x 10 mL), dried over MgSO4, filtered, and condensed under vacuum 
to yield complex 4.22 as a pale yellow oil (283 mg, 82%). The crude oil (259 mg, 0.834 
mmol), sodium acetate (0.342 g, 4.17 mmol), ethanol (5.0 mL), and H2O (5.0 mL) were 
refluxed for 8 h. TLC analysis (10% MeOH/DCM) of the reaction mixture indicated the 
starting material was consumed. The solvent was removed under reduced pressure, and 
the residue was dissolved in EtOAc (30 mL) and washed with water (2 x 10 mL). The 











(5 x 10 mL). The combined organics were dried over magnesium sulfate, filtered, and 
concentrated. The crude oil was purified by flash chromatography (10 g SiO2, 0–10% 
MeOH/DCM) to yield amide 4.22 as a pale yellow oil (147 mg, 67%). Rf: 0.50 (9:1 
DCM:MeOH); 1H NMR (300 MHz, CDCl3) δ 7.99 (d, J = 7.4 Hz, 2H), 7.61-7.57 (m, 1H) 
7.50-7.45 (m, 2H), 3.96 (s, 2H), 3.48 (q, J = 5.5 Hz, 2H), 2.79-2.73 (m, 6H), 1.14 (t, J = 
7.1 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 195.2, 178.2, 136.4, 133.8, 128.8, 128.7, 51.5, 






1,3-Diethyl 2-(hydroxyimino)propanedioate (4.25). To a 250 mL oven-dried flask with 
stir bar, NaOH (1.32 g, 33.0 mmol) was dissolved in glacial acetic acid (10 mL) at 0 ºC in 
an ice bath under constant stirring. A solution of diethyl malonate (8.01 g, 50.0 mmol) in 
glacial acetic acid (2.8 mL) was added dropwise over 5 min and the mixture was stirred 
for 30 min at 0 ºC. Then a solution of sodium nitrite (6.90 g, 100.0 mmol) in water (55 mL) 
was added dropwise over 1.5 h via an addition funnel. After the addition of the sodium 
nitrite solution was completed, the addition funnel was replaced with a septum fitted with 
an empty balloon. The reaction mixture was allowed to warm to 20 ºC and stirred for 16 
h. The reaction mixture was saturated with NaCl and extracted with EtOAc (3 x 50 mL). 
The combined organic extracts were washed with a 1:1 mixture of saturated NaHCO3 and 
brine (6 x 50 mL) until the pH of the aqueous layer was basic (pH 8–9). The organic layer 
was dried over anhydrous Na2SO4, filtered, and concentrated. The crude colorless liquid 
was dissolved in DCM and purified via flash chromatography (100g SiO2, 0–60% 












has been previously reported and characterized (CAS# 6829-41-0). Rf: 0.41 (50:50 
EtOAc:hexanes); 1H NMR (300 MHz, CDCl3) δ 10.13 (br s, 1H), 4.41 (q, J = 7.1 Hz, 2H), 
4.36 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H), 1.35 (t, J = 7.1 Hz, 3H); 13C NMR (75 






1,3-Diethyl 2-aminopropanedioate (4.26). Hydroxyimino 4.25 (1.73 g, 9.15 mmol) and 
EtOH (8.0 mL) were added to a 25 mL pressure tube with stir bar. The headspace was 
purged with N2 before 10% Pd/C (97.3 mg, 0.092 mmol) was quickly added. The reaction 
flask was attached to a Parr hydrogenator, evacuated, and backfilled with hydrogen x 3. 
The reaction was stirred vigorously under H2 (3 bar) for 2.5 h. LCMS and TLC analysis 
indicated complete conversion. The reaction mixture was filtered through a Celite plug 
using MeOH and concentrated to afford amino malonate 4.26 as a clear yellow oil (1.51 
g, 94%). This compound has been previously reported and characterized (CAS# 6829-40-
9).). Rf: 0.79 (9:1 DCM:MeOH); 1H NMR (300 MHz, CDCl3) δ 4.29–4.20 (m, 4H), 3.80 (s, 







1,3-Diethyl 2-{[(tert-butoxy)carbonyl]amino}propanedioate (4.27). Amino malonate 

















Anhydrous THF (10 mL) and TEA (2.3 mL, 16.5 mmol) were added and the solution was 
cooled to 0 ºC in an ice bath. BOC anhydride (2.00 g, 9.16 mol) was added and the 
reaction mixture was allowed to warm to 20 ºC and stirred for 16 h. TLC analysis (50:50 
EtOAc:hexanes; vanillin and ninhydrin stains) indicated complete conversion. DCM (50 
mL) and H2O (30 mL) were added. The organic layer was separated and the aqueous 
layer was extracted with DCM (3 x 50 mL). The combined organic extracts were washed 
with brine (30 mL), dried over anhydrous Na2SO4, filtered, and concentrated. The crude 
yellow oil was dissolved in DCM and purified via flash chromatography (100 g SiO2, 0–
60% EtOAc/hexanes) to afford 4.27 as a clear and colorless oil (2.00 g, 88%). This 
compound has been previously reported and characterized (CAS# 102831-44-7). Rf: 
0.70 (50:50 EtOAc:hexanes; vanillin stain); 1H NMR (300 MHz, CDCl3) δ 5.58 (d, J = 7.6 
Hz, 1H), 4.94 (d, J – 7.6 Hz, 1H), 4.33–4.21 (m, 4H), 1.45 (s, 9H), 1.30 (t, J = 7.1 Hz, 6H); 






Tert-butyl N-[bis({[2-(diethylamino)ethyl]carbamoyl})methyl]carbamate (4.28). Boc 
protected amino malonate 4.27 (712 mg, 2.59 mmol), N,N-diethylethylenediamine (2.40 
g, 20.7 mmol), and xylenes (5.0 mL) were added to a 25 mL oven-dried flask with stir bar. 
The flask was fitted with a reflux condenser, sealed under N2, and refluxed for 24 h. LCMS 
analysis indicated near complete conversion with some mixed amide-ester intermediate. 
The reflux condenser was replaced with a short path distillation condenser and xylenes 
and excess N,N-diethylethylenediamine were distilled off under ambient pressure. The 














95% MeOH/H2O w/ 0.1% NH4OH) to afford diamide 4.28 as a pale yellow oil (396 mg, 
37%). 1H NMR (300 MHz, CDCl3) δ 7.42 (br s, 2H), 6.01 (br s, 1H), 4.63 (s, 1H), 3.29 (m, 
4H), 2.55–2.49 (m, 12H), 1.45 (s, 9H), 1.01 (t, J = 7.1 H, 12H); 13C NMR (75 MHz, CDCl3) 







(4.29). Magnesium (15.0 mg, 0.616 mmol) and CCl4 (150 uL) were added to a 10 mL oven-
dried flask with stir bar and sealed under N2. Ethanol (74.6 uL, 1.28 mmol) was added 
dropwise at 20 ºC and the reaction was stirred for 20 min at 20 ºC. Then diethyl ether (0.5 
mL) as added, a reflux condenser was attached, and the reaction mixture was refluxed for 
1.5 h. After cooling to 20 ºC, a solution of diamide 4.28 (128 mg, 0.308 mmol) in EtOH 
(0.5 mL) was added dropwise. Then diethyl ether (0.5 mL) was added and the reaction 
mixture was stirred at room temperature for 1 h before benzoyl chloride (17.5 uL, 0.150 
mmol) was added dropwise. LCMS analysis indicated incomplete conversion so additional 
benzoyl chloride (15.0 uL, 0.130 mmol) was added dropwise and the reaction mixture was 
stirred an additional 30 min. Saturated NaHCO3 (5 mL) was added and the mixture was 
extracted with EtOAc (3 x 8 mL). The combined organic layers were dried over anhydrous 
Na2SO4, filtered, and concentrated. The crude oil was taken up into DCM and purified via 
flash chromatography (10 g SiO2, 0–10% MeOH/DCM) to afford b-keto-amide 4.29 as an 
off white solid (46 mg, 44%). Rf: 0.54 (9:1 DCM:MeOH); 1H NMR (300 MHz, CDCl3) δ 8.10 
(m, 2H), 7.60 (m, 1H), 7.48 (m, 2H), 6.20 (d, J = 6.1 Hz, 1H), 5.75 (d, J = 6.1 Hz, 1H), 3.30 












MHz, CDCl3) δ 193.7, 166.4, 155.3, 134.7, 134.1, 129.7, 128.7, 80.7, 60.9, 51.2, 46.9, 






2-(2-Oxo-1,2-dihydropyridin-1-yl)acetic acid (4.32). Ester 4.21 (3.59 g, 19.8 mmol) and 
EtOH:H2O (1:1, 60 mL) were added to a 250 mL oven-dried flask with stir bar and cooled 
to 0 °C. A 1 N aqueous solution of LiOH (40 mL, 40 mmol) was added and the solution 
was stirred for 2 h at 20 ºC. After 2 h, ethanol was removed under vacuum and 2 M HCl 
was added to the aqueous solution to reach a pH ~ 6. Next, the solution was concentrated 
down to dryness and the crude solid was dissolved with DCM and purified via flash 
chromatography (50 g SiO2, 0–10% MeOH/DCM w/ 0.1% formic acid) to afford 4.32 as a 
white powder (2.04 g, 67%). This compound has been previously reported and 
characterized (CAS# 56546-36-2).196 1H NMR (400 MHz, acetone-d6) δ 7.62–7.60 (m, 1H), 






[2-(Diethylamino)ethyl][(4-methoxyphenyl)methyl]amine (4.33b). To a 100 mL oven-
dried flask with stir bar, N,N-diethylethylenediamine (1.25 g, 10.6 mmol) was added and 
the flask was sealed under N2. i-PrOH (25 mL) was added and the flask was cooled to 0 














was slowly warmed to 20 ºC and stirred for 16 h. MeOH (20 mL) was added, the solution 
was cooled to 0 ºC, and NaBH4 (1.69 g, 44.7 mmol) was added in portions over 1 h. The 
solution was stirred for an additional 1 h, while warmed to 20 ºC. A solution of 10% NaOH 
in H2O (25 mL) was added and the resulting mixture was extracted with DCM (3 x 40 mL). 
The combined organic layers were washed with a 10% aqueous solution of NaI (50 mL). 
The organic layers were dried over Na2SO4, filtered, and concentrated. The resulting crude 
yellow oil was dissolved in DCM (5 mL) and ether (10 mL), cooled to 0 ºC, and a 4 M HCl 
solution in 1,4-dioxane (5.6 mL, 22.4 mmol) was added dropwise. The white precipitate 
was filtered and washed with DCM and diethyl ether to yield an off-white solid. This was 
dissolved in water (30 mL), cooled to 0 ºC, and the solution was basified with NaOH (to 
pH ~ 9). The resulting mixture was extracted with DCM (3 x 40 mL). The combined 
organics were dried over Na2SO4, filtered, and concentrated to afford amine 4.33b as a 
yellow oil (1.86 g, 74% yield). This compound has been previously reported (CAS# 65875-
40-3).210 Rf = 0.57 (9:1 DCM:MeOH); 1H NMR (300 MHz, CDCl3) δ 7.23 (d, J = 8.6 Hz, 
2H), 6.85 (d, J = 8.6 Hz, 2H), 3.79 (s, 3H), 3.74 (s, 2H), 2.66 (t, J = 6.2 Hz, 2H), 2.55 (t, J 
= 6.2 Hz, 2H), 2.49 (q, J = 7.1 Hz, 4H), 0.99 (t, 6H); 13C NMR (75 MHz, CDCl3) δ 158.6, 








Carboxylic acid 4.32 (37.0 mg, 0.242 mmol) was added to an oven-dried 50 mL flask with 











mg, 0.363 mmol), DIPEA (62.0 uL, 0.362 mmol), and N,N-diethyethylenediamine (33.7 
mg, 0.290 mmol) were sequentially added. The reaction mixture was stirred for 5 min at 
20 ºC before EDC-HCl (69.4 mg, 0.362 mmol) was added in one portion. The reaction 
mixture was stirred at 20 ºC for 48 h. Monitoring via LC-MS showed conversion to the 
desired product. The solvent was removed under vacuum and the residue was dry loaded 
using Celite and purified via flash chromatography (12 g C18, 0-95% MeOH/H2O gradient 
w/ 0.1% NH4OH) to afford amide 4.34a as a pale yellow oil (21 mg, 35%). 1H NMR (300 
MHz, CDCl3) δ 7.38–7.38 (m, 2H), 6.61 (d, J = 9.0 Hz, 1H), 6.24 (td, J = 1.3, 6.7 Hz, 1H), 
4.56 (s, 2H), 3.30 (q, J = 5.7 Hz, 2H), 2.57–2.50 (m, 7H), 0.99 (t, J = 7.1 Hz, 6H); 13C NMR 
(75 MHz, CD3OD) δ 168.1, 163.6, 141.5, 139.8, 139.7, 119.3, 107.2, 52.0, 51.2, 46.9, 36.6, 







dihydropyridin-1-yl)acetamide (4.34b). Carboxylic acid 4.32 (0.300 g, 19.6 mmol) was 
added to an oven dried 50 mL flask with stir bar and sealed under N2. Anhydrous DCE 
(20.0 mL) was added, and the resulting mixture was cooled to 0 ºC using an ice bath 
before EDC-HCl (0.563, 29.4 mmol), amine 4.34b (0.300 g, 19.6 mmol), and DMAP (23.9 
mg, 1.96 mmol) were added. The reaction was allowed to warm up to 20 ºC and stirred 
under N2 for 16 h. The resulting solution was washed with 1 M NaOH (10 mL). The 
aqueous layer was extracted with DCM (2 x 5 mL), and the combined organic layers were 
dried over anhydrous Na2SO4, filtered, and concentrated. The crude yellow oil was 











with 0.1% NH4OH) to afford amide 4.34b as a colorless oil (213 mg, 29%). The 1H and 13C 
NMR are complicated due to rotamers. 1H NMR (300 MHz, CDCl3) δ 7.39–7.24 (m, 3H), 
7.20–7.18 (m, 1H), 6.93–6.91 (m, 1H), 6.85–6.82 (m, 1H), 6.58–6.54 (m-1H), 6.22–6.16 
(m, 1H), 4.89 (s, 1H), 4.73 (s, 1H), 4.66 (s, 1H), 4.59 (s, 1H), 3.80–3.77 (s, 3H), 3.46–3.37 
(m, 2H), 2.64–2.45 (m, 6H), 1.03–0.95 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 167.0, 166.7, 
162.5, 162.4, 159.2, 159.0, 140.0, 140.0, 138.9, 138.7, 129.5, 129.1, 128.2, 127.9, 120.4, 
114.3, 114.0, 105.8, 105.7, 55.3, 55.2, 51.5, 51.3, 50.3, 49.7, 49.4, 48.9, 47.5, 47.4, 45.6, 






Benzyl 2-bromo-3-hydroxy-3-phenylpropanoate (4.42a). To a 25 mL flask with stir bar, 
benzyl cinnamate (477 mg, 2.00 mmol), NBS (427 mg, 2.40 mmol) and MeCN:H2O (4:1) 
(10 mL) were added and the solution was cooled to 0 ºC. Iodine (50.8 mg, 0.200 mmol) 
was added and the mixture was stirred for 72 h. The reaction mixture was washed with 10 
% aq. sodium thiosulfate (20 mL) and extracted with EtOAc (3 x 40 mL). The combined 
organic extracts were washed with brine, dried over anhydrous Na2SO4, filtered, and 
concentrated. The crude product was dissolved in DCM and purified by flash 
chromatography (50 g SiO2, 0–100% EtOAc/hexanes) to afford bromohydrin 4.42a as a 
colorless liquid (276 mg, 41%). This compound has been previously reported (CAS# 
1332928-50-3).211 Rf = 0.47 (50:50 EtOAc:hexanes); 1H NMR (300 MHz, CDCl3) δ 7.23-
7.37 (m, 10H), 5.20 (s, 2H), 5.07 (dd, J = 5.5, 8.2 Hz, 1H), 4.41 (d, J = 8.2 Hz, 1H), 3.26 
(br d, J = 5.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 169.3, 139.0, 134.9, 128.9, 128.7, 















Methyl 2-bromo-3-hydroxy-3-phenylpropanoate (4.42b). The procedure for the 
synthesis of bromohydrin 4.42a was used with the following modifications: methyl trans-
cinnamate (1.62 g, 10.0 mmol) was used instead of benzyl trans-cinnamate, NBS (2.14 g, 
12.0 mmol), MeCN:H2O (4:1) (50 mL), and iodine (254 mg, 1.00 mmol). The crude product 
was dissolved in DCM and purified by flash chromatography (100 g SiO2, 0–40% 
EtOAc/hexanes) to afford bromohydrin 4.42b as an off-white solid (1.45 g, 56%). This 
compound has been previously reported (CAS# 90841-69-3).197 Rf = 0.38 (70:30 
hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.35–7.38 (m, 5H), 5.06 (dd, J = 5.3, 8.4 
Hz, 1H), 4.37 (d, J = 8.4 Hz, 1H), 3.79 (s, 3H), 3.28 (d, J = 5.3 Hz, 1H); 13C NMR (75 MHz, 






Benzyl 3-phenyloxirane-2-carboxylate (4.43). In a 4 mL oven-dried vial with stir bar, a 
suspension of 2-hydroxypryidone (6.8 mg, 0.072 mmol), tetrabutylammonium bromide 
(1.9 mg, 0.0060 mmol), and ground potassium carbonate (24.7 mg, 0.179 mmol) in 
acetone (0.5 mL) was heated at 40 ºC for 30 min. A solution of the bromohydrin 4.42a 
(20.0 mg, 0.0597 mmol) in acetone (0.2 mL) was added dropwise over 5 min and the 
mixture was stirred at 40 ºC for 30 min. The reaction mixture was monitored via LCMS 
and TLC (50:50 EtOAc:hexanes) and stained with PAA. Saturated NH4Cl (1 mL) and H2O 














with H2O (5 mL) and extracted with DCM (3 x 10 mL). The combined organic layers were 
dried over anhydrous Na2SO4, filtered, and concentrated. The crude pale yellow oil was 
dissolved in DCM and purified by flash chromatography (5 g SiO2, 0–100% 
EtOAc/hexanes) to yield pyridone 4.43 as a colorless oil (11.4 mg, 75%). This compound 
has been previously reported and synthesized (CAS# 144667-57-2).212 1H NMR (300 
MHz, CDCl3) δ 3.55 (d, J = 1.7 Hz, 1H), 4.11 (d, J = 1.7 Hz, 1H), 5.25 (m, 2H), 7.25-7.40 
(m, 10H); 13C NMR (75 MHz, CDCl3) δ 168.2, 135.1, 135.0, 129.2, 128.8, 128.8, 128.7, 






Methyl 2-bromo-3-[(tert-butyldimethylsilyl)oxy]-3-phenylpropanoate (4.44a). 
Bromohydrin 4.42a (70.0 mg, 0.209 mg) was added to a 4 mL oven-dried vial with stir bar 
and sealed under N2. Anhydrous DCM (1.0 mL), 2.6-lutidine (92.0 uL, 0.794 mmol) and 
TBSOTf (72.0 uL, 0.314 mmol) were sequentially added and the solution was stirred at 20 
ºC for 2 h. TLC analysis (50:50 EtOAc:hexanes) indicated consumption of starting 
material. The reaction was quenched with the slow addition of saturated NaCl (2 mL), and 
the mixture was stirred for 15 min. The aqueous layer was extracted with ether (2 x 10 
mL), and the organic layer was washed with brine (5 mL), dried over anhydrous Na2SO4, 
filtered, and condensed. The crude yellow oil was dissolved in DCM and purified by flash 
chromatography (25 g SiO2, 0–20% EtOAc/hexanes) to yield 4.44a as a pale yellow oil 
(277 mg, 77%). This compound has been previously reported and synthesized (CAS# 
175722-72-2).213 Rf = 0.68 (70:30 hexanes:EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.31–










0.01 (s, 3H), –0.29 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 169.6, 140.1, 128.7, 127.7, 76.7, 






Methyl 2-bromo-3-(methoxymethoxy)-3-phenylpropanoate (4.44b). Bromohydrin 
4.42a (100 mg, 0.386 mmol) was added to a 4 mL oven-dried vial with stir bar and sealed 
under N2. Anhydrous DCM (1.0 mL) was added and the solution was cooled to 0 ºC. Then, 
2,6-lutidine (67.4 uL, 0.579 mmol) was added followed by dropwise addition of 
methoxychloromethane (44 uL, 0.579 mmol). The solution was stirred at 0 ºC for 1 h, 
allowed to warm up to 20 ºC, and then stirred for 16 h under N2. After 16 h, the reaction 
was diluted with EtOAc (15 mL) and washed with saturated aq. NaHCO3 (10 mL). The 
aqueous layer was extracted with EtOAc (2 x 10 mL), and the combined organic layers 
were dried over anhydrous Na2SO4, filtered, and concentrated. The crude yellow oil was 
dissolved in DCM and purified by flash chromatography (5 g SiO2, 0–40% EtOAc/hexanes) 
to yield 4.44b as a colorless oil (78 mg, 66%). Rf: 0.59 (70:30 hexanes:EtOAc); 1H NMR 
(300 MHz, CDCl3) δ 7.40–7.35 (m, 5H), 5.00 (d, J = 10.1 Hz, 1H), 4.54–4.45 (m, 2H), 4.33 
(d, J = 10.1 Hz, 1H), 3.85 (s, 3H), 3.25 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 169.4, 136.9, 















Methyl 3-(acetyloxy)-2-bromo-3-phenylpropanoate (4.46). Bromohydrin 4.42b (3.28 g, 
12.6 mmol) was added to a 50 mL oven-dried flask with stir bar and sealed under N2. 
Anhydrous DCM (20.0 mL), acetic anhydride (1.34 mL, 14.3 mmol) and DMAP (61.8 mg, 
0.506 mmol) were sequentially added. The solution was stirred at 20 ºC for 16 h. TLC 
analysis (50:50 hexanes:EtOAc) confirmed consumption of starting material. The reaction 
mixture was poured into ice cold H2O (100 mL), and extracted with DCM (3 x 100 mL). 
The combined organic layers were washed with brine (100 mL), dried over anhydrous 
Na2SO4, filtered, and concentrated. The crude pale yellow oil was dissolved in DCM and 
purified by flash chromatography (100 g SiO2, 0–20% EtOAc/hexanes) to yield 4.46 as a 
colorless oil (3.55 g, 93%). This compound has been previously reported and synthesized 
(CAS# 59339-56-9).214 Rf = 0.73 (50:50 EtOAc:hexanes); 1H NMR (300 MHz, CDCl3) δ 
7.43–7.35 (m, 5H), 6.11 (d, J = 9.9 Hz, 1H), 4.50 (d, J = 9.9 Hz, 1H), 3.81 (s, 3H), 2.02 (s, 







Methyl 2-(acetyloxy)-3-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylpropanoate (4.47b); 
methyl (2Z)-3-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylprop-2-enoate (4.48b). 2-
Hydroxypyridine (3.55 g, 37.4 mmol) and Cs2CO3 (8.11 g, 24.9 mmol) were added to a 




















added and the suspension was heated at 50 ºC for 1 h, then cooled to 20 ºC. A solution of 
alkyl bromide 4.46 (7.50 g, 24.9 mmol) in anhydrous DMF (20 mL) was added and the 
reaction mixture was stirred at 20 ºC for 16 h. The reaction was quenched with saturated 
aq. NH4Cl (75 mL), diluted with EtOAc (500 mL), and washed with H2O (6 x 200 mL). The 
organic layer was dried over anhydrous Na2SO4, filtered, and concentrated. The resulting 
crude yellow oil was dissolved in DCM and purified by flash chromatography (100 g SiO2, 
0–100% EtOAc/hexanes) to yield 4.47b as a waxy off-white solid (1.98 g, 25%) and 4.48b 
as an off-white solid (0.60 g, 9%). 4.47b: 1H NMR (400 MHz, CDCl3) δ 7.49–7.47 (m, 2H), 
7.39–7.38 (m, 3H), 7.27–7.25 (m, 1H), 7.05 (d, J = 7.1 Hz, 1H), 6.87 (d, J = 5.1 Hz, 1H), 
6.60 (d, J = 9.7 Hz, 1H), 6.02 (t, J = 6.7 Hz, 1H), 5.89 (d, J = 7.1 Hz, 1H), 3.65 (s, 3H), 
2.14 (s, 3H) ; 13C NMR (100 MHz, CDCl3) δ 169.4, 167.9, 162.2, 139.4, 135.9, 134.6, 
129.5, 129.3, 129.1, 120.7, 105.8, 71.3, 57.2, 53.0, 20.7; LC-MS tR =5.50; m/z = 255.75 
(M+H). 4.48b: 1H NMR (400 MHz, CDCl3) δ 7.47–7.40 (m, 7H), 7.12 (ddd, J = 6.8, 2.1, 0.7 
Hz, 1H), 6.66–6.63 (m, 2H), 6.27 (td, J = 6.8, 1.2 Hz, 1H), 3.69 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 164.0, 161.8, 151.1, 140.6, 137.5, 131.2, 129.5, 129.2, 126.6, 122.1, 115.8, 






2-Hydroxy-3-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylpropanoic acid (4.49b). To a 50 
mL flask with stir bar, acetate 4.47b (1.98 g, 6.28 mmol), THF (48 mL), H2O (12 mL), and 
LiOH-H2O (580 mg, 13.8 mmol) were sequentially added and the reaction was stirred at 
20 ºC for 30 min. Analysis via LC-MS indicated complete conversion. THF was removed 










The solution was concentrated, the crude product was dry loaded using Celite, and 
purified via flash chromatography (12 g C18, 0–95% 0.5 N NH3 in MeOH/H2O) to afford 
carboxylic acid 4.49b as an off-white solid (1.49 g, 92%). 1H NMR (400 MHz, DMSO-d6) 
δ 7.49–7.47 (m, 3H), 7.37–7.29 (m, 4H), 6.43–6.40 (m, 2H), 6.15 (t, J = 6.7 Hz, 1H), 4.66 
(d, J = 5.0 Hz, 1H). 13C NMR (100 MHz, DMSO-d6) δ 173.2, 161.2, 139.7, 137.6, 136.8, 






(2-Aminoethoxy)(tert-butyl)dimethylsilane (4.51). Ethanolamine (2.07 g, 33.9 mmol) 
was added to a 25 mL oven-dried flask with stir bar and sealed under N2. Imidazole (4.61 
g, 67.8 mmol) and anhydrous DCM (30 mL) were added before a solution of TBSCl (5.11 
g, 33.9 mmol) in anhydrous DCM (5 mL) was added dropwise over 10 min via syringe 
pump at 20 ºC. The solution was allowed to stir at 20 ºC for 1 h. Next, the solution was 
diluted with DCM (150 mL) and washed with water (3 x 50 mL) and brine (50 mL). The 
organic layer was dried over MgSO4, filtered, and concentrated to give amine 4.51 as a 
pale yellow oil (4.77 g, 80%). This compound has been previously reported and 
synthesized (CAS# 101711-55-1).215 1H NMR (CDCl3, 400 MHz) δ 3.63 (t, J = 5.2 Hz, 2H), 
2.77 (t, J = 5.2 Hz, 2H), 1.47, (br s, 2H), 0.91 (s, 9H), 0.07 (s, 6H); 13C NMR (CDCl3, 100 















yl)-3-phenylpropanamide (4.53). To an oven-dried 50 mL round bottom flask, acid 4.49 
(420 mg, 1.62 mmol), amine 4.51 (568 mg, 3.24), anhydrous DMF (10 mL), and anhydrous 
DCE (10 mL) were added. Next, NMM (356 uL, 3.24 mmol) was added via syringe and 
HATU (739 mg, 1.94 mmol) was added in one portion. The reaction mixture was stirred at 
20 ºC for 16 h under N2. After 16 h, the reaction mixture was diluted with EtOAc (200 mL) 
and washed with H2O (2 x 50 mL) and brine (50 mL). The organic layer was dried over 
anhydrous Na2SO4, filtered, and condensed under vacuum to yield a crude yellow oil. The 
crude oil was purified by flash chromatography (25 g SiO2, 0–100% EtOAc/hexanes) to 
afford amide 4.53 as a colorless oil (620 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 7.44–
7.40 (m, 1H), 7.35–7.30 (m, 7H), 6.81 (br s, 1H), 6.68 (d, J = 9.1 Hz, 1H), 6.25 (t, J = 7.3 
Hz, 1H), 6.00 (s, 1H), 4.84 (s, 1H), 3.66–3.53 (m, 2H), 3.42–3.30 (m, 2H), 0.87 (s, 9H), 
0.02 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 170.9, 164.9, 140.6, 139.2, 135.0, 128.7, 128.6, 


















phenylpropanamide (4.54). Alcohol 4.53 (205 mg, 0.492 mmol) was added to a 20 mL 
oven-dried vial with stir bar and sealed under N2. Anhydrous DCM (10 mL) and DMP (251 
mg, 0.592 mmol) were added and the reaction was stirred at 20 ºC for 2 h under N2. A 
10% Na2S2O3 aqueous solution (10 mL) was added and the biphasic mixture was stirred 
for 20 min until the two layers became clear. The aqueous layer was separated and the 
organic layer was washed with saturated NaHCO3 (2 x 5 mL). The combined aqueous 
layers were extracted with EtOAc (1 x 10 mL) and the combined organics were dried over 
anhydrous Na2SO4, filtered, and concentrated. The crude oil was dissolved in DCM and 
purified via flash chromatography (25 g SiO2, 0–80% EtOAc/hexanes) to afford ketone 
4.54 as an off-white solid (170 mg, 83%). 1H NMR (400 MHz, CDCl3) δ 7.38–7.26 (m, 7H), 
6.93 (d, J = 7.0 Hz, 1H), 6.85 (s, 1H), 6.52 (d, J = 9.1 Hz, 1H), 6.08 (t, J = 6.7 Hz, 1H), 
3.64–3.60 (m, 2H), 3.43–3.25 (m, 2H), 0.80 (s, 9H), –0.04 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 189.8, 162.4, 159.4, 140.2, 135.5, 130.7, 130.2, 130.0, 129.7, 119.7, 106.5, 64.3, 

















(4.55). To a 100 mL flask charged with a stir bar, silyl ether 4.54 (100 mg, 0.241 mmol) 
and MeOH (10.0 mL) were added. Then a 2% aqueous HCl in MeOH solution (10.0 mL) 
was added, and the reaction was stirred for 1 h at 20 ºC. The solution was concentrated, 
dry loaded on to Celite, and purified via flash chromatography (12 g C18, 0–40% 
MeOH/H2O) to afford alcohol 4.55 as a colorless oil (56.7 mg, 78%). LC-MS tR = 3.64; m/z 







azanium chloride (4.57). Alcohol 4.55 (40.0 mg, 0.133 mmol) was added to a 20 mL 
oven-dried vial with stir bar and sealed under Ar. Anhydrous MeCN (4.0 mL), DIPEA (22.8 
uL, 0.133 mmol), and MsCl (30.9 uL, 0.400 mmol) were respectively added and the 
solution was stirred at 20 ºC for 24 h. Analysis via TLC confirmed conversion to the 
mesylate. Freshly distilled diethylamine (275 uL, 2.66 mmol) stored over 4 Å mol sieves 
was added and the reaction was heated at 70 ºC for 16 h under Ar. The reaction was 
concentrated, dry loaded using Celite, and purified via flash chromatography (10 g C18, 

















white powder (11.0 mg, 28%). Rf = 0.61 (95:5 DCM:MeOH); 1H NMR (400 MHz, CDCl3) δ 
8.61 (s, 1H), 8.03 (s, 1H), 7.51–7.49 (m, 3H), 7.41 (ddd, J = 8.8, 6.6, 1.9 Hz, 1H), 7.37–
7.35 (m, 2H), 6.90 (dd, J = 7.1, 1.7 Hz, 1H), 6.55 (d, J = 8.8 Hz, 1H), 6.15 (td, J = 6.6, 1.2 
Hz, 1H), 6.07 (s, 1H), 4.73–4.70 (m, 1H), 4.26–4.22 (m, 1H), 3.86–3.58 (m, 6H), 1.36–
1.24 (m, 6H). This compound had poor solubility in chloroform and MeOH. The HCl salt 
was formed prior to 13C NMR analysis. The product was taken up into minimal H2O and 
0.5 mL of 1M HCl was added. The solution was lyophilized to afford a yellow oil. 13C NMR 
(75 MHz, D2O) δ 170.4, 164.2, 155.1, 143.0, 136.5, 131.0, 131.0, 130.4, 129.9, 129.8, 







Ethyl 2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylpropanoate (4.58). In a 20 mL oven-
dried vial with stir bar, HMDS (1.90 mL, 9.11 mmol) and anhydrous THF (9.0 mL) were 
added under N2. The solution was cooled to 0 ºC in an ice bath before n-butyl lithium (5.43 
mL of a 1.6 M solution in hexanes, 8.69 mmol) was added dropwise over 10 min. The 
solution was cooled to –78 ºC before a solution of ester 4.21 (1.50 g, 8.28 mmol) in 
anhydrous THF (25.0 mL) was added dropwise. The solution was stirred at –78 ºC for 1 h 
under N2 before benzylbromide (985 uL, 8.28 mmol) was added dropwise. The reaction 
mixture was stirred at –78 ºC for 1 h, allowed to warm up to 0 ºC, quenched with saturated 
NH4Cl (10 mL), and diluted with EtOAc (50 mL). The organic layer was separated, washed 
with brine, dried over anhydrous Na2SO4, filtered, and concentrated. The crude material 









EtOAc/hexanes) to afford 4.58 as a colorless oil (1.52 g, 68%). 1H NMR (300 MHz, CDCl3) 
δ 7.28 –7.18 (m, 4H), 7.11–7.08 (m, 2H), 7.03 (dd, J = 6.9, 1.5 Hz, 1H), 6.50 (d, J = 9.2 
Hz, 1H), 6.03 (td, J = 6.8, 1.3 Hz, 1H), 5.41 (dd, J = 9.7, 5.6 Hz, 1H), 4.21 (q, J = 7.1 Hz, 
2H), 3.50 (m, 1H), 3.33 (m, 1H), 1.23 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
169.5, 162.2, 139.6, 136.5, 136.1, 129.1, 128.7, 127.1, 120.8, 105.6, 61.9, 61.2, 36.3, 






Ethyl (2Z)-2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylprop-2-enoate (4.60). The 
procedure for the synthesis of 4.58 was followed using HMDS (392 mg, 2.43 mmol), 
anhydrous THF (9.0 mL), n-butyl lithium (1.45 mL of a 1.6 M solution in hexanes, 2.32 
mmol), 4.21 (400 mg, 2.21 mmol) in anhydrous THF (3.0 mL), and benzaldehyde (0.247 
mL, 2.43 mmol) instead of benzylbromide. After workup, the product was dissolved in DCM 
and purified via flash chromatography (25 g SiO2, 0–50% EtOAc/hexanes) to afford alkene 
4.60 as an off-white solid (272 mg, 46%). 1H NMR (400 MHz, CDCl3) δ 7.83 (s, 1H), 7.43 
(ddd, J = 9.0, 6.6, 2.0 Hz, 1H), 7.33–7.26 (m, 3H), 7.20–7.18 (m, 2H), 6.96 (dd, J = 6.7, 
1.8 Hz, 1H), 6.67 (d, J = 8.7 Hz, 1H), 6.18 (td, J = 6.7, 1.0 Hz, 1H), 4.31 (q, J = 7.1 Hz, 
2H), 1.31 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 163.4, 162.4, 140.8, 137.7, 
137.4, 131.4, 130.5, 130.2, 129.9, 128.9, 121.8, 106.8, 62.0, 14.1. LC-MS tR = 6.06; m/z 












(2Z)-2-(2-Oxo-1,2-dihydropyridin-1-yl)-3-phenylprop-2-enoic acid (4.61). To a 15 mL 
flask with stir bar, ester 4.60 (136 mg, 0.504 mmol), THF (6.0 mL), H2O (1.5 mL), and 
LiOH-H2O (25.4 mg, 0.604 mmol) were added and the solution was stirred at 20 ºC for 12 
h. THF was removed under vacuum before a 1M HCl solution was added dropwise until 
the pH reached ~ 1. The solution was concentrated under vacuum and the crude product 
was dry loaded using Celite and purified via flash chromatography (12 g C18, 0–75% 
MeOH/H2O w/ 0.1% formic acid) to afford carboxylic acid 4.61 as an off-white solid (108 
mg, 89%). 1H NMR (400 MHz, CD3OD) δ 7.94 (s, 1H), 7.65 (ddd, J = 9.1, 6.7, 2.0 Hz, 1H), 
7.39–7.30 (m, 4H), 7.20–7.18 (m, 2H), 6.67 (d, J = 9.1 Hz, 1H), 6.42 (td, J = 6.7, 1.0 Hz, 
1H); 13C NMR (100 MHz, CD3OD) δ 166.2, 164.8, 143.6, 140.0, 139.0, 133.1, 131.7, 131.6, 






Ethyl 3-hydroxy-2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylpropanoate (4.62). In a 
100 mL oven-dried flask with stir bar, diisopropylamine (309 μL, 2.21 mmol) and anhydrous 
THF (35.0 mL) were added via syringe under N2. The solution was cooled to –78 ºC in a 
dry ice/acetone bath before n-butyl lithium (1.38 mL of a 1.6 M solution in hexanes, 2.21 
mmol) was added dropwise over 10 min. The solution was allowed to stir for 30 min before 














over 5 min. The heterogenous solution was stirred at –78 ºC for 1 h before benzaldehyde 
(0.247 mL, 2.43 mmol) was added, and the solution was stirred at –78 ºC for 2 h. The 
reaction was quenched at –78 ºC via the addition saturated aq. NH4Cl (15 mL) and diluted 
with EtOAc (75 mL). The organic layer was separated, washed with brine, dried over 
anhydrous Na2SO4, filtered, and concentrated. The crude material was dissolved in DCM 
and purified via flash chromatography (50 g SiO2, 0–100% EtOAc/hexanes) to afford 
alcohol 4.62 as a colorless oil (307 mg, 48%). The NMR spectra are complex due to 
diastereomers. 1H NMR (300 MHz, CDCl3) δ 7.59 (dd, J = 6.8, 1.3 Hz, 1H), 7.26–7.15 (m, 
12H), 6.80 (dd, J = 6.8, 1.5 Hz, 1H), 6.39 (d, J = 9.1 Hz, 1H), 6.28 (d, J = 9.1 Hz, 1H), 6.05 
(td, J = 6.7, 1.2 Hz, 1H), 5.86 (td, J = 6.7 Hz, 1.2 Hz, 1H), 5.81 (d, J = 4.3 Hz, 1H), 5.63 
(d, J = 4.3 Hz, 1H), 5.45 (d, J = 7.5 Hz, 1H), 4.74 (d, J = 7.5 Hz, 1H), 4.22–4.16 (m, 4H), 
1.24–1.19 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 169.4, 168.2, 162.9, 162.3, 140.2, 140.1, 
139.5, 138.9, 138.5, 137.9, 128.4, 128.3, 127.8, 126.4, 125.9, 120.3, 119.7, 105.9, 105.6, 
73.5, 72.1, 67.5, 63.5, 62.1, 62.1, 60.4, 21.1, 14.2, 14.1, 14.0; LC-MS tR = 4.78, 4.92; m/z 







propanoate (4.63). The procedure for the synthesis of 4.44a was used with the following 
modifications: 4.62 (153 mg, 0.533 mmol), DCM (6.0 mL), 2,6-lutidine (74.4 uL, 0.639 
mmol) and TBSOTf (147 uL, 0.639 mmol) were used. The crude oil was dissolved in DCM 
and purified via flash chromatography (25 g SiO2, 0–50% EtOAc/hexanes) to yield 4.63 










1H), 7.87 (dd, J = 6.9, 1.4 Hz, 1H), 7.56–7.38 (m, 11H), 6.62 (d, J = 9.2 Hz, 1H), 6.53 (d, 
J = 9.2 Hz, 1H), 6.44–6.39 (m, 1H), 6.33–6.28 (m, 1H), 6.12 (d, J = 7.2 Hz, 1H), 5.87 (d, 
J = 3.9 Hz, 1H), 5.44 (d, J = 7.2 Hz, 1H), 4.59–4.51 (m, 1H), 4.45–4.33 (m, 3H), 1.53 (t, J 
= 7.1 Hz, 3H), 1.46 (t, J = 7.1 Hz, 3H), 1.13 (s, 9H), 1.11 (s, 9H), 0.29 (s, 3H), 0.25 (s, 3H), 
0.02 (s, 3H), 0.00 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 169.0, 168.5, 162.2, 161.8, 139.6, 
139.5, 139.4, 139.3, 138.7, 136.6, 128.3, 128.2, 128.2, 128.2, 127.0, 126.4, 120.4, 119.7, 
105.4, 104.5, 75.6, 75.4, 62.1, 61.9, 61.7, 61.5, 25.8, 25.8, 18.1, 18.1, 14.2, 14.1, –4.4, –






Prop-2-en-1-yl 2-(2-oxo-1,2-dihydropyridin-1-yl)acetate (4.64). NaH (60% dispersion 
in mineral oil, 1.77 g, 46.3 mmol) was added to a 500 mL oven-dried flask with stir bar and 
sealed under N2. Anhydrous DMF (125 mL) was added and the suspension was cooled to 
0 °C in an ice bath. A solution of 2-hydroxypyridine (4.00 g, 42.1 mmol) in anhydrous DMF 
(25.0 mL) was slowly added and stirred for 1 h at 0 ºC. Allyl chloroacetate (5.98 mL, 
50.5 mmol) was added and the mixture was stirred at 20 ºC for 12 h. The reaction was 
quenched with saturated NH4Cl (200 mL) and diluted with EtOAc (750 mL). The organic 
layer was washed with water (6 x 200 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated. The crude product was dissolved in DCM and purified via flash 
chromatography (100 g SiO2, 0–85% EtOAc/hexanes) to afford pyridone 4.64 as a pale 
yellow oil (3.40 g, 42%). 1H NMR (400 MHz, CDCl3) δ 7.30 (ddd, J = 9.2, 6.7, 2.1 Hz, 1H), 
7.20 (ddd, J = 6.7, 2.1, 0.7 Hz, 1H), 6.49 (ddd, J = 9.2, 1.4, 0.7 Hz, 1H), 6.13 (td, J = 6.7, 









(dq, J = 10.5, 1.3 Hz, 1H), 4.60 (s, 2H), 4.58 (dt, J = 5.7, 1.4 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) δ 167.5, 162.4, 140.3, 138.0, 131.3, 121.0, 119.0, 106.2, 66.3, 50.5. LC-MS tR = 







(4.65). In an oven-dried 100 mL flask with stir bar, anhydrous THF (50.0 mL) and 
diisopropylamine (1.55 mL, 11.0 mmol) were added via syringe under N2. The solution 
was cooled to –78 ºC before n-butyl lithium (6.90 mL of a 1.6 M solution in hexanes, 11.0 
mmol) was added dropwise over 5 min. The solution was stirred for 30 min before a 
solution of ester 4.64 (1.94 g, 10.0 mmol) in anhydrous THF (8.0 mL) was added dropwise 
over 5 min and stirred at –78 ºC for 1 h. Benzaldehyde (1.53 mL, 15.1 mmol) was added 
and the resulting solution was stirred at –78 ºC for 2 h. The reaction was quenched at –
78 ºC with saturated aq. NH4Cl and diluted with EtOAc (200 mL) and H2O (10 mL). The 
layers were separated and the organic layer was washed with brine, dried over anhydrous 
Na2SO4, and concentrated. The crude yellow oil was dissolved in DCM and purified via 
flash chromatography (100 g SiO2, 0–70% EtOAc/hexanes) to afford alcohol 4.65 as a 
yellow oil (2.45 g, 82%). 1H NMR (400 MHz, CDCl3) δ  7.43 (d, J = 7.9 Hz, 1H), 7.27–7.22 
(m, 13H), 6.71 (dd, J = 6.8, 1.5 Hz, 1H), 6.46 (d, J = 9.1 Hz, 1H), 6.40 (d, J = 8.8 Hz, 1H), 
6.09 (td, J = 6.8, 1.3 Hz, 1H), 5.94–5.81 (m, 3H), 5.73 (s, 2H), 5.57 (d, J = 7.9 Hz, 1H), 
5.34–5.20 (m, 4H), 4.72–4.64 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 169.2, 167.9, 163.1, 










126.4, 125.9, 120.5, 120.0, 119.1, 119.0, 106.0, 105.8, 73.7, 72.1, 68.0, 66.6, 66.6, 64.0; 






3-Hydroxy-2-(2-oxo-1,2-dihydropyridin-1-yl)-3-phenylpropanoic acid (4.66). Alcohol 
4.65 (1.90 g, 0.264 mmol) and Pd(PPh3)4 (12.2 mg, 0.0106 mmol) were added to a 500 
mL oven-dried flash with stir bar and sealed under N2. Anhydrous THF (6.0 mL) and 
morpholine (24.2 uL, 0.277 mmol) were added via syringe and the reaction was stirred at 
20 ºC for 30 min. After 30 min, analysis via LC-MS indicated consumption of starting 
material. The reaction mixture was concentrated, dry loaded using Celite, and purified 
using flash chromatography (30 g C18, 0–95% MeOH/H2O w/ 0.1% formic acid) to afford 
carboxylic acid 4.66 as a yellow oil (1.20 g, 73%). 1H NMR (400 MHz, CD3OD) δ 8.10 (d, 
J = 6.5 Hz, 1H), 7.44 (d, J = 6.5 Hz, 1H), 7.36–7.15 (m, 10H), 6.37 (d, J = 9.0 Hz, 1H), 
6.30–6.27 (m, 1H), 6.14–6.10 (m, 1H), 5.73 (d, J = 3.8 Hz, 1H), 5.45 (d, J = 7.9 Hz, 1H), 







propanamide (4.67). Carboxylic acid 4.66 (886 mg, 3.42 mmol) was added to a 500 mL 

















g, 5.13 mmol), DIPEA (655 uL, 3.76 mmol), and N,N-diethyethylenediamine (624 uL, 4.44 
mmol) were sequentially added and the solution was stirred at 20 ºC for 12 h. After 12 h, 
the reaction was concentrated under vacuum, dry loaded using Celite, and purified via 
flash chromatography (30 g C18, 0–95% MeOH/H2O w/ 0.1% formic acid) to afford amide 
4.67 as an off-white waxy solid (918 mg, 75%). m.p. 75–77 ºC; 1H NMR (400 MHz, CD3OD) 
δ 7.44 (dd, J = 6.9, 1.5 Hz, 1H), 7.34 (ddd, J = 9.0, 6.7, 2.0 Hz, 1H), 7.28–7.26 (m, 2H), 
7.24–7.19 (m, 3H), 6.36 (dd, J = 9.0, 0.6 Hz, 1H), 6.14 (td, J = 6.7, 1.3 Hz, 1H), 5.39 (d, J 
= 9.5 Hz, 1H), 5.19 (d, J = 9.5 Hz, 1H), 3.79–3.73 (m, 1H), 3.64–3.57 (m, 1H), 3.38–3.22 
(m, 6H), 1.31 (t, J = 7.3 Hz, 6H); 13C NMR (100 MHz, CD3OD) δ 171.8, 164.4, 142.5, 
141.1, 140.0, 129.5, 129.4, 128.0, 120.5, 108.4, 73.4, 67.3, 53.0, 49.1, 35.7, 9.2. LC-MS 







propanamide (4.68). Alcohol 4.67 (47.5 mg, 0.133 mmol) was added to a 20 mL oven-
dried vial with stir bar and sealed under N2. Anhydrous DCM (6.0 mL) and DMP (84.5 mg, 
0.199 mmol) were sequentially added and the reaction mixture was stirred at 20 ºC for 1 
h. After 1 h, H2O (2.7 uL, 0.15 mmol) was added via microsyringe. The reaction solution 
was stirred at 20 ºC for 48 h before being quenched with saturated Na2S2O3 (3 mL). The 
product was extracted with DCM (3 x 10 mL) and concentrated. The crude product was 
dissolved in DCM and purified via flash chromatography (12 g SiO2, 0–20% MeOH/DCM) 
to afford ketone 4.68 as an off-white solid (11.7 mg, 25%). Rf = 0.71 (80:20 DCM:MeOH); 












1.7 Hz, 1H), 7.60–7.56 (m, 1H), 7.48–7.44 (m, 1H), 7.40–7.34 (m, 2H), 6.60 (d, J = 9.2 
Hz, 1H), 6.24 (td, J = 6.8, 1.3 Hz, 1H), 3.39–3.28 (m, 2H), 2.57–2.48 (m, 6H), 0.96 (t, J = 
7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 192.0, 165.2, 162.0, 140.7, 137.4, 135.0, 134.3, 







5.6. X-ray Crystallographic Structures and Sample Preparation 
 
 




4.48b Preparation and Structure Description: Colorless prism crystals were obtained 
via slow evaporation in a saturated solution of 4.48b in EtOAc. The trans-cinnamic acid 
residue is essentially planar with 2-pyridinone group almost perpendicular (dihedral angle 
85°) to it. 
 
 
4.49b Preparation and Structure Description: Colorless thin plates were obtained via 









diastereomer (crystallizing as a racemate). The molecule has a staggered conformation 
along the bond C2-C3. 
 
 
4.61 Preparation and Structure Description: Colorless tablets were obtained via slow 
cooling 4.61 (40 mg) in MeOH (0.5 mL). The cinnamic acid residue has trans-configuration 
with the double bond and carboxy groups well-conjugated (dihedral angle O=C-C=C 
169.6º). The styrene moiety is also conjugated (dihedral angle between benzene ring and 




4.68 Preparation and Structure Description: Colorless prisms were obtained by slow 
evaporation of 4.68 (3 mg) in DCE:Dioxane (300 uL). The groups around the central 
tertiary carbon atom are arranged in a propeller-like order, with two α-carbonyl groups 
oriented anti relative to C-H bond and pyridinone carbonyl – syn (possibly – because of 
attraction between the carbonyl and acidic C-H group, although modern rules do not 
recognize 5-membered H-bonded rings). The amide group is in trans-conformation. The 
terminal NEt2 group is orientationally disordered over two positions with equal population. 






5.7 NMR Spectra 
 
 
5.7.1 NMR Spectra of Bifunctional Catalyst Synthesis 
 
 















































































































































































































































































































































































































































































































































































5.7.3 NMR Spectra for Synthesis of STK076545 
 
 



































































































































































































































































































































































































































































































































































































































































































































































































1. Zhang, Z.; Li, W.-D. Z.; Li, Y., Novel Approach for the Stereocontrolled 
Construction of Eudesmane Skeleton:  A Concise Synthesis of (±)-Balanitol. Org. 
Lett. 2001, 3 (16), 2555-2557. 
 
2. Stork, G.; Niu, D.; Fujimoto, A.; Koft, E. R.; Balkovec, J. M.; Tata, J. R.; Dake, G. 
R., The First Stereoselective Total Synthesis of Quinine. J. Am. Chem. Soc. 2001, 
123 (14), 3239-3242. 
 
3. Mori, K.; Nomi, H.; Chuman, T.; Kohno, M.; Kato, K.; Noguchi, M., Synthesis and 
Absolute Stereochemistry of Serricornin [(4S,6S,7S)-4,6-Dimethyl-7-hydroxy-3-
nonanone]: The Sex Pheromone of the Cigarette Beetle. Tetrahedron 1982, 38 (24), 
3705-3711. 
 
4. Nicolaou, K. C.; Nadin, A.; Leresche, J. E.; Yue, E. W.; Greca, S. L., Total Synthesis 
of Zaragozic Acid A/Squalestatin S1. Angewandte Chemie International Edition in 
English 1994, 33 (21), 2190-2191. 
 
5. Eckford, P. D. W.; Sharom, F. J., ABC Efflux Pump-Based Resistance to 
Chemotherapy Drugs. Chem. Rev. 2009, 109 (7), 2989-3011. 
 
6. Norbert, L. W.; Jed, F. F.; Paul, H.; Olaf, W., Inhibition of Histone Deacetylases: A 
Pharmacological Approach to the Treatment of Non-Cancer Disorders. Curr. Top. 
Med. Chem. 2009, 9 (3), 257-271. 
 
7. Mishra, N.; Brown, D. R.; Olorenshaw, I. M.; Kammer, G. M., Trichostatin A 
Reverses Skewed Expression of CD154, Interleukin-10, and Interferon-γ Gene and 
Protein Expression in Lupus T Cells. Proceedings of the National Academy of 
Sciences 2001, 98 (5), 2628. 
 
8. Jackson, M.; Karwowski, J. P.; Theriault, R. J.; Rasmussen, D. R.; Hensey, D. M.; 
Humphrey, P. E.; Swanson, S. J.; Barlow, G. J.; Premachandran, U.; Mcalpine, J. B., 
Macquarimicins, Microbial Metabolites from Micromonospora. J. Antibiot. Res. 
1995, 48 (6), 462-466. 
 
9. Tanka, M.; Nara, F.; Yamasato, Y.; Masuda-Inoue, S.; Doi-Yoshioka, H.; Kumakura, 
S.; Enokita, R.; Ogita, T., Macquarimicin A Inhibits Membrane-bound Neutral 
Sphingomyelinase from Rat Brain. J. Antibiot. Res. 1999, 52 (7), 670-673. 
 
10. von Oettingen, W. F., The Halogenated Hydrocarbons of Industrial and 
Toxicological Importance. Elsevier: Amsterdam, New York, 1964. 
 






12. Kohler, M. C.; Wengryniuk, S. E.; Coltart, D. M., Asymmetric α-Alkylation of 
Aldehydes, Ketones, and Carboxylic Acids. In Stereoselective Synthesis of Drugs and 
Natural Products, John Wiley & Sons, Inc.: 2013. 
 
13. Chan, T.-H., 2.3 - Formation and Addition Reactions of Enol Ethers. In 
Comprehensive Organic Synthesis, Trost, B. M.; Fleming, I., Eds. Pergamon: Oxford, 
1991; pp 595-628. 
 
14. Stork, G.; Landesman, H. K., A New Alkylation of Carbonyl Compounds. II. J. Am. 
Chem. Soc. 1956, 78 (19), 5128-5129. 
 
15. Stork, G.; Terrell, R.; Szmuszkovicz, J., A New Synthesis of 2-Alkyl and 2-Acyl 
Ketones. J. Am. Chem. Soc. 1954, 76 (7), 2029-2030. 
 
16. Millard, A. A.; Rathke, M. W., A Nickel Catalyst for the Arylation and Vinylation of 
Lithium Ester Enolates. J. Am. Chem. Soc. 1977, 99 (14), 4833-4835. 
 
17. Grigalunas, M.; Ankner, T.; Norrby, P.-O.; Wiest, O.; Helquist, P., Ni-Catalyzed 
Alkenylation of Ketone Enolates under Mild Conditions: Catalyst Identification and 
Optimization. J. Am. Chem. Soc. 2015, 137 (22), 7019-7022. 
 
18. Huang, J.; Bunel, E.; Faul, M. M., Palladium-Catalyzed α-Vinylation of Carbonyl 
Compounds. Org. Lett. 2007, 9 (21), 4343-4346. 
 
19. Somei, M.; Yamada, F., Simple Indole Alkaloids and those with a Nonrearranged 
Monoterpenoid Unit. Nat. Prod. Rep. 2003, 20 (2), 216-242. 
 
20. Hibino, S.; Choshi, T., Simple Indole Alkaloids and those with a Nonrearranged 
Monoterpenoid Unit. Nat. Prod. Rep. 2002, 19 (2), 148-180. 
 
21. Tang, Y.-Q.; Sattler, I.; Thiericke, R.; Grabley, S.; Feng, X.-Z., Maremycins C and 
D, New Diketopiperazines, and Maremycins E and F, Novel Polycyclic spiro-Indole 
Metabolites Isolated from Streptomyces sp. Eur. J. Org. Chem. 2001, 2001 (2), 261-
267. 
 
22. Riou, M.; Barriault, L., De Novo Synthesis of (+)-Isofregenedol. The Journal of 
Organic Chemistry 2008, 73 (18), 7436-7439. 
 
23. Ankner, T.; Cosner, C. C.; Helquist, P., Palladium- and Nickel-Catalyzed 
Alkenylation of Enolates. Chemistry – A European Journal 2013, 19 (6), 1858-1871. 
 
24. Hama, T.; Liu, X.; Culkin, D. A.; Hartwig, J. F., Palladium-Catalyzed α-Arylation of 







25. Cosner, C. C.; Helquist, P., Concise, Convergent Syntheses of (±)-Trichostatin A 
Utilizing a Pd-Catalyzed Ketone Enolate α-Alkenylation Reaction. Org. Lett. 2011, 
13 (14), 3564-3567. 
 
26. Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B., Asymmetric Enamine Catalysis. 
Chem. Rev. 2007, 107 (12), 5471-5569. 
 
27. Notz, W.; Tanaka, F.; Barbas, C. F., Enamine-Based Organocatalysis with Proline 
and Diamines:  The Development of Direct Catalytic Asymmetric Aldol, Mannich, 
Michael, and Diels−Alder Reactions. Acc. Chem. Res. 2004, 37 (8), 580-591. 
 
28. Erkkilä, A.; Majander, I.; Pihko, P. M., Iminium Catalysis. Chem. Rev. 2007, 107 
(12), 5416-5470. 
 
29. Machajewski, T. D.; Wong, C.-H., The Catalytic Asymmetric Aldol Reaction. 
Angew. Chem. Int. Ed. 2000, 39 (8), 1352-1375. 
 
30. Eder, U.; Sauer, G. R.; Wiechert, R. German Pat., DE 2014757, 1971. 
 
31. Hajos, Z. G.; Parrish, D. R. German Pat., DE 2102623, 1971. 
 
32. Wagner, J.; Lerner, R. A.; Barbas, C. F., Efficient Aldolase Catalytic Antibodies That 
Use the Enamine Mechanism of Natural Enzymes. Science 1995, 270 (5243), 1797-
1800. 
 
33. List, B.; Lerner, R. A.; Barbas, C. F., Proline-Catalyzed Direct Asymmetric Aldol 
Reactions. J. Am. Chem. Soc. 2000, 122 (10), 2395-2396. 
 
34. Trost, B. M.; Brindle, C. S., The Direct Catalytic Asymmetric Aldol Reaction. Chem. 
Soc. Rev. 2010, 39 (5), 1600-1632. 
 
35. Job, A.; Janeck, C. F.; Bettray, W.; Peters, R.; Enders, D., The SAMP-/RAMP-
Hydrazone Methodology in Asymmetric Synthesis. Tetrahedron 2002, 58 (12), 
2253-2329. 
 
36. Zhang, L.; Fu, N.; Luo, S., Pushing the Limits of Aminocatalysis: Enantioselective 
Transformations of α-Branched β-Ketocarbonyls and Vinyl Ketones by Chiral 
Primary Amines. Acc. Chem. Res. 2015, 48 (4), 986-997. 
 
37. Corey, E. J.; Enders, D., Applications of N,N-Dimethylhydrazones to Synthesis. Use 
in Efficient, Positionally and Stereochemically Selective Carbon-Carbon Bond 
Formation; Oxidative Hydrolysis to Carbonyl Compounds. Tetrahedron Lett. 1976, 
17 (1), 3-6. 
 
38. Enders, D.; Eichenauer, H.; Baus, U.; Schubert, H.; Kremer, K. A. M., Asymmetric 






39. Enders, D.; Eichenauer, H.; Pieter, R., Enantioselektive Synthese von (-)-(R)-und(+)-
(S)-[6]-Gingerol-Gewürzprinzip des Ingwers1). Chem. Ber. 1979, 112 (11), 3703-
3714. 
 
40. Enders, D.; Wortmann, L.; Peters, R., Recovery of Carbonyl Compounds from N,N-
Dialkylhydrazones. Acc. Chem. Res. 2000, 33 (3), 157-169. 
 
41. Lim, D.; Coltart, D. M., Simple and Efficient Asymmetric α-Alkylation and α,α-
Bisalkylation of Acyclic Ketones by Using Chiral N-Amino Cyclic Carbamate 
Hydrazones. Angew. Chem. Int. Ed. 2008, 47 (28), 5207-5210. 
 
42. Wengryniuk, S. E.; Lim, D.; Coltart, D. M., Regioselective Asymmetric α,α-
Bisalkylation of Ketones via Complex-Induced Syn-Deprotonation of Chiral N-
Amino Cyclic Carbamate Hydrazones. J. Am. Chem. Soc. 2011, 133 (22), 8714-8720. 
 
43. Kim, H.; MacMillan, D. W. C., Enantioselective Organo-SOMO Catalysis:  The α-
Vinylation of Aldehydes. J. Am. Chem. Soc. 2008, 130 (2), 398-399. 
 
44. Mangion, I. K.; Northrup, A. B.; MacMillan, D. W. C., The Importance of Iminium 
Geometry Control in Enamine Catalysis: Identification of a New Catalyst 
Architecture for Aldehyde–Aldehyde Couplings. Angew. Chem. Int. Ed. 2004, 43 
(48), 6722-6724. 
 
45. Skucas, E.; MacMillan, D. W. C., Enantioselective α-Vinylation of Aldehydes via 
the Synergistic Combination of Copper and Amine Catalysis. J. Am. Chem. Soc. 
2012, 134 (22), 9090-9093. 
 
46. Stevens, J. M.; MacMillan, D. W. C., Enantioselective α-Alkenylation of Aldehydes 
with Boronic Acids via the Synergistic Combination of Copper(II) and Amine 
Catalysis. J. Am. Chem. Soc. 2013, 135 (32), 11756-11759. 
 
47. Smidt, J.; Hafner, W.; Jira, R.; Sedlmeier, J.; Sieber, R.; Rüttinger, R.; Kojer, H., 
Katalytische Umsetzungen von Olefinen an Platinmetall-Verbindungen Das 
Consortium-Verfahren zur Herstellung von Acetaldehyd. Angew. Chem. 1959, 71 
(5), 176-182. 
 
48. Phillips, F. C., Note on a Form of Silver Obtained in the Reduction of Sulphide by 
Hydrogen. J. Am. Chem. Soc. 1894, 16 (10), 700-703. 
 
49. Keith, J. A.; Henry, P. M., The Mechanism of the Wacker Reaction: A Tale of Two 
Hydroxypalladations. Angew. Chem. Int. Ed. 2009, 48 (48), 9038-9049. 
 
50. Trend, R. M.; Ramtohul, Y. K.; Stoltz, B. M., Oxidative Cyclizations in a Nonpolar 
Solvent Using Molecular Oxygen and Studies on the Stereochemistry of 





51. Hosokawa, T.; Yamashita, S.; Murahashi, S.-I.; Sonoda, A., Regrioselectivity of 
Palladium(II)-Induced Intramolecular Cyclization of 2-(3-Methyl-2-butenyl)phenol. 
Bull. Chem. Soc. Jpn. 1976, 49 (12), 3662-3665. 
 
52. Liu, G.; Stahl, S. S., Two-Faced Reactivity of Alkenes:  cis- versus trans-
Aminopalladation in Aerobic Pd-Catalyzed Intramolecular Aza-Wacker Reactions. 
J. Am. Chem. Soc. 2007, 129 (19), 6328-6335. 
 
53. Nakhla, J. S.; Kampf, J. W.; Wolfe, J. P., Intramolecular Pd-Catalyzed 
Carboetherification and Carboamination. Influence of Catalyst Structure on Reaction 
Mechanism and Product Stereochemistry. J. Am. Chem. Soc. 2006, 128 (9), 2893-
2901. 
 
54. Pei, T.; Widenhoefer, R. A., Palladium-Catalyzed Intramolecular Addition of 1,3-
Diones to Unactivated Olefins. J. Am. Chem. Soc. 2001, 123 (45), 11290-11291. 
 
55. Qian, H.; Pei, T.; Widenhoefer, R. A., Development, Scope, and Mechanism of the 
Palladium-Catalyzed Intramolecular Hydroalkylation of 3-Butenyl β-Diketones. 
Organometallics 2005, 24 (2), 287-301. 
 
56. McDonald, R. I.; Liu, G.; Stahl, S. S., Palladium(II)-Catalyzed Alkene 
Functionalization via Nucleopalladation: Stereochemical Pathways and 
Enantioselective Catalytic Applications. Chem. Rev. 2011, 111 (4), 2981-3019. 
 
57. Hahn, C.; Morvillo, P.; Herdtweck, E.; Vitagliano, A., Coordination of Alkenes at a 
Highly Electrophilic Site. New Dicationic Platinum(II) Complexes:  Synthesis, 
Structure, and Reactions with Nucleophiles. Organometallics 2002, 21 (9), 1807-
1818. 
 
58. Hahn, C.; Morvillo, P.; Vitagliano, A., Olefins Coordinated at a Highly Electrophilic 
Site − Dicationic Palladium(II) Complexes and Their Equilibrium Reactions with 
Nucleophiles. Eur. J. Inorg. Chem. 2001, 2001 (2), 419-429. 
 
59. Hahn, C.; Vitagliano, A.; Giordano, F.; Taube, R., Coordination of Olefins and N-
Donor Ligands at the Fragment [2,6-Bis((diphenylphosphino)methyl)pyridine]- 
palladium(II). Synthesis, Structure, and Amination of the New Dicationic Complexes 
[Pd(PNP)(CH2CHR)](BF4)2 (R = H, Ph). Organometallics 1998, 17 (10), 2060-
2066. 
 
60. Åkermark, B.; Bäckvall, J. E.; Hegedus, L. S.; Zetterberg, K.; Siirala-Hansén, K.; 
Sjöberg, K., Palladium-Promoted Addition of Amines to Isolated Double Bonds. J. 
Organomet. Chem. 1974, 72 (1), 127-138. 
 
61. Kraatz, H.-B.; Milstein, D., The Reactions of Tridentate Cationic Palladium(II) 






62. Hahn, C.; Cucciolito, M. E.; Vitagliano, A., Coordinated Olefins as Incipient 
Carbocations:  Catalytic Codimerization of Ethylene and Internal Olefins by a 
Dicationic Pt(II)−Ethylene Complex. J. Am. Chem. Soc. 2002, 124 (31), 9038-9039. 
 
63. Koh, J. H.; Gagné, M. R., PdII- and PtII-Mediated Polycyclization Reactions of 1,5- 
and 1,6-Dienes: Evidence in Support of Carbocation Intermediates. Angew. Chem. 
Int. Ed. 2004, 43 (26), 3459-3461. 
 
64. Sokol, J. G.; Korapala, C. S.; White, P. S.; Becker, J. J.; Gagné, M. R., Terminating 
Platinum-Initiated Cation-Olefin Reactions with Simple Alkenes. Angew. Chem. Int. 
Ed. 2011, 50 (25), 5658-5661. 
 
65. Nguyen, H.; Gagné, M. R., Enantioselective Cascade Cyclization/Protodemetalation 
of Polyenes with N3Pt2+ Catalysts. ACS Catalysis 2014, 4 (3), 855-859. 
 
66. Hack, D.; Blümel, M.; Chauhan, P.; Philipps, A. R.; Enders, D., Catalytic Conia-ene 
and related reactions. Chem. Soc. Rev. 2015, 44 (17), 6059-6093. 
 
67. Hegedus, L. S.; Williams, R. E.; McGuire, M. A.; Hayashi, T., Palladium-assisted 
Alkylation of Olefins. J. Am. Chem. Soc. 1980, 102 (15), 4973-4979. 
 
68. Ito, Y.; Aoyama, H.; Hirao, T.; Mochizuki, A.; Saegusa, T., Cyclization Reactions 
via Oxo-pi-allylpalladium(II) Intermediates. J. Am. Chem. Soc. 1979, 101 (2), 494-
496. 
 
69. Conia, J. M.; Le Perchec, P., The Thermal Cyclisation of Unsaturated Carbonyl 
Compounds. Synthesis 1975, 1975 (01), 1-19. 
 
70. Widenhoefer Ross, A., Palladium-catalyzed Alkylation of Unactivated Olefins. In 
Pure Appl. Chem., 2004; Vol. 76, p 671. 
 
71. Fanizzi, F. P.; Intini, F. P.; Maresca, L.; Natile, G., Irreversible Addition of Carbon 
Nucleophiles to Ethylene in Cationic Platinum(II) Complexes. J. Chem. Soc., Dalton 
Trans. 1992,  (2), 309-312. 
 
72. Bonadies, F.; Lattanzi, A.; Orelli, L. R.; Pesci, S.; Scettri, A., Lanthanides in Organic 
Synthesis: Eu+3-Catalyzed Michael Addition of 1,3- Dicarbonyl Compounds. 
Tetrahedron Lett. 1993, 34 (47), 7649-7650. 
 
73. Liu, C.; Widenhoefer, R. A., Platinum(II)/Europium(III)-Catalyzed Intramolecular 
Hydroalkylation of 4-Pentenyl β-Dicarbonyl Xompounds. Tetrahedron Lett. 2005, 
46 (2), 285-287. 
 
74. Han, X.; Wang, X.; Pei, T.; Widenhoefer, R. A., Palladium-Catalyzed Intramolecular 





the Presence of Me3SiCl or HCl. Chemistry – A European Journal 2004, 10 (24), 
6333-6342. 
 
75. Wang, X.; Pei, T.; Han, X.; Widenhoefer, R. A., Palladium-Catalyzed Intramolecular 
Hydroalkylation of Unactivated Olefins with Dialkyl Ketones. Org. Lett. 2003, 5 
(15), 2699-2701. 
 
76. Nevado, C.; Cárdenas, D. J.; Echavarren, A. M., Reaction of Enol Ethers with 
Alkynes Catalyzed by Transition Metals: 5exo-dig versus 6endo-dig Cyclizations via 
Cyclopropyl Platinum or Gold Carbene Complexes. Chemistry – A European Journal 
2003, 9 (11), 2627-2635. 
 
77. Staben, S. T.; Kennedy-Smith, J. J.; Huang, D.; Corkey, B. K.; LaLonde, R. L.; Toste, 
F. D., Gold(I)-Catalyzed Cyclizations of Silyl Enol Ethers: Application to the 
Synthesis of (+)-Lycopladine A. Angew. Chem. 2006, 118 (36), 6137-6140. 
 
78. Yamamoto, Y., From σ- to π-Electrophilic Lewis Acids. Application to Selective 
Organic Transformations. The Journal of Organic Chemistry 2007, 72 (21), 7817-
7831. 
 
79. Xiao, Y.-P.; Liu, X.-Y.; Che, C.-M., Efficient Gold(I)-Catalyzed Direct 
Intramolecular Hydroalkylation of Unactivated Alkenes with α-Ketones. Angew. 
Chem. Int. Ed. 2011, 50 (21), 4937-4941. 
 
80. Corkey, B. K.; Toste, F. D., Catalytic Enantioselective Conia-Ene Reaction. J. Am. 
Chem. Soc. 2005, 127 (49), 17168-17169. 
 
81. Yang, T.; Ferrali, A.; Campbell, L.; Dixon, D. J., Combination iminium, enamine and 
copper(i) cascade catalysis: a carboannulation for the synthesis of cyclopentenes. 
Chem. Commun. 2008,  (25), 2923-2925. 
 
82. Binder, J. T.; Crone, B.; Haug, T. T.; Menz, H.; Kirsch, S. F., Direct Carbocyclization 
of Aldehydes with Alkynes:  Combining Gold Catalysis with Aminocatalysis. Org. 
Lett. 2008, 10 (5), 1025-1028. 
 
83. Montaignac, B.; Vitale, M. R.; Ratovelomanana-Vidal, V.; Michelet, V., 
InCl3/CyNH2 Cocatalyzed Carbocyclization Reaction: An Entry to α-Disubstituted 
exo-Methylene Cyclopentanes. The Journal of Organic Chemistry 2010, 75 (23), 
8322-8325. 
 
84. Praveen, C.; Montaignac, B.; Vitale, M. R.; Ratovelomanana-Vidal, V.; Michelet, V., 
Enantioselective Merger of Aminocatalysis with π-Lewis Acid Metal Catalysis: 







85. Ito, Y.; Nakatsuka, M.; Kise, N.; Saegusa, T., Preparation of Pd(II) Enolate 
Complexes and their Reactions. Tetrahedron Lett. 1980, 21 (30), 2873-2876. 
 
86. Dénès, F.; Pérez-Luna, A.; Chemla, F., Addition of Metal Enolate Derivatives to 
Unactivated Carbon−Carbon Multiple Bonds. Chem. Rev. 2010, 110 (4), 2366-2447. 
 
87. Nakamura, M.; Hatakeyama, T.; Nakamura, E., α-Alkylation of Ketones by Addition 
of Zinc Enamides to Unactivated Olefins. J. Am. Chem. Soc. 2004, 126 (38), 11820-
11825. 
 
88. Hájek, M.; Málek, J., Radical Addition of Ketones to Alkenes Initiated by Transition 
Metal Oxides. Synthesis 1976, 5, 315-318. 
 
89. Hájek, M.; Šilhavý, P.; Málek, J., Free-Radical Addition Reactions Initiated by Metal 
Oxides. I. Anti-markovnikov Addition of Acetone to Olefins Initiated by Argentic 
Oxide. Tetrahedron Lett. 1974, 15 (36), 3193-3196. 
 
90. Citterio, A.; Ferrario, F.; De Bernardinis, S., Addition of Ketones to Olefins by Silver 
Cation-Catalyzed Decomposition of Peroxydisulfate. J. Chem. Res. (S) 1983, 12, 
310-311. 
 
91. Linker, U.; Kersten, B.; Linker, T., Potassium Permanganate-mediated Radical 
Reactions: Chemoselective Addition of Acetone to Olefins. Tetrahedron 1995, 51 
(36), 9917-9926. 
 
92. Iwahama, T.; Sakaguchi, S.; Ishii, Y., Catalytic Radical Addition of Ketones to 
Alkenes by a Metal-dioxygen Redox System. Chem. Commun. 2000,  (23), 2317-
2318. 
 
93. Wang, X.; Widenhoefer, R. A., Palladium(II)- and Platinum(II)-Catalyzed Addition 
of Stabilized Carbon Nucleophiles to Ethylene and Propylene. Chem. Commun. 2004,  
(6), 660-661. 
 
94. Han, X.; Widenhoefer, R. A., Palladium-Catalyzed Oxidative Alkoxylation of α-
Alkenyl β-Diketones To Form Functionalized Furans. The Journal of Organic 
Chemistry 2004, 69 (5), 1738-1740. 
 
95. Itoh, Y.; Tsuji, H.; Yamagata, K.-i.; Endo, K.; Tanaka, I.; Nakamura, M.; Nakamura, 
E., Efficient Formation of Ring Structures Utilizing Multisite Activation by Indium 
Catalysis. J. Am. Chem. Soc. 2008, 130 (50), 17161-17167. 
 
96. Endo, K.; Hatakeyama, T.; Nakamura, M.; Nakamura, E., Indium-Catalyzed 2-
Alkenylation of 1,3-Dicarbonyl Compounds with Unactivated Alkynes. J. Am. Chem. 





97. Fujimoto, T.; Endo, K.; Tsuji, H.; Nakamura, M.; Nakamura, E., Construction of a 
Chiral Quaternary Carbon Center by Indium-Catalyzed Asymmetric α-Alkenylation 
of β-Ketoesters. J. Am. Chem. Soc. 2008, 130 (13), 4492-4496. 
 
98. Xi, Y.; Wang, D.; Ye, X.; Akhmedov, N. G.; Petersen, J. L.; Shi, X., Synergistic 
Au/Ga Catalysis in Ambient Nakamura Reaction. Org. Lett. 2014, 16 (1), 306-309. 
 
99. Mo, F.; Dong, G., Regioselective Ketone α-Alkylation with Simple Olefins via Dual 
Activation. Science 2014, 345 (6192), 68-72. 
 
100. Mo, F.; Lim, H. N.; Dong, G., Bifunctional Ligand-Assisted Catalytic Ketone α-
Alkenylation with Internal Alkynes: Controlled Synthesis of Enones and Mechanistic 
Studies. J. Am. Chem. Soc. 2015, 137 (49), 15518-15527. 
 
101. Capacci, A. G.; Malinowski, J. T.; McAlpine, N. J.; Kuhne, J.; MacMillan, D. W. C., 
Direct, Enantioselective α-Alkylation of Aldehydes Using Simple Olefins. Nat. 
Chem. 2017, 9 (11), 1073-1077. 
 
102. Paull, D. H.; Abraham, C. J.; Scerba, M. T.; Alden-Danforth, E.; Lectka, T., 
Bifunctional Asymmetric Catalysis: Cooperative Lewis Acid/Base Systems. Acc. 
Chem. Res. 2008, 41 (5), 655-663. 
 
103. Zhong, C.; Shi, X., When Organocatalysis Meets Transition-Metal Catalysis. Eur. J. 
Org. Chem. 2010, 2010 (16), 2999-3025. 
 
104. Hamashima, Y.; Sawada, D.; Kanai, M.; Shibasaki, M., A New Bifunctional 
Asymmetric Catalysis:  An Efficient Catalytic Asymmetric Cyanosilylation of 
Aldehydes. J. Am. Chem. Soc. 1999, 121 (11), 2641-2642. 
 
105. Liu, L.; Sarkisian, R.; Xu, Z.; Wang, H., Asymmetric Michael Addition of Ketones 
to Alkylidene Malonates and Allylidene Malonates via Enamine–Metal Lewis Acid 
Bifunctional Catalysis. The Journal of Organic Chemistry 2012, 77 (17), 7693-7699. 
 
106. Xu, Z.; Daka, P.; Budik, I.; Wang, H.; Bai, F.-Q.; Zhang, H.-X., Enamine–Metal 
Lewis Acid Bifunctional Catalysis: Application to Direct Asymmetric Aldol 
Reaction of Ketones. Eur. J. Org. Chem. 2009, 2009 (27), 4581-4585. 
 
107. Xu, Z.; Liu, L.; Wheeler, K.; Wang, H., Asymmetric Inverse-Electron-Demand 
Hetero-Diels–Alder Reaction of Six-membered Cyclic Ketones: An Enamine/Metal 
Lewis Acid Bifunctional Approach. Angew. Chem. Int. Ed. 2011, 50 (15), 3484-3488. 
 
108. Wang, Y.; Chai, J.; You, C.; Zhang, J.; Mi, X.; Zhang, L.; Luo, S., π-Coordinating 
Chiral Primary Amine/Palladium Synergistic Catalysis for Asymmetric Allylic 





109. Trost, B. M.; Bartlett, M. J., ProPhenol-Catalyzed Asymmetric Additions by 
Spontaneously Assembled Dinuclear Main Group Metal Complexes. Acc. Chem. Res. 
2015, 48 (3), 688-701. 
 
110. Liu, X.; Lin, L.; Feng, X., Chiral N,N′-Dioxides: New Ligands and Organocatalysts 
for Catalytic Asymmetric Reactions. Acc. Chem. Res. 2011, 44 (8), 574-587. 
 
111. Shibasaki, M.; Matsunaga, S., Design and Application of Linked-BINOL Chiral 
ligands in Bifunctional Asymmetric Catalysis. Chem. Soc. Rev. 2006, 35 (3), 269-
279. 
 
112. Lu, L.-Q.; An, X.-L.; Chen, J.-R.; Xiao, W.-J., Dual Activation in Organocatalysis: 
Design of Tunable and Bifunctional Organocatalysts and Their Applications in 
Enantioselective Reactions. Synlett 2012,  (4), 490-508. 
 
113. Houk, K. N.; Cheong, P. H.-Y., Computational Prediction of Small-Molecule 
Catalysts. Nature 2008, 455 (7211), 309-313. 
 
114. Bogdan, A. R.; Jerome, S. V.; Houk, K. N.; James, K., Strained Cyclophane 
Macrocycles: Impact of Progressive Ring Size Reduction on Synthesis and Structure. 
J. Am. Chem. Soc. 2012, 134 (4), 2127-2138. 
 
115. Porter, J. D.; Greve, E.; Alsafran, A.; Benoit, A. R.; Lindeman, S. V.; Dockendorff, 
C., DFT-Assisted Design and Evaluation of Bifunctional Copper(I) Catalysts for the 
Direct Intermolecular Addition of Aldehydes and Ketones to Alkynes. Tetrahedron 
2018, 74 (37), 4823-4836. 
 
116. Montaignac, B.; Praveen, C.; Vitale, M. R.; Michelet, V.; Ratovelomanana-Vidal, V., 
Enantioselective metallo-organocatalyzed preparation of cyclopentanes bearing an 
all-carbon quaternary stereocenter. Chem. Commun. 2012, 48 (52), 6559-6561. 
 
117. Staben, S. T.; Kennedy-Smith, J. J.; Toste, F. D., Gold(I)-Catalyzed 5-endo-dig 
Carbocyclization of Acetylenic Dicarbonyl Compounds. Angew. Chem. Int. Ed. 
2004, 116 (40), 5350-5352. 
 
118. Kennedy-Smith, J. J.; Staben, S. T.; Toste, F. D., Gold(I)-Catalyzed Conia-Ene 
Reaction of β-Ketoesters with Alkynes. J. Am. Chem. Soc. 2004, 126 (14), 4526-
4527. 
 
119. Cucciolito, M. E.; Vitagliano, A., Intermolecular Cross-coupling Between η2-Olefin 
and η1-Allyl Ligands in Cationic Platinum(II) and Palladium(II) Complexes. 
Organometallics 2008, 27 (23), 6360-6363. 
 
120. Pierce, C. J.; Nguyen, M.; Larsen, C. H., Copper/Titanium Catalysis Forms Fully 
Substituted Carbon Centers from the Direct Coupling of Acyclic Ketones, Amines, 





121. Tang, X.; Kuang, J.; Ma, S., CuBr for KA2 Reaction: En Route to Propargylic 
Amines Bearing a Quaternary Carbon Center. Chem. Commun. 2013, 49 (79), 8976-
8978. 
 
122. Wiedenhoeft, D.; Benoit, A. R.; Porter, J. D.; Wu, Y.; Virdi, R. S.; Shanaa, A.; 
Dockendorff, C., Design and Synthesis of Oxazoline-Based Scaffolds for Hybrid 
Lewis Acid/Lewis Base Catalysis of Carbon–Carbon Bond Formation. Synthesis 
2016, 48 (15), 2413-2422. 
 
123. Wiedenhoeft, D.; Benoit, A. R.; Wu, Y.; Porter, J. D.; Meyle, E.; Yeung, T. H. W.; 
Huff, R.; Lindeman, S. V.; Dockendorff, C., Multifunctional Heterocyclic Scaffolds 
for Hybrid Lewis Acid/Lewis Base Catalysis of Carbon–Carbon Bond Formation. 
Tetrahedron 2016, 72 (27), 3905-3916. 
 
124. Montaignac, B.; Vitale, M. R.; Ratovelomanana-Vidal, V.; Michelet, V., Cooperative 
Copper(I) and Primary Amine Catalyzed Room-Temperature Carbocyclization of 
Formyl Alkynes. Eur. J. Org. Chem. 2011, 2011 (20-21), 3723-3727. 
 
125. Thomsen, I.; Pedersen, U.; Rasmussen, P. B.; Yde, B.; Andersen, T. P.; Lawesson, 
S.-O., Novel and Convenient Methods for the Preparation of Substituted Thiophenes, 
Thiazoles, and 1,3,4-Thiadiazole-2(3H)-Thiones from Bifunctional Substrates. O. 
Chem. Lett. 1983, 12 (6), 809-810. 
 
126. Sánchez, D.; Bastida, D.; Burés, J.; Isart, C.; Pineda, O.; Vilarrasa, J., Relative 
Tendency of Carbonyl Compounds To Form Enamines. Org. Lett. 2012, 14 (2), 536-
539. 
 
127. Glaser, C., Untersuchungen über einige Derivate der Zimmtsäure. Justus Liebigs 
Ann. Chem. 1870, 154 (2), 137-171. 
 
128. Trofimov, B. A.; Schmidt, E. Y.; Zorina, N. V.; Ivanova, E. V.; Ushakov, I. A., 
Transition-Metal-Free Superbase-Promoted Stereoselective α-Vinylation of Ketones 
with Arylacetylenes: A General Strategy for Synthesis of β,γ-Unsaturated Ketones. 
The Journal of Organic Chemistry 2012, 77 (16), 6880-6886. 
 
129. Greve, E.; Porter, J. D.; Dockendorff, C., DFT-Assisted Design and Evaluation of 
Bifunctional Amine/Pyridine-Oxazoline Metal Catalysts for Additions of Ketones to 
Unactivated Alkenes and Alkynes. Synthesis 2019, 51 (2), 450-462. 
 
130. Uozumi, Y.; Kato, K.; Hayashi, T., Catalytic Asymmetric Wacker-Type Cyclization. 
J. Am. Chem. Soc. 1997, 119 (21), 5063-5064. 
 
131. O'Brien, P.; A. Osborne, S.; D. Parker, D., Asymmetric Aminohydroxylation of 
Substituted Styrenes: Applications in the Synthesis of Enantiomerically Enriched 





132. Saha, A.; Yu, X. Y.; Lobera, M.; Lin, J.; Cheruku, S. R.; Becker, O.; Marantz, Y.; 
Schutz, N.; Burli, R.; Cee, V. J.; Golden, J.; Lanman, B. A.; Neira, S. Benzofurans 
and Related Compounds as S1P Receptor Modulators and their Preparation, 
Pharmaceutical Compositions and Use in the Treatment of Autoimmune and Related 
Immune Diseases. WO 2007109334 A2, Sep, 27, 2007. 
 
133. Kerins, F.; O'Shea, D. F., Generation of Substituted Styrenes via Suzuki Cross-
Coupling of Aryl Halides with 2,4,6-Trivinylcyclotriboroxane. J. Org. Chem. 2002, 
67 (14), 4968. 
 
134. Bennasar, M. L.; Roca, T.; Monerris, M.; García-Díaz, D., Sequential N-Acylamide 
Methylenation−Enamide Ring-Closing Metathesis:  Construction of Benzo-Fused 
Nitrogen Heterocycles. The Journal of Organic Chemistry 2006, 71 (18), 7028-7034. 
 
135. Scott, I. L.; Kuksa, V. A.; Orme, M. W.; Little, T.; Gall, A.; Gage, J.; Hong, F. 
Preparation of Alkynylphenyl Derivatives for use in Treating Ophthalmic Diseases. 
WO 2008US08169, 2009. 
 
136. Molander, G. A.; Brown, A. R., Suzuki—Miyaura Cross-Coupling Reactions of 
Potassium Vinyltrifluoroborate with Aryl and Heteroaryl Electrophiles. J. Org. 
Chem. 2006, 71 (26), 9681-9686. 
 
137. Wang, H.-Y.; Huang, K.; De Jesús, M.; Espinosa, S.; Piñero-Santiago, L. E.; Barnes, 
C. L.; Ortiz-Marciales, M., Synthesis of Enantiopure 1,2-Azido and 1,2-Amino 
Alcohols via Regio- and Stereoselective Ring-opening of Enantiopure Epoxides by 
Sodium Azide in Hot Water. Tetrahedron: Asymmetry 2016, 27 (2–3), 91-100. 
 
138. Lal, G. S.; Pez, G. P.; Pesaresi, R. J.; Prozonic, F. M.; Cheng, H., Bis(2-
methoxyethyl)aminosulfur Trifluoride:  A New Broad-Spectrum Deoxofluorinating 
Agent with Enhanced Thermal Stability. The Journal of Organic Chemistry 1999, 64 
(19), 7048-7054. 
 
139. Phillips, A. J.; Uto, Y.; Wipf, P.; Reno, M. J.; Williams, D. R., Synthesis of 
Functionalized Oxazolines and Oxazoles with DAST and Deoxo-Fluor. Org. Lett. 
2000, 2 (8), 1165-1168. 
 
140. Stork, G.; Brizzolara, A.; Landesman, H.; Szmuszkovicz, J.; Terrell, R., The Enamine 
Alkylation and Acylation of Carbonyl Compounds. J. Am. Chem. Soc. 1963, 85 (2), 
207-222. 
 
141. de Renzi, A.; Panunzi, A.; Vitagliano, A.; Paiaro, G., Catalytic dimerisation of olefins 
by a cationic platinum(II) complex. J. Chem. Soc., Chem. Commun. 1976,  (2), 47-
47. 
 
142. Sen, A.; Lai, T.-W., Catalysis by Solvated Transition-Metal Cations. Novel Catalytic 





Evidence for the Formation of Incipient Carbonium Ions as Intermediates. J. Am. 
Chem. Soc. 1981, 103 (15), 4627-4629. 
 
143. Albietz, P. J.; Yang, K.; Lachicotte, R. J.; Eisenberg, R., Cationic Unsymmetrical 
1,4-Diazabutadiene Complexes of Platinum(II). Organometallics 2000, 19 (18), 
3543-3555. 
 
144. Hu, X., Nickel-Catalyzed Cross Coupling of non-Activated Alkyl Halides: A 
Mechanistic Perspective. Chemical Science 2011, 2 (10), 1867-1886. 
 
145. Stark, M. A.; Richards, C. J., Synthesis and application of cationic 2,6-bis(2-
oxazolinyl)phenylpalladium(II) complexes. Tetrahedron Lett. 1997, 38 (33), 5881-
5884. 
 
146. Denmark, S. E.; Stavenger, R. A.; Faucher, A.-M.; Edwards, J. P., Cyclopropanation 
with Diazomethane and Bis(oxazoline)palladium(II) Complexes. The Journal of 
Organic Chemistry 1997, 62 (10), 3375-3389. 
 
147. Nishiyama, H.; Yamaguchi, S.; Kondo, M.; Itoh, K., Electronic Substituent Effect of 
Nitrogen Ligands in Catalytic Asymmetric Hydrosilylation of Ketones: Chiral 4-
Substituted Bis(oxazolinyl)pyridines. The Journal of Organic Chemistry 1992, 57 
(15), 4306-4309. 
 
148. Nesper, R.; Pregosin, P.; Püntener, K.; Wörle, M.; Albinati, A., Palladium(II) 
complexes of chiral tridentate nitrogen pybox ligands. J. Organomet. Chem. 1996, 
507 (1), 85-101. 
 
149. Geier, M. J.; Gagné, M. R., Diastereoselective Pt Catalyzed Cycloisomerization of 
Polyenes to Polycycles. J. Am. Chem. Soc. 2014, 136 (8), 3032-3035. 
 
150. Greve, E.; Porter, J. D.; Dockendorff, C., Computationally-Guided Investigation of 
Dual Amine/pi Lewis Acid Catalysts for Direct Additions of Aldehydes and Ketones 
to Unactivated Alkenes and Alkynes. ChemistrySelect 2020, 5 (28), 8405-8414. 
 
151. Hahn, C., Enhancing Electrophilic Alkene Activation by Increasing the Positive Net 
Charge in Transition-Metal Complexes and Application in Homogeneous Catalysis. 
Chemistry – A European Journal 2004, 10 (23), 5888-5899. 
 
152. Marigo, M.; Wabnitz, T. C.; Fielenbach, D.; Jørgensen, K. A., Enantioselective 
Organocatalyzed α Sulfenylation of Aldehydes. Angew. Chem. Int. Ed. 2005, 44 (5), 
794-797. 
 
153. Bugarin, A.; Connell, B. T., Chiral Nickel(II) and Palladium(II) NCN-Pincer 
Complexes Based on Substituted Benzene: Synthesis, Structure, and Lewis Acidity. 






154. Shiomi, T.; Ito, J.-i.; Yamamoto, Y.; Nishiyama, H., 4-Substituted-
Phenyl(bisoxazoline)-Rhodium Complexes: Efficiency in the Catalytic Asymmetric 
Reductive Aldol Reaction. Eur. J. Org. Chem. 2006, 2006 (24), 5594-5600. 
 
155. Park, S.-B.; Murata, K.; Matsumoto, H.; Nishiyama, H., Remote Electronic Control 
in Asymmetric Cyclopropanation with Chiral Ru-Pybox Catalysts. Tetrahedron: 
Asymmetry 1995, 6 (10), 2487-2494. 
 
156. Felix, R. J.; Munro-Leighton, C.; Gagné, M. R., Electrophilic Pt(II) Complexes: 
Precision Instruments for the Initiation of Transformations Mediated by the Cation-
Olefin Reaction. Acc. Chem. Res. 2014, 47 (8), 2319-2331. 
 
157. Bootsma, A. N.; Wheeler, S., Popular Integration Grids Can Result in Large Errors 
in DFT-Computed Free Energies. ChemRxiv (preprint) 2019, 
https://doi.org/10.26434/chemrxiv.8864204.v5. 
 
158. Kowacs, T.; O’Reilly, L.; Pan, Q.; Huijser, A.; Lang, P.; Rau, S.; Browne, W. R.; 
Pryce, M. T.; Vos, J. G., Subtle Changes to Peripheral Ligands Enable High Turnover 
Numbers for Photocatalytic Hydrogen Generation with Supramolecular 
Photocatalysts. Inorg. Chem. 2016, 55 (6), 2685-2690. 
 
159. Porter, J. D. Hybrid Catalysis for the Direct Addition of Unactivated Aldehydes and 
Ketones to Alkenes and Alkynes. Marquette University, Milwaukee, WI, 2019. 
 
160. Hatahet, F.; Ruddock, L. W., Protein Disulfide Isomerase: A Critical Evaluation of 
Its Function in Disulfide Bond Formation. Antioxid. Redox Signal. 2009, 11 (11), 
2807-2850. 
 
161. Wang, C.; Li, W.; Ren, J.; Fang, J.; Ke, H.; Gong, W.; Feng, W.; Wang, C. C., 
Structural Insights into the Redox-Regulated Dynamic Conformations of Human 
Protein Disulfide Isomerase. Antioxid. Redox Signal. 2013, 19 (1), 36-45. 
 
162. Xu, S.; Sankar, S.; Neamati, N., Protein Disulfide Isomerase: A Promising Target for 
Cancer Therapy. Drug Discov. Today 2014, 19 (3), 222-240. 
 
163. Flaumenhaft, R., Advances in Vascular Thiol Isomerase Function. Curr. Opin. 
Hematol. 2017, 24 (5). 
 
164. Cho, J.; Furie, B. C.; Coughlin, S. R.; Furie, B., A Critical Role for Extracellular 
Protein Disulfide Isomerase During Thrombus Formation in Mice. J. Clin. Investig. 
2008, 118 (3), 1123-1131. 
 
165. Reinhardt, C.; von Brühl, M.-L.; Manukyan, D.; Grahl, L.; Lorenz, M.; Altmann, B.; 
Dlugai, S.; Hess, S.; Konrad, I.; Orschiedt, L.; Mackman, N.; Ruddock, L.; Massberg, 





that Enhances Fibrin Generation via Tissue Factor Activation. J. Clin. Investig. 2008, 
118 (3), 1110-1122. 
 
166. Jasuja, R.; Passam, F. H.; Kennedy, D. R.; Kim, S. H.; van Hessem, L.; Lin, L.; 
Bowley, S. R.; Joshi, S. S.; Dilks, J. R.; Furie, B.; Furie, B. C.; Flaumenhaft, R., 
Protein Disulfide Isomerase Inhibitors Constitute a New Class of Antithrombotic 
Agents. J. Clin. Investig. 2012, 122 (6), 2104-2113. 
 
167. Kim, K.; Hahm, E.; Li, J.; Holbrook, L.-M.; Sasikumar, P.; Stanley, R. G.; Ushio-
Fukai, M.; Gibbins, J. M.; Cho, J., Platelet Protein Disulfide Isomerase is Required 
for Thrombus Formation but not for Hemostasis in Mice. Blood 2013, 122 (6), 1052-
1061. 
 
168. Bekendam, R. H.; Bendapudi, P. K.; Lin, L.; Nag, P. P.; Pu, J.; Kennedy, D. R.; 
Feldenzer, A.; Chiu, J.; Cook, K. M.; Furie, B.; Huang, M.; Hogg, P. J.; Flaumenhaft, 
R., A Substrate-driven Allosteric Switch that Enhances PDI Catalytic Activity. Nat. 
Commun. 2016, 7, 12579. 
 
169. Mandel, R.; Ryser, H. J.; Ghani, F.; Wu, M.; Peak, D., Inhibition of a Reductive 
Function of the Plasma Membrane by Bacitracin and Antibodies Against Protein 
Disulfide-Isomerase. Proceedings of the National Academy of Sciences 1993, 90 (9), 
4112. 
 
170. Lovat, P. E.; Corazzari, M.; Armstrong, J. L.; Martin, S.; Pagliarini, V.; Hill, D.; 
Brown, A. M.; Piacentini, M.; Birch-Machin, M. A.; Redfern, C. P. F., Increasing 
Melanoma Cell Death Using Inhibitors of Protein Disulfide Isomerases to Abrogate 
Survival Responses to Endoplasmic Reticulum Stress. Cancer Res. 2008, 68 (13), 
5363. 
 
171. Karala, A.-R.; Ruddock, L. W., Bacitracin Is Not a Specific Inhibitor of Protein 
Disulfide Isomerase. The FEBS Journal 2010, 277 (11), 2454-2462. 
 
172. Khan, M. M. G.; Simizu, S.; Lai, N. S.; Kawatani, M.; Shimizu, T.; Osada, H., 
Discovery of a Small Molecule PDI Inhibitor That Inhibits Reduction of HIV-1 
Envelope Glycoprotein gp120. ACS Chem. Biol. 2011, 6 (3), 245-251. 
 
173. Zwicker, J. I.; Schlechter, B. L.; Stopa, J. D.; Liebman, H. A.; Aggarwal, A.; 
Puligandla, M.; Caughey, T.; Bauer, K. A.; Kuemmerle, N.; Wong, E.; Wun, T.; 
McLaughlin, M.; Hidalgo, M.; Neuberg, D.; Furie, B.; Flaumenhaft, R., Targeting 
Protein Disulfide Isomerase with the Flavonoid Isoquercetin to Improve 
Hypercoagulability in Advanced Cancer. JCI Insight 2019, 4 (4). 
 
174. Khodier, C.; VerPlank, L.; Nag, P. P.; Pu, J.; Wurst, J.; Pilyugina, T.; Dockendorff, 
C.; Galinski, C. N.; Scalise, A. A.; Passam, F.; Hessem, L. v.; Dilks, J.; Kennedy, D. 





Identification of ML359 as a Small Molecule Inhibitor of Protein Disulfide 
Isomerase. https://www.ncbi.nlm.nih.gov/books/NBK189925/. 
 
175. Claisen, L.; Meyer, K., Ueber das Amid der Acetessigsäure. Ber. Dtsch. Chem. Ges. 
1902, 35 (1), 583-584. 
 
176. Sørensen, U. S.; Falch, E.; Krogsgaard-Larsen, P., A Novel Route to 5-Substituted 3-
Isoxazolols. Cyclization of N,O-DiBoc β-Keto Hydroxamic Acids Synthesized via 
Acyl Meldrum's Acids. J. Org. Chem. 2000, 65 (4), 1003-1007. 
 
177. Witzeman, J. S.; Nottingham, W. D., Transacetoacetylation with tert-butyl 
acetoacetate: synthetic applications. J. Org. Chem. 1991, 56 (5), 1713-1718. 
 
178. Kim, H. O.; Olsen, R. K.; Choi, O. S., Copper(I)-promoted Condensation of .alpha.-
amino Acids with .beta.-keto Thio Esters: Synthesis of N-acylated L-leucine 
Derivatives Containing (S)-4-Hydroxy-5-methyl- and (S)-4-Hydroxy-2,5-dimethyl-
3-oxohexanoic acid. J. Org. Chem. 1987, 52 (20), 4531-4536. 
 
179. Hoffmann, R. V.; Huizenga, D. J., A Simple Synthesis of 2,3-Diketo Amides from 
3-Keto Amides. J. Org. Chem. 1991, 56 (22), 6435-6439. 
 
180. García, M. J.; Rebolledo, F.; Gotor, V., Lipase-catalyzed Aminolysis and 
Ammonolysis of β-Ketoesters. Synthesis of Optically Active β-Ketoamides. 
Tetrahedron 1994, 50 (23), 6935-6940. 
 
181. Kumar, P.; Pandey, R. K., A Facile and Selective Procedure for Transesterification 
of β-Keto Esters Promoted by Yttria-Zirconia Based Lewis Acid Catalyst. Synlett 
2000,  (2), 251-253. 
 
182. Vandavasi, J. K.; Hsiao, C.-T.; Hu, W.-P.; Boominathan, S. S. K.; Wang, J.-J., 
Silver(I)-Catalyzed Tandem Approach to β-Oxo Amides. Eur. J. Org. Chem. 2015, 
2015 (14), 3171-3177. 
 
183. Gramain, J. C.; Remuson, R.; Vallee, D., Intramolecular Photoreduction of .alpha.-
keto Esters. Total Synthesis of (.+-.)-Isoretronecanol. J. Org. Chem. 1985, 50 (5), 
710-712. 
 
184. Kuzma, P. C.; Brown, L. E.; Harris, T. M., Generation of the Dianion of N-
(Trimethylsilyl)acetamide and Reaction of the Dianion with Electrophilic Reagents. 
J. Org. Chem. 1984, 49 (11), 2015-2018. 
 
185. Chen, L.; Dovalsantos, E.; Yu, J.; O'Neill-Slawecki, S.; Mitchell, M.; Sakata, S.; 
Borer, B., A Simple Preparation of a (Pyridonyl-1)propargylacetic Acid Derivative. 






186. Nicolaou, K. C.; Estrada, A. A.; Zak, M.; Lee, S. H.; Safina, B. S., A Mild and 
Selective Method for the Hydrolysis of Esters with Trimethyltin Hydroxide. Angew. 
Chem. Int. Ed. 2005, 44 (9), 1378-1382. 
 
187. Goodreid, J. D.; Duspara, P. A.; Bosch, C.; Batey, R. A., Amidation Reactions from 
the Direct Coupling of Metal Carboxylate Salts with Amines. J. Org. Chem. 2014, 
79 (3), 943-954. 
 
188. Tirpak, R. E.; Olsen, R. S.; Rathke, M. W., Carboxylation of Ketones using 
Triethylamine and Magnesium Halides. J. Org. Chem. 1985, 50 (24), 4877-4879. 
 
189. Li, H.; He, Z.; Guo, X.; Li, W.; Zhao, X.; Li, Z., Iron-Catalyzed Selective Oxidation 
of N-Methyl Amines: Highly Efficient Synthesis of Methylene-Bridged bis-1,3-
Dicarbonyl Compounds. Org. Lett. 2009, 11 (18), 4176-4179. 
 
190. Pericas, À.; Shafir, A.; Vallribera, A., Zinc(II) Oxide: An Efficient Catalyst for 
Selective Transesterification of β-Ketoesters. Tetrahedron 2008, 64 (39), 9258-9263. 
 
191. Meshram, H. M.; Reddy, P. N.; Sadashiv, K.; Yadav, J. S., Amberlyst-15®-Promoted 
Efficient 2-Halogenation of 1,3-Keto-esters and Cyclic Ketones using N-
Halosuccinimides. Tetrahedron Lett. 2005, 46 (4), 623-626. 
 
192. Štefane, B.; Polanc, S., A New Regio- and Chemoselective Approach to β-Keto 
Amides and β-Enamino Carboxamides via 1,3,2-Dioxaborinanes. Synlett  (04). 
 
193. Courtney, S.; Yarnold, C.; Flanagan, S.; Brace, G.; Barker, J.; Ichihara, O.; 
Gadouleau, E.; Richardson, A.; Kondo, T.; Imagawa, A.; Nakatani, S.; Suzuki, R.; 
Kouyama, S., Pyridinone and pyrimidinone derivatives as factor xia inhibitors. 2013, 
WO2013093484A1. 
 
194. Kattamuri, P. V.; Yin, J.; Siriwongsup, S.; Kwon, D.-H.; Ess, D. H.; Li, Q.; Li, G.; 
Yousufuddin, M.; Richardson, P. F.; Sutton, S. C.; Kürti, L., Practical Singly and 
Doubly Electrophilic Aminating Agents: A New, More Sustainable Platform for 
Carbon–Nitrogen Bond Formation. J. Am. Chem. Soc. 2017, 139 (32), 11184-11196. 
 
195. Goujon, J.-Y.; Shipman, M., Concise route to α-acylamino-β-keto amides: 
application to the synthesis of a simplified azinomycin A analogue. Tetrahedron Lett. 
2002, 43 (52), 9573-9576. 
 
196. Micale, N.; Ettari, R.; Lavecchia, A.; Di Giovanni, C.; Scarbaci, K.; Troiano, V.; 
Grasso, S.; Novellino, E.; Schirmeister, T.; Zappalà, M., Development of 
Peptidomimetic Boronates as Proteasome Inhibitors. Eur. J. Med. Chem. 2013, 64, 
23-34. 
 
197. Lodh, R. S.; Borah, A. J.; Phukan, P., Synthesis of Bromohydrins using NBS in 





198. Mercadante, M. A.; Kelly, C. B.; Bobbitt, J. M.; Tilley, L. J.; Leadbeater, N. E., 
Synthesis of 4-Acetamido-2,2,6,6-tetramethylpiperidine-1-oxoammonium 
Tetrafluoroborate and 4-Acetamido-(2,2,6,6-tetramethyl-piperidin-1-yl)oxyl and 
their use in Oxidative Reactions. Nat. Protoc. 2013, 8 (4), 666-676. 
 
199. Prévost, C., Sur un Complexe Iodo-argento-benzoïque et son Application à 
l'oxydation des Combinaisons éthyléniques en α-Glycols. Comptes rendus. 1933, 
196, 1129-1131. 
 
200. Woodward, R. B.; Brutcher, F. V., cis-Hydroxylation of a Synthetic Steroid 
Intermediate with Iodine, Silver Acetate and Wet Acetic Acid. J. Am. Chem. 1958, 
80 (1), 209-211. 
 
201. Easton, C. J.; Hutton, C. A.; Eng, W. T.; Tiekink, E. R. T., Synthesis of Homochiral 
Hydroxy-α-amino Acid Derivatives. Tetrahedron Lett. 1990, 31 (48), 7059-7062. 
 
202. Suyama, T. L.; Gerwick, W. H.; McPhail, K. L., Survey of Marine Natural Product 
Structure Revisions: A Synergy of Spectroscopy and Chemical Synthesis. Bioorg. 
Med. Chem. 2011, 19 (22), 6675-6701. 
 
203. Jacob, N. T.; Lockner, J. W.; Kravchenko, V. V.; Janda, K. D., Pharmacophore 
Reassignment for Induction of the Immunosurveillance Cytokine TRAIL. Angew. 
Chem. Int. Ed. 2014, 53 (26), 6628-6631. 
 
204. Hanwell, M. D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; 
Hutchison, G. R., Avogadro: An Advanced Semantic Chemical Editor, Visualization, 
and Analysis Platform. J. Cheminform. 2012, 4 (1), 17. 
 
205. Feng, B.; Li, Y.; Li, H.; Zhang, X.; Xie, H.; Cao, H.; Yu, L.; Xu, Q., Specific N-
Alkylation of Hydroxypyridines Achieved by a Catalyst- and Base-Free Reaction 
with Organohalides. The Journal of Organic Chemistry 2018, 83 (12), 6769-6775. 
 
206. Li, H.; He, Z.; Guo, X.; Li, W.; Zhao, X.; Li, Z., Iron-Catalyzed Selective Oxidation 
of N-Methyl Amines: Highly Efficient Synthesis of Methylene-Bridged bis-1,3-
Dicarbonyl Compounds. Org. Lett. 2009, 11 (18), 4176-4179. 
 
207. Howard, J. L.; Sagatov, Y.; Browne, D. L., Mechanochemical Electrophilic 
Fluorination of Liquid Beta-ketoesters. Tetrahedron 2018, 74 (25), 3118-3123. 
 
208. Katritzky, A. R.; Sengupta, S., Facile Desilylative Hydroxyalkylation and Acylation 
of 1-Trimethylsilylmethyl-2-pyridone. Tetrahedron Lett. 1987, 28 (45), 5419-5422. 
 






210. Iimura, S.; Muro, F.; Yamasaki, T.; Hamada, T., Preparation of Imidazopyridazine 
Derivatives having Inhibitory Activity on the Production of TNF-α. 2009, 
WO2009041456. 
 
211. Zhang, J.; Wang, J.; Qiu, Z.; Wang, Y., Highly Regio- and Diastereoselective 
Halohydroxylation of Plefins: A Facile Synthesis of Vicinal Halohydrins. 
Tetrahedron 2011, 67 (36), 6859-6867. 
 
212. Cussó, O.; Garcia-Bosch, I.; Ribas, X.; Lloret-Fillol, J.; Costas, M., Asymmetric 
Epoxidation with H2O2 by Manipulating the Electronic Properties of Non-heme Iron 
Catalysts. J. Am. Chem. Soc. 2013, 135 (39), 14871-14878. 
 
213. Guindon, Y.; Rancourt, J., The Use of Lewis Acids in Radical Chemistry. Chelation-
Controlled Radical Reductions of Substituted α-Bromo-β-alkoxy Esters and 
Chelation-Controlled Radical Addition Reactions. The Journal of Organic Chemistry 
1998, 63 (19), 6554-6565. 
 
214. Anand, N.; Kapoor, M.; Koul, S.; Taneja, S. C.; Sharma, R. L.; Qazi, G. N., 
Chemoenzymatic Approach to Optically Active Phenylglycidates: Resolution of 
Bromo- and Iodohydrins. Tetrahedron: Asymmetry 2004, 15 (19), 3131-3138. 
 
215. Palomo, C.; Aizpurua, J. M.; Balentová, E.; Jimenez, A.; Oyarbide, J.; Fratila, R. M.; 
Miranda, J. I., Synthesis of β-Lactam Scaffolds for Ditopic Peptidomimetics. Org. 
Lett. 2007, 9 (1), 101-104. 
 
